No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 3gw9B, 1.0000, 0.00, 1.000, 449, 449, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI BOUND TO AN INHIBITOR N-(1-(24- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-13 4-OXAZIAZOL-2-YL)BENZAMIDE
2, 4g3jB, 0.9971, 0.19, 1.000, 448, 448, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(24-DICHLOROPHENYL)-2-(1H-124- TRIAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [R- VNI-TRIAZOLE (VNT)]
3, 3tikD, 0.9965, 0.46, 1.000, 450, 449, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE TIPIFARNIB DERIVATIVE 6-((4-CHLOROPHENYL)(METHOXY)(1-METHYL- 1H-IMIDAZOL-5-YL)METHYL)-4-(26-DIFLUOROPHENYL)-1-METHYLQUINOLIN- 2(1H)-ONE
4, 3gw9D, 0.9955, 0.52, 1.000, 449, 449, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI BOUND TO AN INHIBITOR N-(1-(24- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-13 4-OXAZIAZOL-2-YL)BENZAMIDE
5, 3g1qA, 0.9952, 0.39, 1.000, 448, 448, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN LIGAND FREE STATE
6, 3tikC, 0.9951, 0.57, 1.000, 450, 449, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE TIPIFARNIB DERIVATIVE 6-((4-CHLOROPHENYL)(METHOXY)(1-METHYL- 1H-IMIDAZOL-5-YL)METHYL)-4-(26-DIFLUOROPHENYL)-1-METHYLQUINOLIN- 2(1H)-ONE
7, 4g7gA, 0.9950, 0.40, 1.000, 448, 448, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(34 -DIFLUOROBIPHENYL-4-YL)-2-(1H- IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [VNI/VNF (VFV)]
8, 3tikA, 0.9939, 0.62, 1.000, 450, 449, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE TIPIFARNIB DERIVATIVE 6-((4-CHLOROPHENYL)(METHOXY)(1-METHYL- 1H-IMIDAZOL-5-YL)METHYL)-4-(26-DIFLUOROPHENYL)-1-METHYLQUINOLIN- 2(1H)-ONE
9, 4g3jC, 0.9934, 0.51, 1.000, 448, 448, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(24-DICHLOROPHENYL)-2-(1H-124- TRIAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [R- VNI-TRIAZOLE (VNT)]
10, 4g7gD, 0.9928, 0.55, 1.000, 448, 448, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(34 -DIFLUOROBIPHENYL-4-YL)-2-(1H- IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [VNI/VNF (VFV)]
11, 4g7gC, 0.9927, 0.55, 1.000, 448, 448, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(34 -DIFLUOROBIPHENYL-4-YL)-2-(1H- IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [VNI/VNF (VFV)]
12, 3g1qD, 0.9922, 0.59, 1.000, 448, 448, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN LIGAND FREE STATE
13, 3gw9A, 0.9920, 0.70, 1.000, 450, 449, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI BOUND TO AN INHIBITOR N-(1-(24- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-13 4-OXAZIAZOL-2-YL)BENZAMIDE
14, 3tikB, 0.9912, 0.80, 1.000, 450, 449, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE TIPIFARNIB DERIVATIVE 6-((4-CHLOROPHENYL)(METHOXY)(1-METHYL- 1H-IMIDAZOL-5-YL)METHYL)-4-(26-DIFLUOROPHENYL)-1-METHYLQUINOLIN- 2(1H)-ONE
15, 4g3jD, 0.9909, 0.64, 1.000, 448, 448, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(24-DICHLOROPHENYL)-2-(1H-124- TRIAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [R- VNI-TRIAZOLE (VNT)]
16, 4g7gB, 0.9900, 0.68, 1.000, 448, 448, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(34 -DIFLUOROBIPHENYL-4-YL)-2-(1H- IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [VNI/VNF (VFV)]
17, 3p99D, 0.9887, 0.73, 1.000, 448, 448, STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH DELTA7-14ALPHA-METHYLENE-CYCLOPROPYL-DIHYDROLANOSTEROL
18, 4bjkC, 0.9885, 0.85, 0.991, 450, 449, CYP51 OF TRYPANOSOMA BRUCEI BOUND TO (S)-N-(3-(1H-INDOL-3- YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-( 11 -BIPHENYL)-4-CARBOXAMIDE
19, 4g3jA, 0.9883, 0.76, 1.000, 448, 448, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(24-DICHLOROPHENYL)-2-(1H-124- TRIAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [R- VNI-TRIAZOLE (VNT)]
20, 3p99A, 0.9883, 0.74, 1.000, 448, 448, STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH DELTA7-14ALPHA-METHYLENE-CYCLOPROPYL-DIHYDROLANOSTEROL
21, 3gw9C, 0.9877, 1.02, 1.000, 449, 449, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI BOUND TO AN INHIBITOR N-(1-(24- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-13 4-OXAZIAZOL-2-YL)BENZAMIDE
22, 4bjkA, 0.9870, 0.92, 0.991, 450, 449, CYP51 OF TRYPANOSOMA BRUCEI BOUND TO (S)-N-(3-(1H-INDOL-3- YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-( 11 -BIPHENYL)-4-CARBOXAMIDE
23, 3p99B, 0.9862, 0.83, 1.000, 448, 448, STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH DELTA7-14ALPHA-METHYLENE-CYCLOPROPYL-DIHYDROLANOSTEROL
24, 4ck8A, 0.9842, 0.93, 0.848, 449, 448, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH (R)-1-(24-DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL 4-(4-(34-DICHLOROPHENYL)PIPERAZIN-1-YL)PHENYLCARBAMATE (LFD)
25, 4ck8B, 0.9840, 0.95, 0.848, 450, 448, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH (R)-1-(24-DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL 4-(4-(34-DICHLOROPHENYL)PIPERAZIN-1-YL)PHENYLCARBAMATE (LFD)
26, 4bjkB, 0.9833, 1.06, 0.991, 450, 449, CYP51 OF TRYPANOSOMA BRUCEI BOUND TO (S)-N-(3-(1H-INDOL-3- YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-( 11 -BIPHENYL)-4-CARBOXAMIDE
27, 3g1qC, 0.9830, 0.70, 1.000, 447, 445, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN LIGAND FREE STATE
28, 2x2nA, 0.9822, 0.92, 0.987, 448, 447, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH POSACONAZOLE IN TWO DIFFERENT CONFORMATIONS
29, 3p99C, 0.9807, 0.71, 1.000, 444, 444, STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH DELTA7-14ALPHA-METHYLENE-CYCLOPROPYL-DIHYDROLANOSTEROL
30, 5ajrA, 0.9803, 1.07, 0.848, 449, 448, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH THE 1-TETRAZOLE DERIVATIVE VT-1161 ((R)-2-( 24-DIFLUOROPHENYL)-11-DIFLUORO-3-(1H-TETRAZOL-1-YL)-1-(5- (4-(222-TRIFLUOROETHOXY)PHENYL)PYRIDIN-2-YL)PROPAN-2-OL)
31, 3zg2A, 0.9796, 1.01, 0.850, 449, 447, STEROL 14 ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH THE PYRIDINE INHIBITOR (S)-2-(4-CHLOROPHENYL)-2- (PYRIDIN-3-YL)-1-(4-(4-(TRIFLUOROMETHYL)PHENYL)PIPERAZIN-1-YL) ETHANONE (EPL-BS1246UDO)
32, 3g1qB, 0.9796, 0.74, 1.000, 444, 444, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN LIGAND FREE STATE
33, 2wv2A, 0.9783, 0.73, 0.995, 443, 443, X-RAY STRUCTURE OF CYP51 FROM THE HUMAN PATHOGEN TRYPANOSOMA BRUCEI IN COMPLEX WITH FLUCONAZOLE
34, 2x2nD, 0.9781, 1.07, 0.987, 447, 447, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH POSACONAZOLE IN TWO DIFFERENT CONFORMATIONS
35, 2x2nB, 0.9742, 0.97, 0.989, 444, 444, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH POSACONAZOLE IN TWO DIFFERENT CONFORMATIONS
36, 3l4dA, 0.9733, 1.24, 0.790, 448, 447, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM LEISHMANIA INFANTUM IN COMPLEX WITH FLUCONAZOLE
37, 4c0cA, 0.9721, 1.11, 0.861, 446, 445, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-4-(4-(24-DIFLUOROPHENYL)PIPERAZIN-1- YL)-2-FLUOROBENZAMIDE.
38, 4bjkD, 0.9710, 1.01, 0.993, 444, 443, CYP51 OF TRYPANOSOMA BRUCEI BOUND TO (S)-N-(3-(1H-INDOL-3- YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-( 11 -BIPHENYL)-4-CARBOXAMIDE
39, 3l4dB, 0.9708, 1.30, 0.790, 449, 447, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM LEISHMANIA INFANTUM IN COMPLEX WITH FLUCONAZOLE
40, 3zg3A, 0.9705, 1.14, 0.851, 445, 444, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH THE PYRIDINE INHIBITOR N-(1-(5-( TRIFLUOROMETHYL)(PYRIDIN-2-YL))PIPERIDIN-4YL)-N-(4-( TRIFLUOROMETHYL)PHENYL)PYRIDIN-3-AMINE (EPL-BS967 UDD)
41, 4bmmD, 0.9702, 0.96, 0.860, 442, 442, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)- 2 35 -TRIFLUORO-(11 -BIPHENYL)-4-CARBOXAMIDE
42, 4bmmB, 0.9702, 0.95, 0.862, 442, 442, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)- 2 35 -TRIFLUORO-(11 -BIPHENYL)-4-CARBOXAMIDE
43, 4bmmA, 0.9702, 0.87, 0.862, 441, 441, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)- 2 35 -TRIFLUORO-(11 -BIPHENYL)-4-CARBOXAMIDE
44, 4by0A, 0.9693, 0.93, 0.862, 441, 441, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-(11 -BIPHENYL)-4- CARBOXAMIDE
45, 4by0B, 0.9687, 1.02, 0.860, 442, 442, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-(11 -BIPHENYL)-4- CARBOXAMIDE
46, 3l4dC, 0.9684, 1.33, 0.791, 447, 446, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM LEISHMANIA INFANTUM IN COMPLEX WITH FLUCONAZOLE
47, 4uqhA, 0.9672, 1.05, 0.862, 443, 442, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-4-(4-(34-DIFLUOROPHENYL)PIPERAZIN-1- YL)-2-FLUOROBENZAMIDE.
48, 4c27A, 0.9671, 1.36, 0.856, 444, 443, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-2- FLUORO-4-(4-(4-(TRIFLUOROMETHYL)PHENYL)PIPERAZIN-1-YL)BENZAMIDE
49, 4c28A, 0.9670, 1.37, 0.856, 443, 443, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-4-(4-(4-CHLOROPHENYL)PIPERAZIN-1-YL)- 2-FLUOROBENZAMIDE.
50, 2x2nC, 0.9668, 0.99, 0.991, 441, 441, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH POSACONAZOLE IN TWO DIFFERENT CONFORMATIONS
51, 2wuzA, 0.9667, 1.07, 0.853, 444, 442, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA CRUZI IN COMPLEX WITH FLUCONAZOLE IN ALTERNATIVE CONFORMATION
52, 3l4dD, 0.9660, 1.16, 0.792, 445, 443, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM LEISHMANIA INFANTUM IN COMPLEX WITH FLUCONAZOLE
53, 4c27B, 0.9655, 1.32, 0.857, 443, 442, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-2- FLUORO-4-(4-(4-(TRIFLUOROMETHYL)PHENYL)PIPERAZIN-1-YL)BENZAMIDE
54, 3k1oA, 0.9649, 1.17, 0.855, 442, 442, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH A POTENTIAL ANTICHAGASIC DRUG POSACONAZOLE
55, 4bmmC, 0.9641, 1.01, 0.861, 440, 440, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)- 2 35 -TRIFLUORO-(11 -BIPHENYL)-4-CARBOXAMIDE
56, 4c28B, 0.9637, 1.31, 0.855, 441, 441, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-4-(4-(4-CHLOROPHENYL)PIPERAZIN-1-YL)- 2-FLUOROBENZAMIDE.
57, 2wuzB, 0.9635, 1.03, 0.855, 444, 440, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA CRUZI IN COMPLEX WITH FLUCONAZOLE IN ALTERNATIVE CONFORMATION
58, 4uvrA, 0.9628, 0.99, 0.861, 439, 439, BINDING MODE SELECTIVITY AND POTENCY OF N-INDOLYL- OXOPYRIDINYL-4-AMINO-PROPANYL-BASED INHIBITORS TARGETING TRYPANOSOMA CRUZI CYP51
59, 4cohB, 0.9572, 1.64, 0.855, 445, 442, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE SULFONAMIDE DERIVATIVE OF THE 4-AMINOPYRIDYL-BASED INHIBITOR
60, 4cohA, 0.9564, 1.61, 0.857, 442, 441, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE SULFONAMIDE DERIVATIVE OF THE 4-AMINOPYRIDYL-BASED INHIBITOR
61, 4ckaA, 0.9537, 0.90, 0.859, 434, 434, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH (S)-1-(4-FLUOROPHENYL)-2-(1H-IMIDAZOL-1-YL) ETHYL 4-ISOPROPYLPHENYLCARBAMATE (LFS)
62, 4ck9A, 0.9528, 0.93, 0.859, 434, 434, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH (S)-1-(4-CHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL) ETHYL 4-ISOPROPYLPHENYLCARBAMATE (LFT)
63, 4h6oA, 0.9525, 0.95, 0.859, 435, 434, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH THE INHIBITOR NEU321 (1-(3-(4-CHLORO-35-DIMETHYLPHENOXY) BENZYL)-1H-IMIDAZOLE
64, 3khmA, 0.9502, 1.07, 0.853, 441, 434, CRYSTAL STRUCTURE OF STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH INHIBITOR FLUCONAZOLE
65, 3kswA, 0.9458, 1.71, 0.849, 444, 444, CRYSTAL STRUCTURE OF STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH AN INHIBITOR VNF ((4-(4- CHLOROPHENYL)-N-[2-(1H-IMIDAZOL-1-YL)-1-PHENYLETHYL]BENZAMIDE)
66, 2wx2A, 0.9312, 1.47, 0.819, 441, 432, X-RAY STRUCTURE OF CYP51 FROM THE HUMAN PATHOGEN TRYPANOSOMA CRUZI IN COMPLEX WITH FLUCONAZOLE
67, 2wx2B, 0.9181, 1.86, 0.810, 444, 432, X-RAY STRUCTURE OF CYP51 FROM THE HUMAN PATHOGEN TRYPANOSOMA CRUZI IN COMPLEX WITH FLUCONAZOLE
68, 4uhlH, 0.9163, 1.88, 0.346, 445, 434, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
69, 4uhlD, 0.9156, 1.90, 0.346, 445, 434, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
70, 3jusB, 0.9155, 1.89, 0.341, 445, 434, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51) IN COMPLEX WITH ECONAZOLE
71, 3jusA, 0.9150, 1.90, 0.341, 445, 434, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51) IN COMPLEX WITH ECONAZOLE
72, 4uhlC, 0.9140, 1.94, 0.346, 445, 434, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
73, 4uhlG, 0.9139, 1.89, 0.339, 445, 433, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
74, 4uhlA, 0.9126, 1.91, 0.339, 445, 433, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
75, 3ld6A, 0.9126, 1.96, 0.341, 445, 434, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51) IN COMPLEX WITH KETOCONAZOLE
76, 3ld6B, 0.9124, 1.92, 0.342, 444, 433, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51) IN COMPLEX WITH KETOCONAZOLE
77, 4uhlE, 0.9121, 1.99, 0.346, 445, 434, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
78, 4uhlB, 0.9114, 1.99, 0.346, 445, 434, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
79, 6ay4A, 0.9104, 2.06, 0.357, 450, 434, NAEGLERIA FOWLERI CYP51-FLUCONAZOLE COMPLEX
80, 4uhlF, 0.9104, 1.97, 0.337, 445, 433, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
81, 6ay6A, 0.9092, 2.05, 0.360, 448, 433, NAEGLERIA FOWLERI CYP51-VORICONAZOLE COMPLEX
82, 6aycA, 0.9091, 2.10, 0.359, 449, 434, NAEGLERIA FOWLERI CYP51-ITRACONAZOLE COMPLEX
83, 3juvA, 0.9084, 2.05, 0.333, 448, 433, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51)
84, 4uhiD, 0.9079, 1.89, 0.333, 442, 430, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN C121 SPACE GROUP
85, 4uhiB, 0.9077, 1.88, 0.335, 442, 430, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN C121 SPACE GROUP
86, 4uhiA, 0.9060, 1.98, 0.341, 442, 431, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN C121 SPACE GROUP
87, 6aybA, 0.9045, 2.10, 0.359, 447, 432, NAEGLERIA FOWLERI CYP51-KETOCONAZOLE COMPLEX
88, 5tl8A, 0.9044, 2.10, 0.361, 448, 432, NAEGLERIA FOWLERI CYP51-POSACONAZOLE COMPLEX
89, 4uhiC, 0.9043, 2.00, 0.343, 442, 431, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN C121 SPACE GROUP
90, 5frbA, 0.9038, 2.31, 0.305, 470, 436, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH A TETRAZOLE-BASED INHIBITOR VT-1598
91, 5eagA, 0.9018, 2.35, 0.289, 528, 436, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR PROCHLORAZ
92, 4uymA, 0.9014, 2.35, 0.305, 470, 436, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH VORICONAZOLE
93, 4uylA, 0.9012, 2.38, 0.303, 470, 436, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH VNI
94, 6cr2B, 0.9005, 2.33, 0.301, 469, 435, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM ASPERGILLUS FUMIGATUS IN COMPLEX WITH THE VNI DERIVATIVE N-(1-(2;4- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-(2-FLUORO-4-(2;2;2- TRIFLUOROETHOXY)PHENYL)-1;3;4-OXADIAZOL-2-YL)BENZAMIDE 
95, 4uymB, 0.9003, 2.35, 0.305, 470, 436, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH VORICONAZOLE
96, 5esiA, 0.9001, 2.38, 0.289, 530, 436, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73W MUTANT
97, 5eqbA, 0.8999, 2.50, 0.288, 531, 438, CRYSTAL STRUCTURE OF LANOSTEROL 14-ALPHA DEMETHYLASE WITH INTACT TRANSMEMBRANE DOMAIN BOUND TO ITRACONAZOLE
98, 5jlcA, 0.8997, 2.39, 0.289, 506, 436, STRUCTURE OF CYP51 FROM THE PATHOGEN CANDIDA GLABRATA
99, 5esnA, 0.8996, 2.42, 0.286, 528, 437, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) T322I MUTANT STRUCTURE
100, 4ze0A, 0.8995, 2.39, 0.287, 530, 436, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140F MUTANT COMPLEXED WITH VORICONAZOLE
101, 4lxjA, 0.8995, 2.42, 0.288, 530, 437, SACCHAROMYCES CEREVISIAE LANOSTEROL 14-ALPHA DEMETHYLASE WITH LANOSTEROL BOUND
102, 5esmA, 0.8994, 2.40, 0.287, 528, 436, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) T322I MUTANT COMPLEXED WITH FLUCONAZOLE
103, 5eabA, 0.8994, 2.39, 0.289, 525, 436, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR S-TEBUCONAZOLE
104, 6cr2A, 0.8993, 2.34, 0.303, 469, 435, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM ASPERGILLUS FUMIGATUS IN COMPLEX WITH THE VNI DERIVATIVE N-(1-(2;4- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-(2-FLUORO-4-(2;2;2- TRIFLUOROETHOXY)PHENYL)-1;3;4-OXADIAZOL-2-YL)BENZAMIDE 
105, 5eafB, 0.8992, 2.40, 0.287, 528, 436, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR FLUQUINCONAZOLE
106, 5eafA, 0.8992, 2.40, 0.287, 528, 436, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR FLUQUINCONAZOLE
107, 4uylB, 0.8992, 2.39, 0.303, 470, 436, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH VNI
108, 5eslA, 0.8990, 2.40, 0.287, 527, 436, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) T322I MUTANT COMPLEXED WITH ITRACONAZOLE
109, 5eaeA, 0.8989, 2.40, 0.289, 529, 436, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR R-DESTHIO-PROTHIOCONAZOLE
110, 5eahA, 0.8988, 2.40, 0.289, 529, 436, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR DIFENOCONAZOLE
111, 4zdyA, 0.8987, 2.41, 0.287, 527, 436, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140F MUTANT COMPLEXED WITH ITRACONAZOLE
112, 4zdzA, 0.8986, 2.44, 0.286, 529, 437, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140F MUTANT COMPLEXED WITH FLUCONAZOLE
113, 5esfA, 0.8985, 2.43, 0.287, 524, 436, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73E MUTANT COMPLEXED WITH FLUCONAZOLE
114, 5tz1A, 0.8983, 2.50, 0.304, 484, 438, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM CANDIDA ALBICANS IN COMPLEX WITH THE TETRAZOLE-BASED ANTIFUNGAL DRUG CANDIDATE VT1161 (VT1)
115, 5eadA, 0.8982, 2.42, 0.291, 529, 436, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR S-DESTHIO-PROTHIOCONAZOLE
116, 5esjA, 0.8981, 2.43, 0.287, 528, 436, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G464S MUTANT COMPLEXED WITH FLUCONAZOLE
117, 5eacA, 0.8981, 2.42, 0.289, 530, 436, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR R-TEBUCONAZOLE
118, 5hs1A, 0.8978, 2.43, 0.289, 528, 436, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) COMPLEXED WITH VORICONAZOLE
119, 5eshA, 0.8977, 2.43, 0.287, 528, 436, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73W MUTANT IN COMPLEX WITH ITRACONAZOLE
120, 5v5zA, 0.8976, 2.52, 0.300, 488, 437, STRUCTURE OF CYP51 FROM THE PATHOGEN CANDIDA ALBICANS
121, 5eseA, 0.8974, 2.45, 0.287, 528, 436, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73R MUTANT COMPLEXED WITH FLUCONAZOLE
122, 4wmzA, 0.8973, 2.47, 0.288, 527, 437, S. CEREVISIAE CYP51 COMPLEXED WITH FLUCONAZOLE IN THE ACTIVE SITE
123, 4ze3A, 0.8967, 2.48, 0.286, 526, 437, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140H MUTANT COMPLEXED WITH FLUCONAZOLE
124, 4ze2A, 0.8964, 2.49, 0.286, 529, 437, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140H MUTANT COMPLEXED WITH ITRACONAZOLE
125, 5esgA, 0.8960, 2.47, 0.287, 526, 436, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73E MUTANT COMPLEXED WITH ITRACONAZOLE
126, 5ul0A, 0.8958, 2.47, 0.289, 528, 436, S. CEREVISIAE CYP51 COMPLEXED WITH VT-1161
127, 4ze1A, 0.8953, 2.51, 0.286, 528, 437, SACCHAROMYCES CEREVISIAE CYP51 Y140F MUTANT COMPLEXED WITH POSACONAZOLE IN THE ACTIVE SITE
128, 5eskA, 0.8952, 2.51, 0.286, 527, 437, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G464S MUTANT COMPLEXED WITH ITRACONAZOLE
129, 5tz1B, 0.8935, 2.51, 0.304, 484, 438, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM CANDIDA ALBICANS IN COMPLEX WITH THE TETRAZOLE-BASED ANTIFUNGAL DRUG CANDIDATE VT1161 (VT1)
130, 5fsaA, 0.8916, 2.56, 0.304, 484, 438, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM A PATHOGENIC YEAST CANDIDA ALBICANS IN COMPLEX WITH THE ANTIFUNGAL DRUG POSACONAZOLE
131, 5fsaB, 0.8898, 2.57, 0.304, 483, 437, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM A PATHOGENIC YEAST CANDIDA ALBICANS IN COMPLEX WITH THE ANTIFUNGAL DRUG POSACONAZOLE
132, 5te8B, 0.8661, 3.15, 0.195, 471, 437, CRYSTAL STRUCTURE OF THE MIDAZOLAM-BOUND HUMAN CYP3A4
133, 4i3qA, 0.8653, 3.09, 0.200, 465, 436, CRYSTAL STRUCTURE OF HUMAN CYP3A4 COORDINATED TO A WATER MOLECULE
134, 1tqnA, 0.8651, 3.01, 0.200, 468, 435, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 3A4
135, 5te8A, 0.8648, 3.10, 0.195, 470, 436, CRYSTAL STRUCTURE OF THE MIDAZOLAM-BOUND HUMAN CYP3A4
136, 5te8C, 0.8636, 3.09, 0.198, 469, 435, CRYSTAL STRUCTURE OF THE MIDAZOLAM-BOUND HUMAN CYP3A4
137, 5a1pA, 0.8629, 3.10, 0.198, 465, 434, CRYSTAL STRUCTURE OF CYTOCHROME P450 3A4 BOUND TO PROGESTERONE AND CITRATE
138, 6bd7A, 0.8616, 3.16, 0.198, 462, 434, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
139, 6bdiA, 0.8614, 3.11, 0.199, 462, 433, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
140, 4d6zA, 0.8608, 3.10, 0.199, 460, 433, CYTOCHROME P450 3A4 BOUND TO IMIDAZOLE AND AN INHIBITOR
141, 6bdkA, 0.8595, 3.11, 0.199, 461, 432, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
142, 5a1rA, 0.8591, 3.10, 0.199, 462, 432, CRYSTAL STRUCTURE OF CYTOCHROME P450 3A4 BOUND TO PROGESTERONE
143, 6c94A, 0.8585, 3.25, 0.168, 482, 440, STRUCTURE OF CYTOCHROME P450 4B1 (CYP4B1) COMPLEXED WITH THE INHIBITOR HET0016 
144, 6bczA, 0.8580, 3.03, 0.202, 461, 431, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
145, 6c93A, 0.8576, 3.26, 0.168, 478, 440, EFFECTS OF THE E310A MUTATION OF CYTOCHROME P450 4B1 (CYP4B1) ON N- OCTANE BINDING AND HEME RUFFLING 
146, 5vcgA, 0.8571, 3.00, 0.200, 461, 431, CRYSTAL STRUCTURE OF THE CYSTEINE DEPLETED CYP3A4 BOUND TO BROMOERGOCRYPTINE
147, 4d75A, 0.8565, 3.14, 0.197, 460, 432, CYTOCHROME P450 3A4 BOUND TO AN INHIBITOR
148, 6bd8A, 0.8561, 2.92, 0.203, 457, 428, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
149, 4ny4A, 0.8556, 2.99, 0.200, 460, 430, CRYSTAL STRUCTURE OF CYP3A4 IN COMPLEX WITH AN INHIBITOR
150, 6bd5A, 0.8555, 3.00, 0.203, 457, 429, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
151, 2v0mC, 0.8547, 3.18, 0.200, 465, 436, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH KETOCONAZOLE
152, 5vccA, 0.8545, 2.96, 0.203, 457, 428, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO GLYCEROL
153, 6bdmA, 0.8544, 3.10, 0.202, 456, 430, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
154, 5vcdA, 0.8535, 2.96, 0.201, 460, 428, CRYSTAL STRUCTURE OF THE CYSTEINE DEPLETED CYP3A4 BOUND TO GLYCEROL
155, 5t6qA, 0.8531, 3.22, 0.165, 472, 436, STRUCTURE OF CYTOCHROME P450 4B1 (CYP4B1) COMPLEXED WITH OCTANE: AN N- ALKANE AND FATTY ACID OMEGA-HYDROXYLASE WITH A COVALENTLY BOUND HEME
156, 6bd6A, 0.8528, 3.12, 0.200, 457, 429, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
157, 5vc0A, 0.8527, 3.08, 0.199, 463, 433, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO RITONAVIR
158, 5veuB, 0.8524, 3.05, 0.194, 458, 432, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
159, 4d7dA, 0.8523, 2.94, 0.200, 458, 429, CYTOCHROME P450 3A4 BOUND TO AN INHIBITOR
160, 4k9tA, 0.8521, 2.99, 0.201, 455, 428, COMPLEX OF CYP3A4 WITH A DESOXYRITONAVIR ANALOG
161, 4k9vA, 0.8518, 3.08, 0.199, 456, 428, COMPLEX OF CYP3A4 WITH A DESOXYRITONAVIR ANALOG
162, 5veuH, 0.8511, 3.07, 0.194, 459, 432, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
163, 3ua1A, 0.8511, 2.93, 0.200, 456, 426, CRYSTAL STRUCTURE OF THE CYTOCHROME P4503A4-BROMOERGOCRYPTINE COMPLEX
164, 5veuD, 0.8508, 3.07, 0.194, 459, 432, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
165, 5veuJ, 0.8507, 3.07, 0.194, 458, 432, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
166, 4i4gA, 0.8507, 2.94, 0.201, 459, 428, CRYSTAL STRUCTURE OF CYP3A4 LIGATED TO OXAZOLE-SUBSTITUTED DESOXYRITONAVIR
167, 4d78A, 0.8505, 2.94, 0.201, 459, 428, CYTOCHROME P450 3A4 BOUND TO AN INHIBITOR
168, 5veuF, 0.8501, 3.07, 0.194, 456, 432, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
169, 5veuI, 0.8494, 3.21, 0.198, 464, 435, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
170, 1w0fA, 0.8487, 2.93, 0.205, 459, 425, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 3A4
171, 5veuC, 0.8484, 3.18, 0.196, 469, 434, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
172, 3kx4B, 0.8484, 3.27, 0.164, 454, 434, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT I401E
173, 2hpdB, 0.8484, 3.27, 0.171, 457, 434, CRYSTAL STRUCTURE OF HEMOPROTEIN DOMAIN OF P450BM-3 A PROTOTYPE FOR MICROSOMAL P450 S
174, 4k9wC, 0.8482, 3.04, 0.205, 458, 430, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
175, 4i4hA, 0.8481, 2.97, 0.203, 457, 428, CRYSTAL STRUCTURE OF CYP3A4 LIGATED TO PYRIDINE-SUBSTITUTED DESOXYRITONAVIR
176, 4ducA, 0.8481, 3.28, 0.166, 456, 434, CYTOCHROME P450 BM3H-2G9 MRI SENSOR NO LIGAND
177, 4dufD, 0.8478, 3.20, 0.169, 456, 433, CYTOCHROME P450 BM3H-2G9 MRI SENSOR BOUND TO SEROTONIN
178, 4dudA, 0.8473, 3.24, 0.166, 456, 433, CYTOCHROME P450 BM3H-2G9C6 MRI SENSOR NO LIGAND
179, 4dufC, 0.8472, 2.99, 0.171, 456, 426, CYTOCHROME P450 BM3H-2G9 MRI SENSOR BOUND TO SEROTONIN
180, 2bmhB, 0.8471, 3.29, 0.168, 455, 434, MODELING PROTEIN-SUBSTRATE INTERACTIONS IN THE HEME DOMAIN OF CYTOCHROME P450BM-3
181, 1fahB, 0.8469, 3.30, 0.168, 455, 434, STRUCTURE OF CYTOCHROME P450
182, 5vceA, 0.8468, 2.97, 0.198, 457, 425, CRYSTAL STRUCTURE OF THE CYSTEINE DEPLETED CYP3A4 BOUND TO RITONAVIR
183, 4dufB, 0.8468, 3.30, 0.166, 456, 434, CYTOCHROME P450 BM3H-2G9 MRI SENSOR BOUND TO SEROTONIN
184, 1bu7B, 0.8468, 3.23, 0.169, 455, 432, CRYOGENIC STRUCTURE OF CYTOCHROME P450BM-3 HEME DOMAIN
185, 4dufA, 0.8467, 3.23, 0.166, 456, 433, CYTOCHROME P450 BM3H-2G9 MRI SENSOR BOUND TO SEROTONIN
186, 2x80B, 0.8467, 3.33, 0.166, 455, 434, P450 BM3 F87A IN COMPLEX WITH DMSO
187, 3nxuB, 0.8464, 3.06, 0.195, 457, 430, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P4503A4 BOUND TO AN INHIBITOR RITONAVIR
188, 2hpdA, 0.8463, 3.31, 0.173, 457, 434, CRYSTAL STRUCTURE OF HEMOPROTEIN DOMAIN OF P450BM-3 A PROTOTYPE FOR MICROSOMAL P450 S
189, 4dudB, 0.8462, 3.11, 0.173, 456, 428, CYTOCHROME P450 BM3H-2G9C6 MRI SENSOR NO LIGAND
190, 1zo4B, 0.8462, 3.27, 0.169, 457, 433, CRYSTAL STRUCTURE OF A328S MUTANT OF THE HEME DOMAIN OF P450BM-3
191, 1fahA, 0.8462, 3.16, 0.175, 455, 429, STRUCTURE OF CYTOCHROME P450
192, 4k9wD, 0.8461, 3.12, 0.195, 458, 431, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
193, 2x80A, 0.8461, 3.23, 0.171, 455, 432, P450 BM3 F87A IN COMPLEX WITH DMSO
194, 5veuK, 0.8459, 3.11, 0.197, 458, 431, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
195, 5b2xA, 0.8458, 2.95, 0.182, 453, 424, CRYSTAL STRUCTURE OF P450BM3 MUTANT WITH N-PERFLUOROHEPTANOYL-L- TRYPTOPHAN
196, 4duaA, 0.8457, 3.26, 0.169, 457, 433, CYTOCHROME P450 BM3H-9D7 MRI SENSOR NO LIGAND
197, 3nxuA, 0.8456, 3.07, 0.195, 457, 430, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P4503A4 BOUND TO AN INHIBITOR RITONAVIR
198, 2j0dA, 0.8456, 2.98, 0.200, 446, 424, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH ERYTHROMYCIN
199, 5veuA, 0.8454, 3.20, 0.184, 462, 434, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
200, 5g5jA, 0.8452, 3.07, 0.198, 452, 424, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO METFORMIN
201, 5jtdA, 0.8451, 3.12, 0.166, 458, 427, CRYSTAL STRUCTURE OF THE RU(BPY)2PHENA FUNCTIONALIZED P450 BM3 L407C HEME DOMAIN MUTANT IN COMPLEX WITH DMSO.
202, 4k9wA, 0.8451, 3.12, 0.197, 458, 431, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
203, 3benB, 0.8450, 3.23, 0.169, 457, 431, STRUCTURE OF N-(12-IMIDAZOLYL-DODECANOYL)-L-LEUCINE INHIBITOR BOUND TO THE HEME DOMAIN OF CYTOCHROME P450-BM3
204, 4dueA, 0.8449, 2.98, 0.176, 453, 425, CYTOCHROME P450 BM3H-2G9C6 MRI SENSOR BOUND TO SEROTONIN
205, 4hghA, 0.8447, 3.19, 0.168, 455, 429, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT COMPLEXED WITH STYRENE (DATASET I)
206, 3kx4A, 0.8447, 3.13, 0.172, 453, 429, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT I401E
207, 4hgiA, 0.8446, 3.25, 0.167, 455, 430, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT COMPLEXED WITH STYRENE (DATASET II)
208, 2bmhA, 0.8446, 3.24, 0.172, 455, 430, MODELING PROTEIN-SUBSTRATE INTERACTIONS IN THE HEME DOMAIN OF CYTOCHROME P450BM-3
209, 3kx5B, 0.8444, 3.21, 0.167, 455, 431, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT F261E
210, 4ducB, 0.8443, 3.12, 0.171, 456, 428, CYTOCHROME P450 BM3H-2G9 MRI SENSOR NO LIGAND
211, 2ij3B, 0.8443, 3.25, 0.164, 454, 433, STRUCTURE OF THE A264H MUTANT OF CYTOCHROME P450 BM3
212, 5e7yB, 0.8442, 3.20, 0.172, 452, 430, CRYSTAL STRUCTURE OF P450 BM3 HEME DOMAIN M7 VARIANT
213, 5ucwA, 0.8441, 3.00, 0.169, 453, 427, CYTOCHROME P411 P-4 A82L A78V F263L AMINATION CATALYST
214, 4k9wB, 0.8441, 3.08, 0.203, 457, 429, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
215, 4hghB, 0.8440, 3.23, 0.165, 455, 430, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT COMPLEXED WITH STYRENE (DATASET I)
216, 4dubA, 0.8440, 3.23, 0.167, 456, 432, CYTOCHROME P450 BM3H-9D7 MRI SENSOR BOUND TO DOPAMINE
217, 3k9yA, 0.8440, 3.23, 0.160, 461, 432, CRYSTAL STRUCTURE OF RAT MITOCHONDRIAL P450 24A1 S57D IN COMPLEX WITH CYMAL-5
218, 4k9uA, 0.8439, 2.94, 0.206, 450, 423, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
219, 2j1mB, 0.8439, 3.09, 0.171, 454, 426, P450 BM3 HEME DOMAIN IN COMPLEX WITH DMSO
220, 1p0wB, 0.8438, 3.07, 0.168, 448, 428, F393W MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
221, 1bu7A, 0.8438, 3.12, 0.169, 455, 426, CRYOGENIC STRUCTURE OF CYTOCHROME P450BM-3 HEME DOMAIN
222, 4h23A, 0.8436, 2.98, 0.167, 454, 426, CYTOCHROME P411BM3-CIS CYCLOPROPANATION CATALYST
223, 5xa3D, 0.8435, 3.10, 0.183, 453, 427, CRYSTAL STRUCTURE OF P450BM3 WITH BENZYLOXYCARBONYL-L-PROLYL-L- PHENYLALANINE
224, 5xa3C, 0.8434, 3.09, 0.183, 453, 427, CRYSTAL STRUCTURE OF P450BM3 WITH BENZYLOXYCARBONYL-L-PROLYL-L- PHENYLALANINE
225, 5xa3A, 0.8434, 3.10, 0.183, 453, 427, CRYSTAL STRUCTURE OF P450BM3 WITH BENZYLOXYCARBONYL-L-PROLYL-L- PHENYLALANINE
226, 2ve4B, 0.8434, 2.84, 0.212, 432, 420, SUBSTRATE FREE CYANOBACTERIAL CYP120A1
227, 1w0gA, 0.8434, 3.06, 0.203, 455, 423, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 3A4
228, 1p0xB, 0.8434, 3.08, 0.171, 448, 428, F393Y MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
229, 5xa3B, 0.8433, 3.09, 0.183, 453, 427, CRYSTAL STRUCTURE OF P450BM3 WITH BENZYLOXYCARBONYL-L-PROLYL-L- PHENYLALANINE
230, 5jtdB, 0.8432, 3.24, 0.167, 458, 431, CRYSTAL STRUCTURE OF THE RU(BPY)2PHENA FUNCTIONALIZED P450 BM3 L407C HEME DOMAIN MUTANT IN COMPLEX WITH DMSO.
231, 4duaB, 0.8432, 3.15, 0.178, 457, 428, CYTOCHROME P450 BM3H-9D7 MRI SENSOR NO LIGAND
232, 2v0mA, 0.8432, 3.03, 0.204, 455, 427, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH KETOCONAZOLE
233, 1zo4A, 0.8432, 3.27, 0.174, 456, 432, CRYSTAL STRUCTURE OF A328S MUTANT OF THE HEME DOMAIN OF P450BM-3
234, 4h24A, 0.8431, 3.09, 0.178, 457, 426, CYTOCHROME P450BM3-CIS CYCLOPROPANATION CATALYST
235, 5b2uB, 0.8429, 3.07, 0.177, 453, 424, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUOROHEXANOYL -L-TRYPTOPHAN
236, 2vkuA, 0.8429, 3.08, 0.290, 444, 428, 44 -DIHYDROXYBENZOPHENONE MIMICS STEROL SUBSTRATE IN THE BINDING SITE OF STEROL 14ALPHA-DEMETHYLASE (CYP51) IN THE X-RAY STRUCTURE OF THE COMPLEX
237, 2ij2A, 0.8428, 3.07, 0.168, 450, 428, ATOMIC STRUCTURE OF THE HEME DOMAIN OF FLAVOCYTOCHROME P450- BM3
238, 3tjsA, 0.8427, 2.96, 0.202, 449, 425, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN CYTOCHROME P450 3A4 AND DESTHIAZOLYLMETHYLOXYCARBONYL RITONAVIR
239, 2ve3A, 0.8425, 2.85, 0.207, 435, 420, RETINOIC ACID BOUND CYANOBACTERIAL CYP120A1
240, 5b2yA, 0.8424, 3.13, 0.175, 452, 428, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORODECANOYL-L-TRYPTOPHAN
241, 5e78B, 0.8421, 3.14, 0.169, 454, 425, CRYSTAL STRUCTURE OF P450 BM3 HEME DOMAIN VARIANT COMPLEXED WITH CO(III)SEP
242, 4h24C, 0.8421, 3.05, 0.176, 456, 425, CYTOCHROME P450BM3-CIS CYCLOPROPANATION CATALYST
243, 3benA, 0.8421, 3.12, 0.180, 454, 427, STRUCTURE OF N-(12-IMIDAZOLYL-DODECANOYL)-L-LEUCINE INHIBITOR BOUND TO THE HEME DOMAIN OF CYTOCHROME P450-BM3
244, 3k9vA, 0.8420, 3.30, 0.165, 464, 431, CRYSTAL STRUCTURE OF RAT MITOCHONDRIAL P450 24A1 S57D IN COMPLEX WITH CHAPS
245, 2j4sA, 0.8420, 3.26, 0.166, 452, 429, P450 BM3 HEME DOMAIN IN COMPLEX WITH DMSO
246, 4zf8A, 0.8419, 3.24, 0.169, 460, 432, CYTOCHROME P450 PENTAMUTANT FROM BM3 WITH BOUND METYRAPONE
247, 4dubB, 0.8419, 3.12, 0.178, 456, 427, CYTOCHROME P450 BM3H-9D7 MRI SENSOR BOUND TO DOPAMINE
248, 2ve4A, 0.8419, 2.83, 0.212, 431, 419, SUBSTRATE FREE CYANOBACTERIAL CYP120A1
249, 3wspA, 0.8418, 3.19, 0.172, 453, 429, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORONONANOYL-L-TRYPTOPHAN
250, 3ekbB, 0.8418, 3.18, 0.168, 457, 429, CRYSTAL STRUCTURE OF THE A264C MUTANT HEME DOMAIN OF CYTOCHROME P450 BM3
251, 2uwhA, 0.8418, 3.14, 0.171, 458, 428, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
252, 4hgiB, 0.8416, 3.26, 0.168, 453, 429, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT COMPLEXED WITH STYRENE (DATASET II)
253, 3na1B, 0.8416, 3.33, 0.147, 471, 434, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 20- HYDROXYCHOLESTEROL
254, 4h24D, 0.8415, 3.08, 0.169, 455, 425, CYTOCHROME P450BM3-CIS CYCLOPROPANATION CATALYST
255, 4k9xA, 0.8414, 3.11, 0.202, 449, 425, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
256, 3na1A, 0.8414, 3.34, 0.147, 472, 434, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 20- HYDROXYCHOLESTEROL
257, 4dtyA, 0.8413, 3.22, 0.179, 453, 429, CYTOCHROME P450 BM3H-8C8 MRI SENSOR NO LIGAND
258, 5xhjB, 0.8412, 3.05, 0.174, 453, 425, CRYSTAL STRUCTURE OF P450BM3 WITH 5-CYCLOHEXYLVALEROYL-L-TRYPTOPHAN
259, 4wg2A, 0.8412, 3.07, 0.175, 461, 424, P411BM3-CIS T438S I263F REGIOSELECTIVE C-H AMINATION CATALYST
260, 2v0mD, 0.8412, 3.08, 0.197, 453, 427, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH KETOCONAZOLE
261, 5b2uA, 0.8411, 3.11, 0.178, 453, 427, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUOROHEXANOYL -L-TRYPTOPHAN
262, 5veuG, 0.8410, 3.13, 0.196, 455, 429, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
263, 3wspB, 0.8410, 3.09, 0.185, 453, 426, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORONONANOYL-L-TRYPTOPHAN
264, 3kx5A, 0.8410, 3.14, 0.173, 455, 427, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT F261E
265, 1p0vB, 0.8410, 3.03, 0.169, 444, 426, F393A MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
266, 4dtwB, 0.8409, 3.14, 0.178, 453, 426, CYTOCHROME P450 BM3H-8C8 MRI SENSOR BOUND TO SEROTONIN
267, 5xhjA, 0.8408, 3.16, 0.170, 453, 429, CRYSTAL STRUCTURE OF P450BM3 WITH 5-CYCLOHEXYLVALEROYL-L-TRYPTOPHAN
268, 4dtzA, 0.8408, 3.15, 0.178, 453, 426, CYTOCHROME P450 BM3H-8C8 MRI SENSOR BOUND TO DOPAMINE
269, 3tdaC, 0.8407, 3.50, 0.151, 467, 438, COMPETITIVE REPLACEMENT OF THIORIDAZINE BY PRINOMASTAT IN CRYSTALS OF CYTOCHROME P450 2D6
270, 2j1mA, 0.8407, 3.17, 0.169, 454, 426, P450 BM3 HEME DOMAIN IN COMPLEX WITH DMSO
271, 4dtwA, 0.8406, 3.23, 0.179, 453, 429, CYTOCHROME P450 BM3H-8C8 MRI SENSOR BOUND TO SEROTONIN
272, 3n9zB, 0.8406, 3.33, 0.148, 470, 433, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 22- HYDROXYCHOLESTEROL
273, 4zfaA, 0.8405, 3.38, 0.168, 460, 434, CYTOCHROME P450 WILD TYPE FROM BM3 WITH BOUND PEG
274, 4dtyB, 0.8405, 3.16, 0.178, 453, 426, CYTOCHROME P450 BM3H-8C8 MRI SENSOR NO LIGAND
275, 1zo9A, 0.8405, 3.12, 0.169, 458, 427, CRYSTAL STRUCTURE OF THE WILD TYPE HEME DOMAIN OF P450BM-3 WITH N- PALMITOYLMETHIONINE
276, 5jquB, 0.8404, 3.19, 0.172, 453, 429, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
277, 3n9zA, 0.8404, 3.37, 0.152, 470, 434, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 22- HYDROXYCHOLESTEROL
278, 2v0mB, 0.8404, 3.07, 0.197, 451, 427, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH KETOCONAZOLE
279, 1jpzB, 0.8404, 3.12, 0.169, 458, 427, CRYSTAL STRUCTURE OF A COMPLEX OF THE HEME DOMAIN OF P450BM- 3 WITH N-PALMITOYLGLYCINE
280, 5jq2A, 0.8403, 3.13, 0.166, 457, 427, CRYSTAL STRUCTURE OF THE RU(BPY)2PHENA FUNCTIONALIZED P450 BM3 L407C HEME DOMAIN MUTANT IN COMPLEX WITH N-PALMITOYLGLYCINE
281, 3m4vA, 0.8403, 3.14, 0.178, 451, 426, CRYSTAL STRUCTURE OF THE A330P MUTANT OF CYTOCHROME P450 BM3
282, 4dtzB, 0.8402, 3.14, 0.178, 453, 426, CYTOCHROME P450 BM3H-8C8 MRI SENSOR BOUND TO DOPAMINE
283, 1zo9B, 0.8402, 3.12, 0.169, 458, 427, CRYSTAL STRUCTURE OF THE WILD TYPE HEME DOMAIN OF P450BM-3 WITH N- PALMITOYLMETHIONINE
284, 5b2yB, 0.8401, 3.16, 0.176, 452, 426, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORODECANOYL-L-TRYPTOPHAN
285, 4dueB, 0.8398, 2.97, 0.177, 450, 423, CYTOCHROME P450 BM3H-2G9C6 MRI SENSOR BOUND TO SEROTONIN
286, 1zoaB, 0.8398, 3.15, 0.166, 457, 428, CRYSTAL STRUCTURE OF A328V MUTANT OF THE HEME DOMAIN OF P450BM-3 WITH N-PALMITOYLGLYCINE
287, 1zoaA, 0.8398, 3.09, 0.169, 457, 426, CRYSTAL STRUCTURE OF A328V MUTANT OF THE HEME DOMAIN OF P450BM-3 WITH N-PALMITOYLGLYCINE
288, 5jquA, 0.8397, 3.23, 0.168, 452, 429, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
289, 5b2vA, 0.8397, 3.34, 0.169, 453, 432, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUOROHEXANOYL-L-TRYPTOPHAN
290, 3tbgC, 0.8397, 3.52, 0.151, 467, 438, HUMAN CYTOCHROME P450 2D6 WITH TWO THIORIDAZINES BOUND IN ACTIVE SITE
291, 3n9yB, 0.8397, 3.33, 0.148, 470, 433, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH CHOLESTEROL
292, 3n9yA, 0.8397, 3.33, 0.150, 471, 433, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH CHOLESTEROL
293, 2ij3A, 0.8397, 3.25, 0.164, 453, 428, STRUCTURE OF THE A264H MUTANT OF CYTOCHROME P450 BM3
294, 1smiB, 0.8397, 3.04, 0.167, 455, 424, A SINGLE MUTATION OF P450 BM3 INDUCES THE CONFORMATIONAL REARRANGEMENT SEEN UPON SUBSTRATE-BINDING IN WILD-TYPE ENZYME
295, 5b2xB, 0.8396, 3.19, 0.178, 453, 427, CRYSTAL STRUCTURE OF P450BM3 MUTANT WITH N-PERFLUOROHEPTANOYL-L- TRYPTOPHAN
296, 5b2wA, 0.8396, 3.02, 0.172, 452, 424, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORODODECANOYL-L-TRYPTOPHAN
297, 4zf6A, 0.8396, 3.29, 0.169, 460, 432, CYTOCHROME P450 PENTAMUTANT FROM BM3 WITH BOUND PEG
298, 1smjA, 0.8396, 3.20, 0.164, 455, 428, STRUCTURE OF THE A264E MUTANT OF CYTOCHROME P450 BM3 COMPLEXED WITH PALMITOLEATE
299, 2j0dB, 0.8395, 2.87, 0.200, 445, 419, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH ERYTHROMYCIN
300, 1yqoB, 0.8394, 2.98, 0.165, 441, 423, T268A MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
301, 5b2vB, 0.8393, 3.15, 0.171, 453, 427, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUOROHEXANOYL-L-TRYPTOPHAN
302, 4zfbA, 0.8393, 3.29, 0.167, 460, 430, CYTOCHROME P450 PENTAMUTANT FROM BM3 BOUND TO PALMITIC ACID
303, 4wg2C, 0.8393, 3.23, 0.163, 460, 429, P411BM3-CIS T438S I263F REGIOSELECTIVE C-H AMINATION CATALYST
304, 3na0A, 0.8393, 3.38, 0.147, 470, 434, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 2022- DIHYDROXYCHOLESTEROL
305, 5tftA, 0.8392, 3.55, 0.151, 467, 438, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
306, 5jquD, 0.8392, 3.28, 0.164, 454, 428, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
307, 5e7yA, 0.8391, 3.22, 0.180, 451, 428, CRYSTAL STRUCTURE OF P450 BM3 HEME DOMAIN M7 VARIANT
308, 3tbgA, 0.8391, 3.54, 0.151, 467, 438, HUMAN CYTOCHROME P450 2D6 WITH TWO THIORIDAZINES BOUND IN ACTIVE SITE
309, 3na0B, 0.8391, 3.33, 0.148, 470, 433, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 2022- DIHYDROXYCHOLESTEROL
310, 2uwhF, 0.8391, 3.18, 0.172, 458, 429, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
311, 2nnbB, 0.8390, 2.99, 0.168, 441, 423, THE Q403K MUTNAT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
312, 1fagA, 0.8388, 3.21, 0.166, 455, 428, STRUCTURE OF CYTOCHROME P450
313, 3cbdB, 0.8387, 3.17, 0.164, 455, 427, DIRECTED EVOLUTION OF CYTOCHROME P450 BM3 TO OCTANE MONOXYGENASE 139-3
314, 2ij4B, 0.8387, 3.06, 0.167, 455, 424, STRUCTURE OF THE A264K MUTANT OF CYTOCHROME P450 BM3
315, 1fagB, 0.8387, 3.23, 0.168, 455, 428, STRUCTURE OF CYTOCHROME P450
316, 5b2wB, 0.8386, 3.08, 0.172, 452, 424, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORODODECANOYL-L-TRYPTOPHAN
317, 1smjB, 0.8386, 3.33, 0.163, 455, 430, STRUCTURE OF THE A264E MUTANT OF CYTOCHROME P450 BM3 COMPLEXED WITH PALMITOLEATE
318, 5vbuA, 0.8384, 3.23, 0.152, 442, 428, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 HYDROXYPROGESTERONE COMPLEX
319, 4hgjA, 0.8384, 3.06, 0.175, 448, 424, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT
320, 5jq2B, 0.8383, 3.32, 0.163, 459, 430, CRYSTAL STRUCTURE OF THE RU(BPY)2PHENA FUNCTIONALIZED P450 BM3 L407C HEME DOMAIN MUTANT IN COMPLEX WITH N-PALMITOYLGLYCINE
321, 3tdaA, 0.8383, 3.50, 0.151, 467, 437, COMPETITIVE REPLACEMENT OF THIORIDAZINE BY PRINOMASTAT IN CRYSTALS OF CYTOCHROME P450 2D6
322, 2uwhC, 0.8383, 3.23, 0.168, 458, 428, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
323, 1smjC, 0.8383, 3.22, 0.164, 455, 428, STRUCTURE OF THE A264E MUTANT OF CYTOCHROME P450 BM3 COMPLEXED WITH PALMITOLEATE
324, 1fagD, 0.8383, 3.25, 0.168, 455, 428, STRUCTURE OF CYTOCHROME P450
325, 4y8wC, 0.8382, 3.23, 0.150, 442, 428, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 PROGESTERONE COMPLEX
326, 5e78A, 0.8381, 3.14, 0.174, 447, 425, CRYSTAL STRUCTURE OF P450 BM3 HEME DOMAIN VARIANT COMPLEXED WITH CO(III)SEP
327, 3k9vB, 0.8381, 3.34, 0.162, 464, 431, CRYSTAL STRUCTURE OF RAT MITOCHONDRIAL P450 24A1 S57D IN COMPLEX WITH CHAPS
328, 2uwhD, 0.8380, 3.22, 0.171, 458, 428, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
329, 1jmeB, 0.8380, 2.97, 0.170, 441, 423, CRYSTAL STRUCTURE OF PHE393HIS CYTOCHROME P450 BM3
330, 5jquG, 0.8379, 3.24, 0.169, 451, 426, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
331, 4du2B, 0.8378, 2.91, 0.176, 444, 421, CYTOCHROME P450 BM3H-B7 MRI SENSOR BOUND TO DOPAMINE
332, 3kx3B, 0.8378, 3.16, 0.166, 456, 427, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT L86E
333, 2uwhB, 0.8376, 3.22, 0.168, 458, 428, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
334, 1fagC, 0.8376, 3.15, 0.169, 455, 426, STRUCTURE OF CYTOCHROME P450
335, 1yqpB, 0.8374, 2.98, 0.170, 441, 423, T268N MUTANT CYTOCHROME DOMAIN OF FLAVOCYTOCHROME P450 BM3
336, 5jqvD, 0.8372, 3.26, 0.172, 454, 429, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
337, 5jqvA, 0.8371, 3.32, 0.169, 453, 431, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
338, 2j4sB, 0.8371, 3.35, 0.163, 450, 430, P450 BM3 HEME DOMAIN IN COMPLEX WITH DMSO
339, 1p0wA, 0.8371, 2.97, 0.178, 441, 421, F393W MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
340, 4y8wA, 0.8369, 3.16, 0.153, 440, 426, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 PROGESTERONE COMPLEX
341, 3k9yB, 0.8369, 3.37, 0.157, 462, 432, CRYSTAL STRUCTURE OF RAT MITOCHONDRIAL P450 24A1 S57D IN COMPLEX WITH CYMAL-5
342, 1p0xA, 0.8369, 2.92, 0.179, 441, 420, F393Y MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
343, 1yqpA, 0.8368, 2.97, 0.178, 441, 421, T268N MUTANT CYTOCHROME DOMAIN OF FLAVOCYTOCHROME P450 BM3
344, 3cbdA, 0.8367, 3.33, 0.167, 455, 431, DIRECTED EVOLUTION OF CYTOCHROME P450 BM3 TO OCTANE MONOXYGENASE 139-3
345, 1smjD, 0.8367, 3.24, 0.166, 454, 427, STRUCTURE OF THE A264E MUTANT OF CYTOCHROME P450 BM3 COMPLEXED WITH PALMITOLEATE
346, 5dypC, 0.8366, 3.29, 0.172, 450, 429, CRYSTAL STRUCTURE OF ASP251GLY/GLN307HIS MUTANT OF CYTOCHROME P450 BM3
347, 5og9B, 0.8365, 3.31, 0.170, 454, 430, THE BM3 MUTANT WIFI-WC HEME DOMAIN IN COMPLEX WITH TESTOSTERONE 
348, 5e9zB, 0.8364, 3.22, 0.166, 451, 429, CYTOCHROME P450 BM3 MUTANT M11
349, 5jqvB, 0.8363, 3.30, 0.172, 453, 430, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
350, 2ve3B, 0.8363, 2.87, 0.204, 427, 416, RETINOIC ACID BOUND CYANOBACTERIAL CYP120A1
351, 1jpzA, 0.8363, 3.12, 0.169, 456, 425, CRYSTAL STRUCTURE OF A COMPLEX OF THE HEME DOMAIN OF P450BM- 3 WITH N-PALMITOYLGLYCINE
352, 5jquC, 0.8361, 3.29, 0.164, 453, 427, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
353, 3nplA, 0.8361, 3.27, 0.166, 456, 429, STRUCTURE OF RU(BPY)2(A-PHEN)(K97C) P450 BM3 HEME DOMAIN A RUTHENIUM MODIFIED P450 BM3 MUTANT
354, 5vbuC, 0.8360, 3.20, 0.152, 442, 427, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 HYDROXYPROGESTERONE COMPLEX
355, 4hgjB, 0.8360, 3.24, 0.171, 451, 426, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT
356, 2nnbA, 0.8360, 2.98, 0.178, 441, 421, THE Q403K MUTNAT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
357, 1yqoA, 0.8360, 2.94, 0.179, 441, 420, T268A MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
358, 1jmeA, 0.8360, 2.98, 0.178, 441, 421, CRYSTAL STRUCTURE OF PHE393HIS CYTOCHROME P450 BM3
359, 4y8wB, 0.8359, 3.14, 0.153, 440, 425, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 PROGESTERONE COMPLEX
360, 4wg2B, 0.8359, 3.17, 0.171, 451, 427, P411BM3-CIS T438S I263F REGIOSELECTIVE C-H AMINATION CATALYST
361, 1p0vA, 0.8359, 2.98, 0.178, 441, 421, F393A MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
362, 5dyzC, 0.8357, 3.17, 0.167, 453, 426, CRYSTAL STRUCTURE OF ASP251GLY/GLN307HIS MUTANT OF CYTOCHROME P450 BM3 IN COMPLEX WITH N-PALMITOYLGLYCINE
363, 4kpbB, 0.8356, 3.03, 0.170, 444, 423, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM-3 R47E MUTANT
364, 5jqvG, 0.8355, 3.26, 0.171, 451, 426, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
365, 5jqvF, 0.8355, 3.22, 0.169, 455, 426, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
366, 5jquF, 0.8354, 3.34, 0.166, 455, 428, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
367, 3mzsD, 0.8354, 3.36, 0.139, 470, 433, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP11A1 IN COMPLEX WITH 22- HYDROXY-CHOLESTEROL
368, 2ij2B, 0.8354, 2.87, 0.181, 448, 419, ATOMIC STRUCTURE OF THE HEME DOMAIN OF FLAVOCYTOCHROME P450- BM3
369, 3ekfB, 0.8352, 3.18, 0.171, 452, 426, CRYSTAL STRUCTURE OF THE A264Q HEME DOMAIN OF CYTOCHROME P450 BM3
370, 5vbuB, 0.8351, 3.25, 0.152, 441, 427, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 HYDROXYPROGESTERONE COMPLEX
371, 5jquH, 0.8350, 3.19, 0.167, 450, 426, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
372, 4rsnB, 0.8348, 3.39, 0.163, 460, 430, CRYSTAL STRUCTURE OF THE E267V MUTANT OF CYTOCHROME P450 BM3
373, 4rsnA, 0.8347, 3.39, 0.163, 460, 430, CRYSTAL STRUCTURE OF THE E267V MUTANT OF CYTOCHROME P450 BM3
374, 5e9zA, 0.8343, 3.28, 0.168, 452, 429, CYTOCHROME P450 BM3 MUTANT M11
375, 4h24B, 0.8343, 3.15, 0.165, 452, 423, CYTOCHROME P450BM3-CIS CYCLOPROPANATION CATALYST
376, 2uwhE, 0.8343, 3.36, 0.172, 458, 431, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
377, 4wnvA, 0.8341, 3.50, 0.156, 464, 435, HUMAN CYTOCHROME P450 2D6 QUININE COMPLEX
378, 3dgiA, 0.8341, 3.06, 0.171, 449, 422, CRYSTAL STRUCTURE OF F87A/T268A MUTANT OF CYP BM3
379, 3nplB, 0.8340, 3.30, 0.166, 456, 429, STRUCTURE OF RU(BPY)2(A-PHEN)(K97C) P450 BM3 HEME DOMAIN A RUTHENIUM MODIFIED P450 BM3 MUTANT
380, 4du2A, 0.8339, 3.02, 0.176, 443, 421, CYTOCHROME P450 BM3H-B7 MRI SENSOR BOUND TO DOPAMINE
381, 5jqvC, 0.8337, 3.18, 0.170, 452, 424, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
382, 3kx3A, 0.8337, 3.22, 0.172, 454, 425, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT L86E
383, 5tftB, 0.8334, 3.45, 0.157, 460, 433, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
384, 3mzsC, 0.8334, 3.40, 0.141, 470, 433, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP11A1 IN COMPLEX WITH 22- HYDROXY-CHOLESTEROL
385, 2ij4A, 0.8333, 3.19, 0.167, 451, 424, STRUCTURE OF THE A264K MUTANT OF CYTOCHROME P450 BM3
386, 3mzsA, 0.8332, 3.41, 0.141, 470, 433, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP11A1 IN COMPLEX WITH 22- HYDROXY-CHOLESTEROL
387, 5dypA, 0.8331, 3.03, 0.173, 440, 422, CRYSTAL STRUCTURE OF ASP251GLY/GLN307HIS MUTANT OF CYTOCHROME P450 BM3
388, 4kpaA, 0.8331, 3.15, 0.172, 461, 424, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM-3 IN COMPLEX WITH N- PALMITOYLGLYCINE (NPG)
389, 3mzsB, 0.8331, 3.42, 0.131, 470, 434, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP11A1 IN COMPLEX WITH 22- HYDROXY-CHOLESTEROL
390, 5og9A, 0.8329, 3.30, 0.171, 454, 428, THE BM3 MUTANT WIFI-WC HEME DOMAIN IN COMPLEX WITH TESTOSTERONE 
391, 4h23B, 0.8328, 3.08, 0.171, 448, 422, CYTOCHROME P411BM3-CIS CYCLOPROPANATION CATALYST
392, 4kewA, 0.8325, 3.09, 0.175, 450, 422, STRUCTURE OF THE A82F BM3 HEME DOMAIN IN COMPLEX WITH OMEPRAZOLE
393, 1w0eA, 0.8325, 3.09, 0.203, 450, 418, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 3A4
394, 5e9zC, 0.8324, 3.08, 0.173, 445, 423, CYTOCHROME P450 BM3 MUTANT M11
395, 5ucwB, 0.8323, 3.17, 0.168, 453, 423, CYTOCHROME P411 P-4 A82L A78V F263L AMINATION CATALYST
396, 5dyzA, 0.8322, 3.09, 0.176, 445, 421, CRYSTAL STRUCTURE OF ASP251GLY/GLN307HIS MUTANT OF CYTOCHROME P450 BM3 IN COMPLEX WITH N-PALMITOYLGLYCINE
397, 5jqvE, 0.8321, 3.16, 0.173, 451, 423, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
398, 4xryA, 0.8321, 3.55, 0.161, 464, 435, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 5 COMPLEX
399, 6bdhA, 0.8319, 2.98, 0.199, 439, 417, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
400, 5jquE, 0.8315, 3.21, 0.165, 451, 424, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
401, 4o4pA, 0.8315, 3.15, 0.173, 450, 423, STRUCTURE OF P450 BM3 A82F F87V IN COMPLEX WITH S-OMEPRAZOL
402, 4keyA, 0.8314, 3.18, 0.170, 450, 424, STRUCTURE OF P450 BM3 A82F F87V IN COMPLEX WITH OMEPRAZOLE
403, 5jqvH, 0.8309, 3.34, 0.168, 450, 428, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
404, 3qz1A, 0.8303, 3.38, 0.140, 445, 429, CRYSTAL STRUCTURE OF BOVINE STEROID OF 21-HYDROXYLASE (P450C21)
405, 3m4vB, 0.8302, 3.00, 0.174, 438, 419, CRYSTAL STRUCTURE OF THE A330P MUTANT OF CYTOCHROME P450 BM3
406, 3ekdB, 0.8298, 3.40, 0.167, 455, 430, CRYSTAL STRUCTURE OF THE A264M HEME DOMAIN OF CYTOCHROME P450 BM3
407, 5veuL, 0.8296, 3.14, 0.194, 448, 423, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
408, 4zgxJ, 0.8292, 3.42, 0.170, 463, 430, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
409, 5jl9A, 0.8291, 3.55, 0.159, 452, 434, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1): ANDROSTENEDIONE COMPLEX #4
410, 4dvqG, 0.8289, 3.37, 0.171, 462, 428, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
411, 4fdhG, 0.8288, 3.39, 0.170, 463, 429, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
412, 3s7sA, 0.8287, 3.55, 0.159, 452, 434, CRYSTAL STRUCTURE OF HUMAN PLACENTAL AROMATASE COMPLEXED WITH BREAST CANCER DRUG EXEMESTANE
413, 5jkwA, 0.8285, 3.55, 0.161, 452, 434, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1) COMPLEXED WITH TESTOSTERONE
414, 5jl7A, 0.8284, 3.56, 0.161, 452, 434, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1): ANDROSTENEDIONE COMPLEX #3
415, 4hggB, 0.8283, 3.11, 0.188, 441, 420, CRYSTAL STRUCTURE OF P450 BM3 5F5R HEME DOMAIN VARIANT COMPLEXED WITH STYRENE
416, 1nr6A, 0.8283, 3.61, 0.167, 462, 437, MICROSOMAL CYTOCHROME P450 2C5/3LVDH COMPLEX WITH DICLOFENAC
417, 5jl6A, 0.8282, 3.56, 0.161, 452, 434, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1): ANDROSTENEDIONE COMPLEX #2
418, 3s79A, 0.8281, 3.55, 0.161, 452, 434, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1) REFINED AT 2.75 ANGSTROM
419, 2x7yB, 0.8281, 3.01, 0.181, 439, 419, P450 BM3 F87A IN COMPLEX WITH DMSO
420, 5jkvA, 0.8279, 3.56, 0.161, 452, 434, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1) AT 2.75 ANGSTROM WITH BOUND POLYETHYLENE GLYCOL
421, 3eqmA, 0.8279, 3.56, 0.161, 452, 434, CRYSTAL STRUCTURE OF HUMAN PLACENTAL AROMATASE CYTOCHROME P450 IN COMPLEX WITH ANDROSTENEDIONE
422, 4dvqE, 0.8278, 3.50, 0.167, 470, 432, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
423, 3ekbA, 0.8277, 3.16, 0.168, 442, 422, CRYSTAL STRUCTURE OF THE A264C MUTANT HEME DOMAIN OF CYTOCHROME P450 BM3
424, 2hi4A, 0.8275, 3.64, 0.172, 480, 437, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 1A2 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
425, 4zgxG, 0.8274, 3.54, 0.169, 465, 432, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
426, 4zgxA, 0.8274, 3.56, 0.169, 465, 432, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
427, 4hgfA, 0.8274, 3.11, 0.179, 442, 420, CRYSTAL STRUCTURE OF P450 BM3 5F5K HEME DOMAIN VARIANT COMPLEXED WITH STYRENE
428, 1n6bA, 0.8274, 3.65, 0.172, 462, 437, MICROSOMAL CYTOCHROME P450 2C5/3LVDH COMPLEX WITH A DIMETHYL DERIVATIVE OF SULFAPHENAZOLE
429, 4zgxD, 0.8273, 3.57, 0.167, 465, 432, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
430, 4o4pB, 0.8273, 3.19, 0.171, 446, 422, STRUCTURE OF P450 BM3 A82F F87V IN COMPLEX WITH S-OMEPRAZOL
431, 4kq8A, 0.8273, 3.58, 0.157, 452, 434, STRUCTURE OF RECOMBINANT HUMAN CYTOCHROME P450 AROMATASE
432, 4fdhE, 0.8273, 3.47, 0.165, 470, 431, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
433, 4hgfB, 0.8272, 3.09, 0.186, 441, 419, CRYSTAL STRUCTURE OF P450 BM3 5F5K HEME DOMAIN VARIANT COMPLEXED WITH STYRENE
434, 4zgxB, 0.8271, 3.56, 0.167, 465, 432, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
435, 4zgxH, 0.8270, 3.54, 0.169, 465, 432, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
436, 3ekfA, 0.8270, 3.15, 0.169, 441, 421, CRYSTAL STRUCTURE OF THE A264Q HEME DOMAIN OF CYTOCHROME P450 BM3
437, 4gl7A, 0.8266, 3.53, 0.157, 452, 433, STRUCTURE OF HUMAN PLACENTAL AROMATASE COMPLEXED WITH DESIGNED INHIBITOR HDDG046 (COMPOUND 5)
438, 4gqsA, 0.8265, 3.76, 0.156, 464, 441, STRUCTURE OF HUMAN MICROSOMAL CYTOCHROME P450 (CYP) 2C19
439, 2nnhB, 0.8264, 3.79, 0.159, 463, 440, CYP2C8DH COMPLEXED WITH 2 MOLECULES OF 9-CIS RETINOIC ACID
440, 4zgxC, 0.8263, 3.56, 0.167, 465, 432, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
441, 4fdhF, 0.8263, 3.48, 0.165, 469, 430, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
442, 4dvqF, 0.8263, 3.49, 0.165, 469, 430, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
443, 4gl5A, 0.8262, 3.59, 0.157, 452, 434, STRUCTURE OF HUMAN PLACENTAL AROMATASE COMPLEXED WITH DESIGNED INHIBITOR HDDG029 (COMPOUND 4)
444, 4fdhB, 0.8260, 3.53, 0.169, 465, 431, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
445, 4fdhK, 0.8256, 3.53, 0.167, 469, 431, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
446, 4kpbA, 0.8255, 2.98, 0.180, 440, 417, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM-3 R47E MUTANT
447, 2nnhA, 0.8255, 3.82, 0.159, 463, 440, CYP2C8DH COMPLEXED WITH 2 MOLECULES OF 9-CIS RETINOIC ACID
448, 6b82B, 0.8254, 3.66, 0.179, 470, 436, ZEBRA FISH CYP-450 17A1 MUTANT ABIRATERONE COMPLEX
449, 4fdhD, 0.8249, 3.53, 0.165, 465, 431, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
450, 3ekdA, 0.8248, 3.39, 0.168, 454, 428, CRYSTAL STRUCTURE OF THE A264M HEME DOMAIN OF CYTOCHROME P450 BM3
451, 4zgxK, 0.8247, 3.53, 0.163, 461, 430, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
452, 4dvqB, 0.8246, 3.54, 0.170, 463, 430, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
453, 4dvqH, 0.8245, 3.52, 0.170, 462, 429, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
454, 2x7yA, 0.8245, 2.88, 0.179, 437, 414, P450 BM3 F87A IN COMPLEX WITH DMSO
455, 2vn0A, 0.8245, 3.88, 0.154, 464, 442, CYP2C8DH COMPLEXED WITH TROGLITAZONE
456, 4dvqA, 0.8244, 3.56, 0.160, 463, 431, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
457, 4kf2A, 0.8243, 3.31, 0.180, 451, 422, STRUCTURE OF THE P4509 BM3 A82F F87V HEME DOMAIN
458, 4dvqC, 0.8241, 3.48, 0.171, 462, 428, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
459, 5e9zD, 0.8239, 3.18, 0.173, 444, 421, CYTOCHROME P450 BM3 MUTANT M11
460, 4zgxF, 0.8239, 3.54, 0.169, 464, 431, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
461, 2nniA, 0.8238, 3.83, 0.152, 463, 440, CYP2C8DH COMPLEXED WITH MONTELUKAST
462, 4fdhA, 0.8237, 3.56, 0.160, 463, 431, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
463, 4dvqI, 0.8237, 3.51, 0.168, 462, 429, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
464, 4dvqJ, 0.8236, 3.56, 0.172, 462, 430, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
465, 4fdhI, 0.8235, 3.52, 0.168, 462, 429, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
466, 4zgxL, 0.8234, 3.48, 0.166, 462, 429, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
467, 4kewB, 0.8231, 3.11, 0.172, 443, 418, STRUCTURE OF THE A82F BM3 HEME DOMAIN IN COMPLEX WITH OMEPRAZOLE
468, 4hggA, 0.8231, 3.04, 0.175, 435, 417, CRYSTAL STRUCTURE OF P450 BM3 5F5R HEME DOMAIN VARIANT COMPLEXED WITH STYRENE
469, 4dvqD, 0.8231, 3.51, 0.166, 462, 429, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
470, 4kf0A, 0.8230, 3.41, 0.179, 451, 424, STRUCTURE OF THE A82F P450 BM3 HEME DOMAIN
471, 4fdhC, 0.8230, 3.56, 0.165, 462, 430, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
472, 4fdhH, 0.8229, 3.54, 0.168, 462, 429, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
473, 1e9xA, 0.8228, 3.42, 0.272, 449, 427, CYTOCHROME P450 14 ALPHA-STEROL DEMETHYLASE (CYP51) FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH 4-PHENYLIMIDAZOLE
474, 4nz2B, 0.8226, 3.62, 0.163, 464, 436, CRYSTAL STRUCTURE OF CYP2C9 IN COMPLEX WITH AN INHIBITOR
475, 1pq2A, 0.8224, 3.84, 0.153, 463, 439, CRYSTAL STRUCTURE OF HUMAN DRUG METABOLIZING CYTOCHROME P450 2C8
476, 4dvqK, 0.8223, 3.45, 0.169, 460, 427, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
477, 1pq2B, 0.8223, 3.85, 0.152, 463, 441, CRYSTAL STRUCTURE OF HUMAN DRUG METABOLIZING CYTOCHROME P450 2C8
478, 3ua5A, 0.8222, 3.86, 0.163, 465, 443, CRYSTAL STRUCTURE OF P450 2B6 (Y226H/K262R) IN COMPLEX WITH TWO MOLECULES OF AMLODIPINE
479, 6b82A, 0.8218, 3.57, 0.179, 465, 431, ZEBRA FISH CYP-450 17A1 MUTANT ABIRATERONE COMPLEX
480, 5xxiA, 0.8217, 3.64, 0.159, 463, 435, CRYSTAL STRUCTURE OF CYP2C9 IN COMPLEX WITH MULTIPLE LOSARTAN MOLECULES
481, 4kf2B, 0.8217, 3.37, 0.180, 448, 423, STRUCTURE OF THE P4509 BM3 A82F F87V HEME DOMAIN
482, 3tdaD, 0.8217, 3.45, 0.152, 456, 427, COMPETITIVE REPLACEMENT OF THIORIDAZINE BY PRINOMASTAT IN CRYSTALS OF CYTOCHROME P450 2D6
483, 3qz1C, 0.8216, 3.34, 0.133, 437, 422, CRYSTAL STRUCTURE OF BOVINE STEROID OF 21-HYDROXYLASE (P450C21)
484, 2nnjA, 0.8216, 3.88, 0.154, 463, 441, CYP2C8DH COMPLEXED WITH FELODIPINE
485, 4nz2A, 0.8215, 3.72, 0.155, 464, 438, CRYSTAL STRUCTURE OF CYP2C9 IN COMPLEX WITH AN INHIBITOR
486, 4fdhL, 0.8215, 3.38, 0.162, 456, 425, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
487, 1smiA, 0.8213, 3.13, 0.172, 439, 418, A SINGLE MUTATION OF P450 BM3 INDUCES THE CONFORMATIONAL REARRANGEMENT SEEN UPON SUBSTRATE-BINDING IN WILD-TYPE ENZYME
488, 4xryB, 0.8212, 3.49, 0.161, 455, 428, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 5 COMPLEX
489, 4zgxE, 0.8211, 3.47, 0.169, 459, 426, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
490, 3tbgD, 0.8211, 3.47, 0.150, 456, 427, HUMAN CYTOCHROME P450 2D6 WITH TWO THIORIDAZINES BOUND IN ACTIVE SITE
491, 3tbgB, 0.8207, 3.49, 0.152, 456, 427, HUMAN CYTOCHROME P450 2D6 WITH TWO THIORIDAZINES BOUND IN ACTIVE SITE
492, 4fdhJ, 0.8206, 3.60, 0.167, 462, 430, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
493, 3tdaB, 0.8206, 3.43, 0.155, 456, 426, COMPETITIVE REPLACEMENT OF THIORIDAZINE BY PRINOMASTAT IN CRYSTALS OF CYTOCHROME P450 2D6
494, 3qi8B, 0.8205, 3.38, 0.175, 452, 423, EVOLVED VARIANT OF CYTOCHROME P450 (BM3 CYP102A1)
495, 1ea1A, 0.8204, 3.49, 0.273, 447, 428, CYTOCHROME P450 14 ALPHA-STEROL DEMETHYLASE (CYP51) FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH FLUCONAZOLE
496, 3qz1B, 0.8203, 3.32, 0.128, 436, 421, CRYSTAL STRUCTURE OF BOVINE STEROID OF 21-HYDROXYLASE (P450C21)
497, 5x23A, 0.8202, 3.67, 0.159, 463, 435, CRYSTAL STRUCTURE OF CYP2C9 GENETIC VARIANT A477T (*30) IN COMPLEX WITH MULTIPLE LOSARTAN MOLECULES
498, 4zgxI, 0.8202, 3.42, 0.167, 458, 425, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
499, 5x24A, 0.8199, 3.72, 0.156, 463, 436, CRYSTAL STRUCTURE OF CYP2C9 GENETIC VARIANT I359L (*3) IN COMPLEX WITH MULTIPLE LOSARTAN MOLECULES
500, 4dvqL, 0.8198, 3.37, 0.168, 454, 423, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
501, 4wnvB, 0.8196, 3.45, 0.150, 455, 426, HUMAN CYTOCHROME P450 2D6 QUININE COMPLEX
502, 4i8vB, 0.8196, 3.84, 0.172, 472, 437, HUMAN CYTOCHROME P450 1A1 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
503, 4kf0B, 0.8195, 3.29, 0.179, 441, 420, STRUCTURE OF THE A82F P450 BM3 HEME DOMAIN
504, 3ua5B, 0.8193, 3.89, 0.158, 462, 442, CRYSTAL STRUCTURE OF P450 2B6 (Y226H/K262R) IN COMPLEX WITH TWO MOLECULES OF AMLODIPINE
505, 4keyB, 0.8189, 3.17, 0.168, 442, 417, STRUCTURE OF P450 BM3 A82F F87V IN COMPLEX WITH OMEPRAZOLE
506, 5e0eA, 0.8186, 3.77, 0.167, 463, 438, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B37 FROM DESERT WOODRAT IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
507, 4wnvC, 0.8184, 3.46, 0.160, 454, 425, HUMAN CYTOCHROME P450 2D6 QUININE COMPLEX
508, 3dl9B, 0.8183, 3.64, 0.145, 467, 433, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH 1-ALPHA-HYDROXY- VITAMIN D2
509, 4wntB, 0.8182, 3.43, 0.158, 455, 425, HUMAN CYTOCHROME P450 2D6 AJMALICINE COMPLEX
510, 3hf2A, 0.8181, 2.72, 0.178, 428, 405, CRYSTAL STRUCTURE OF THE I401P MUTANT OF CYTOCHROME P450 BM3
511, 3c6gB, 0.8181, 3.64, 0.145, 467, 433, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH VITAMIN D3
512, 3czhB, 0.8175, 3.66, 0.143, 467, 433, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH VITAMIN D2
513, 3czhA, 0.8175, 3.72, 0.143, 465, 435, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH VITAMIN D2
514, 3dl9A, 0.8174, 3.71, 0.143, 465, 435, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH 1-ALPHA-HYDROXY- VITAMIN D2
515, 2f9qC, 0.8174, 3.52, 0.148, 454, 425, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2D6
516, 2f9qA, 0.8173, 3.52, 0.148, 454, 425, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2D6
517, 3qm4A, 0.8171, 3.71, 0.152, 465, 433, HUMAN CYTOCHROME P450 (CYP) 2D6 - PRINOMASTAT COMPLEX
518, 4xrzB, 0.8170, 3.60, 0.165, 458, 430, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 6 COMPLEX
519, 4i8vA, 0.8170, 3.91, 0.171, 477, 438, HUMAN CYTOCHROME P450 1A1 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
520, 4i8vD, 0.8169, 3.78, 0.175, 467, 435, HUMAN CYTOCHROME P450 1A1 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
521, 4wntA, 0.8167, 3.52, 0.159, 457, 427, HUMAN CYTOCHROME P450 2D6 AJMALICINE COMPLEX
522, 3qz1D, 0.8167, 3.33, 0.138, 434, 420, CRYSTAL STRUCTURE OF BOVINE STEROID OF 21-HYDROXYLASE (P450C21)
523, 4i8vC, 0.8165, 3.85, 0.172, 468, 436, HUMAN CYTOCHROME P450 1A1 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
524, 5veuE, 0.8162, 3.19, 0.199, 441, 418, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
525, 4gqsC, 0.8154, 3.74, 0.154, 462, 435, STRUCTURE OF HUMAN MICROSOMAL CYTOCHROME P450 (CYP) 2C19
526, 3c6gA, 0.8153, 3.71, 0.141, 464, 434, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH VITAMIN D3
527, 1og2B, 0.8153, 3.71, 0.161, 461, 434, STRUCTURE OF HUMAN CYTOCHROME P450 CYP2C9
528, 4xrzD, 0.8150, 3.55, 0.155, 455, 427, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 6 COMPLEX
529, 4wnvD, 0.8148, 3.46, 0.151, 453, 424, HUMAN CYTOCHROME P450 2D6 QUININE COMPLEX
530, 5tfuB, 0.8147, 3.47, 0.156, 451, 424, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
531, 4gqsB, 0.8147, 3.93, 0.153, 456, 437, STRUCTURE OF HUMAN MICROSOMAL CYTOCHROME P450 (CYP) 2C19
532, 4xrzA, 0.8146, 3.61, 0.166, 457, 429, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 6 COMPLEX
533, 4xrzC, 0.8144, 3.54, 0.155, 455, 426, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 6 COMPLEX
534, 4wnuB, 0.8142, 3.50, 0.151, 453, 424, HUMAN CYTOCHROME P450 2D6 QUINIDINE COMPLEX
535, 4ejgH, 0.8142, 3.71, 0.155, 458, 433, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
536, 4ejhH, 0.8138, 3.72, 0.152, 459, 433, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
537, 1og5A, 0.8135, 3.76, 0.154, 461, 435, STRUCTURE OF HUMAN CYTOCHROME P450 CYP2C9
538, 4ejhG, 0.8133, 3.82, 0.167, 463, 436, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
539, 4wnuC, 0.8131, 3.49, 0.158, 452, 423, HUMAN CYTOCHROME P450 2D6 QUINIDINE COMPLEX
540, 5tftD, 0.8129, 3.50, 0.151, 453, 424, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
541, 4wnuA, 0.8129, 3.46, 0.156, 449, 422, HUMAN CYTOCHROME P450 2D6 QUINIDINE COMPLEX
542, 4wnwA, 0.8128, 3.78, 0.145, 461, 433, HUMAN CYTOCHROME P450 2D6 THIORIDAZINE COMPLEX
543, 1bvyB, 0.8128, 3.31, 0.167, 438, 414, COMPLEX OF THE HEME AND FMN-BINDING DOMAINS OF THE CYTOCHROME P450(BM-3)
544, 1og2A, 0.8126, 3.76, 0.161, 461, 434, STRUCTURE OF HUMAN CYTOCHROME P450 CYP2C9
545, 1og5B, 0.8125, 3.71, 0.154, 461, 434, STRUCTURE OF HUMAN CYTOCHROME P450 CYP2C9
546, 3hf2B, 0.8122, 2.78, 0.179, 423, 403, CRYSTAL STRUCTURE OF THE I401P MUTANT OF CYTOCHROME P450 BM3
547, 5tfuD, 0.8118, 3.51, 0.153, 453, 424, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
548, 5tfuA, 0.8118, 3.49, 0.159, 451, 422, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
549, 2f9qB, 0.8117, 3.52, 0.149, 451, 422, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2D6
550, 3qm4B, 0.8116, 3.82, 0.148, 457, 433, HUMAN CYTOCHROME P450 (CYP) 2D6 - PRINOMASTAT COMPLEX
551, 1bvyA, 0.8116, 3.31, 0.169, 439, 414, COMPLEX OF THE HEME AND FMN-BINDING DOMAINS OF THE CYTOCHROME P450(BM-3)
552, 4wnuD, 0.8115, 3.52, 0.151, 450, 423, HUMAN CYTOCHROME P450 2D6 QUINIDINE COMPLEX
553, 2f9qD, 0.8113, 3.53, 0.152, 451, 422, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2D6
554, 5tfuC, 0.8108, 3.49, 0.151, 450, 423, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
555, 3dgiB, 0.8108, 2.70, 0.184, 425, 402, CRYSTAL STRUCTURE OF F87A/T268A MUTANT OF CYP BM3
556, 4xryD, 0.8106, 3.51, 0.154, 452, 423, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 5 COMPLEX
557, 3tmzA, 0.8099, 3.96, 0.162, 463, 439, CRYSTAL STRUCTURE OF P450 2B4(H226Y) IN COMPLEX WITH AMLODIPINE
558, 4ejgG, 0.8098, 3.86, 0.165, 463, 436, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
559, 5tftC, 0.8096, 3.42, 0.152, 447, 420, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
560, 4gqsD, 0.8094, 3.76, 0.157, 452, 432, STRUCTURE OF HUMAN MICROSOMAL CYTOCHROME P450 (CYP) 2C19
561, 2w0bA, 0.8091, 3.37, 0.275, 440, 418, CYP51 OF M. TUBERCULOSIS BOUND TO AN INHIBITOR 3-{[(4- METHYLPHENYL)SULFONYL]AMINO}PROPYL PYRIDIN-4-YLCARBAMATE
562, 2bz9B, 0.8088, 3.22, 0.283, 432, 414, LIGAND-FREE STRUCTURE OF STEROL 14ALPHA-DEMETHYLASE FROM MYCOBACTERIUM TUBERCULOSIS IN P2(1) SPACE GROUP
563, 2p85B, 0.8072, 3.99, 0.176, 464, 438, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
564, 4xryC, 0.8068, 3.45, 0.153, 446, 419, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 5 COMPLEX
565, 1dt6A, 0.8065, 3.67, 0.150, 449, 427, STRUCTURE OF MAMMALIAN CYTOCHROME P450 2C5
566, 3ebsB, 0.8064, 4.00, 0.171, 466, 438, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PHENACETIN
567, 2pg7B, 0.8058, 3.97, 0.162, 464, 437, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q/I300V
568, 1suoA, 0.8057, 4.02, 0.158, 465, 438, STRUCTURE OF MAMMALIAN CYTOCHROME P450 2B4 WITH BOUND 4-(4- CHLOROPHENYL)IMIDAZOLE
569, 4wnwB, 0.8054, 3.75, 0.150, 452, 428, HUMAN CYTOCHROME P450 2D6 THIORIDAZINE COMPLEX
570, 3ibdA, 0.8052, 4.04, 0.162, 465, 439, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2B6 GENETIC VARIANT IN COMPLEX WITH THE INHIBITOR 4-(4-CHLOROPHENYL)IMIDAZOLE
571, 1z11B, 0.8051, 3.99, 0.162, 464, 437, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH METHOXSALEN BOUND
572, 5iutA, 0.8043, 3.98, 0.151, 460, 437, STRUCTURE OF P450 2B4 F202W MUTANT
573, 2iagA, 0.8043, 3.57, 0.173, 471, 421, CRYSTAL STRUCTURE OF HUMAN PROSTACYCLIN SYNTHASE
574, 2fdwB, 0.8041, 4.01, 0.165, 465, 437, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH THE INHIBITOR (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
575, 3b6hA, 0.8040, 3.57, 0.176, 469, 420, CRYSTAL STRUCTURE OF HUMAN PROSTACYCLIN SYNTHASE IN COMPLEX WITH INHIBITOR MINOXIDIL
576, 2pg6B, 0.8039, 4.02, 0.158, 464, 437, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 L240C/N297Q
577, 2bz9A, 0.8037, 3.39, 0.280, 429, 414, LIGAND-FREE STRUCTURE OF STEROL 14ALPHA-DEMETHYLASE FROM MYCOBACTERIUM TUBERCULOSIS IN P2(1) SPACE GROUP
578, 1x8vA, 0.8034, 3.20, 0.279, 429, 412, ESTRIOL-BOUND AND LIGAND-FREE STRUCTURES OF STEROL 14ALPHA- DEMETHYLASE (CYP51)
579, 3b6hB, 0.8032, 3.57, 0.171, 470, 420, CRYSTAL STRUCTURE OF HUMAN PROSTACYCLIN SYNTHASE IN COMPLEX WITH INHIBITOR MINOXIDIL
580, 2pg5B, 0.8032, 4.03, 0.162, 464, 437, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q
581, 1z11C, 0.8032, 4.03, 0.165, 464, 437, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH METHOXSALEN BOUND
582, 2fduC, 0.8031, 4.03, 0.165, 464, 437, MICROSOMAL P450 2A6 WITH THE INHIBITOR NN-DIMETHYL(5- (PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
583, 1z10B, 0.8031, 4.02, 0.162, 465, 437, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH COUMARIN BOUND
584, 1z10C, 0.8026, 4.04, 0.165, 464, 437, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH COUMARIN BOUND
585, 1u13A, 0.8024, 3.26, 0.276, 433, 413, CRYSTAL STRUCTURE ANALYSIS OF THE C37L/C151T/C442A-TRIPLE MUTANT OF CYP51 FROM MYCOBACTERIUM TUBERCULOSIS
586, 2pg6C, 0.8023, 4.05, 0.165, 464, 437, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 L240C/N297Q
587, 4nkvA, 0.8022, 3.87, 0.163, 466, 429, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH INHIBITOR ABIRATERONE
588, 2fdvC, 0.8022, 4.04, 0.165, 464, 437, MICROSOMAL P450 2A6 WITH THE INHIBITOR N-METHYL(5-(PYRIDIN- 3-YL)FURAN-2-YL)METHANAMINE BOUND
589, 3ebsC, 0.8021, 4.03, 0.167, 464, 437, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PHENACETIN
590, 2pg5C, 0.8020, 4.02, 0.163, 463, 436, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q
591, 2fdvB, 0.8020, 4.05, 0.162, 465, 437, MICROSOMAL P450 2A6 WITH THE INHIBITOR N-METHYL(5-(PYRIDIN- 3-YL)FURAN-2-YL)METHANAMINE BOUND
592, 5uysA, 0.8019, 3.81, 0.164, 471, 428, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 WITH 3ALPHAOH-5ALPHA- ABIRATERONE ANALOG
593, 3me6D, 0.8018, 4.08, 0.153, 465, 438, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG CLOPIDOGREL
594, 3me6B, 0.8018, 4.08, 0.153, 465, 438, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG CLOPIDOGREL
595, 2fdyC, 0.8018, 4.05, 0.165, 464, 437, MICROSOMAL P450 2A6 WITH THE INHIBITOR ADRITHIOL BOUND
596, 1z11A, 0.8018, 4.07, 0.162, 467, 438, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH METHOXSALEN BOUND
597, 6chiA, 0.8017, 3.88, 0.163, 466, 429, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 AMIDE 
598, 2fdwC, 0.8016, 4.05, 0.165, 464, 437, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH THE INHIBITOR (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
599, 5irvB, 0.8015, 3.87, 0.166, 471, 429, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITOR VT-464
600, 5irqB, 0.8015, 3.88, 0.161, 467, 429, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITORS (R)- AND (S)- ORTERONEL
601, 6cizA, 0.8014, 3.88, 0.161, 468, 429, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 NITRILE 
602, 6chiB, 0.8014, 3.84, 0.164, 468, 428, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 AMIDE 
603, 5uysB, 0.8014, 3.83, 0.164, 470, 428, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 WITH 3ALPHAOH-5ALPHA- ABIRATERONE ANALOG
604, 3el3A, 0.8014, 2.97, 0.187, 417, 401, DISTINCT MONOOXYGENASE AND FARNESENE SYNTHASE ACTIVE SITES IN CYTOCHROME P450 170A1
605, 2pg7C, 0.8013, 4.06, 0.162, 464, 437, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q/I300V
606, 2iagB, 0.8013, 3.42, 0.173, 468, 415, CRYSTAL STRUCTURE OF HUMAN PROSTACYCLIN SYNTHASE
607, 6cizB, 0.8012, 3.83, 0.161, 469, 428, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 NITRILE 
608, 5iuzB, 0.8012, 4.04, 0.149, 464, 436, STRUCTURE OF P450 2B4 F202W MUTANT (CYMAL-5)
609, 4ruiE, 0.8012, 4.08, 0.162, 465, 438, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
610, 4nkvB, 0.8012, 3.89, 0.163, 467, 429, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH INHIBITOR ABIRATERONE
611, 3me6C, 0.8012, 4.09, 0.158, 465, 438, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG CLOPIDOGREL
612, 2fduB, 0.8012, 4.03, 0.163, 463, 436, MICROSOMAL P450 2A6 WITH THE INHIBITOR NN-DIMETHYL(5- (PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
613, 3me6A, 0.8011, 4.08, 0.158, 465, 438, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG CLOPIDOGREL
614, 3kw4A, 0.8009, 4.01, 0.158, 466, 436, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG TICLOPIDINE
615, 6cirA, 0.8008, 3.90, 0.163, 466, 429, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 OXIME 
616, 4ruiF, 0.8007, 4.07, 0.164, 465, 438, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
617, 1h5zA, 0.8007, 3.38, 0.280, 434, 414, CYTOCHROME P450 14 ALPHA-STEROL DEMETHYLASE (CYP51) FROM MYCOBACTERIUM TUBERCULOSIS IN FERRIC LOW-SPIN STATE
618, 3uasA, 0.8006, 3.95, 0.152, 461, 434, CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR 9-ETHYNYLPHENANTHRENE
619, 4ruiD, 0.8004, 4.08, 0.164, 465, 438, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
620, 3t3qC, 0.8004, 4.03, 0.167, 463, 436, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PILOCARPINE
621, 3tk3D, 0.8002, 4.10, 0.153, 465, 438, CYTOCHROME P450 2B4 MUTANT L437A IN COMPLEX WITH 4-(4-CHLOROPHENYL) IMIDAZOLE
622, 4jltA, 0.8000, 3.93, 0.150, 458, 433, CRYSTAL STRUCTURE OF P450 2B4(H226Y) IN COMPLEX WITH PAROXETINE
623, 5irvA, 0.7999, 3.85, 0.164, 471, 428, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITOR VT-464
624, 5irqA, 0.7999, 3.87, 0.159, 466, 428, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITORS (R)- AND (S)- ORTERONEL
625, 3tk3B, 0.7999, 4.11, 0.158, 465, 438, CYTOCHROME P450 2B4 MUTANT L437A IN COMPLEX WITH 4-(4-CHLOROPHENYL) IMIDAZOLE
626, 1z11D, 0.7999, 4.07, 0.165, 464, 437, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH METHOXSALEN BOUND
627, 3t3rD, 0.7997, 3.99, 0.159, 464, 435, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH PILOCARPINE
628, 3el3B, 0.7997, 3.06, 0.203, 417, 403, DISTINCT MONOOXYGENASE AND FARNESENE SYNTHASE ACTIVE SITES IN CYTOCHROME P450 170A1
629, 2fduD, 0.7997, 4.07, 0.165, 464, 437, MICROSOMAL P450 2A6 WITH THE INHIBITOR NN-DIMETHYL(5- (PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
630, 5iuzA, 0.7995, 3.96, 0.145, 459, 433, STRUCTURE OF P450 2B4 F202W MUTANT (CYMAL-5)
631, 4ejjC, 0.7995, 4.06, 0.162, 464, 437, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH NICOTINE
632, 4ejgE, 0.7995, 4.07, 0.165, 465, 437, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
633, 3tk3C, 0.7994, 4.12, 0.158, 465, 438, CYTOCHROME P450 2B4 MUTANT L437A IN COMPLEX WITH 4-(4-CHLOROPHENYL) IMIDAZOLE
634, 4ruiB, 0.7993, 4.09, 0.164, 465, 438, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
635, 3tk3A, 0.7993, 4.11, 0.158, 465, 438, CYTOCHROME P450 2B4 MUTANT L437A IN COMPLEX WITH 4-(4-CHLOROPHENYL) IMIDAZOLE
636, 3rukB, 0.7993, 3.91, 0.161, 465, 429, HUMAN CYTOCHROME P450 CYP17A1 IN COMPLEX WITH ABIRATERONE
637, 4nkwA, 0.7992, 3.92, 0.163, 464, 429, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PREGNENOLONE
638, 3swzA, 0.7992, 3.86, 0.164, 471, 428, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH TOK-001
639, 6cirB, 0.7990, 3.88, 0.161, 466, 428, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 OXIME 
640, 4nkxB, 0.7990, 3.92, 0.163, 468, 429, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PROGESTERONE
641, 4nkwB, 0.7990, 3.85, 0.164, 464, 428, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PREGNENOLONE
642, 4ejjA, 0.7990, 4.07, 0.165, 465, 437, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH NICOTINE
643, 2pg7A, 0.7990, 4.08, 0.167, 464, 437, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q/I300V
644, 4ruiC, 0.7989, 4.07, 0.162, 464, 437, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
645, 3t3rA, 0.7989, 4.06, 0.158, 463, 436, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH PILOCARPINE
646, 3t3qD, 0.7989, 4.07, 0.167, 463, 436, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PILOCARPINE
647, 2fduA, 0.7989, 4.09, 0.162, 465, 437, MICROSOMAL P450 2A6 WITH THE INHIBITOR NN-DIMETHYL(5- (PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
648, 2fdvA, 0.7988, 4.09, 0.162, 465, 437, MICROSOMAL P450 2A6 WITH THE INHIBITOR N-METHYL(5-(PYRIDIN- 3-YL)FURAN-2-YL)METHANAMINE BOUND
649, 1z10D, 0.7988, 4.08, 0.165, 464, 437, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH COUMARIN BOUND
650, 4nkyA, 0.7987, 3.88, 0.164, 462, 428, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPROGESTERONE
651, 4ejhE, 0.7987, 4.12, 0.171, 464, 438, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
652, 4ejjB, 0.7985, 4.07, 0.167, 464, 437, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH NICOTINE
653, 4ejgA, 0.7985, 4.14, 0.174, 464, 438, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
654, 3mvrA, 0.7985, 4.09, 0.160, 463, 437, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4-H226Y IN A CLOSED CONFORMATION
655, 2q6nG, 0.7985, 4.10, 0.160, 465, 438, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
656, 3mvrB, 0.7984, 4.10, 0.160, 463, 437, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4-H226Y IN A CLOSED CONFORMATION
657, 4ejgF, 0.7983, 4.10, 0.172, 465, 437, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
658, 2pg5D, 0.7983, 4.10, 0.165, 464, 437, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q
659, 5wbgB, 0.7982, 4.15, 0.160, 464, 438, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
660, 4ruiA, 0.7982, 4.08, 0.165, 464, 437, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
661, 4nkzB, 0.7981, 3.85, 0.159, 461, 427, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPREGNENOLONE
662, 4nkzA, 0.7981, 3.93, 0.163, 463, 429, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPREGNENOLONE
663, 4nkxA, 0.7981, 3.86, 0.164, 466, 428, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PROGESTERONE
664, 3rukA, 0.7981, 3.92, 0.163, 464, 429, HUMAN CYTOCHROME P450 CYP17A1 IN COMPLEX WITH ABIRATERONE
665, 3ebsD, 0.7981, 4.09, 0.169, 464, 437, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PHENACETIN
666, 5uysC, 0.7980, 3.83, 0.171, 473, 426, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 WITH 3ALPHAOH-5ALPHA- ABIRATERONE ANALOG
667, 4nkyB, 0.7980, 3.86, 0.162, 464, 427, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPROGESTERONE
668, 3swzB, 0.7980, 3.88, 0.164, 465, 428, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH TOK-001
669, 2pg7D, 0.7980, 4.11, 0.165, 464, 437, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q/I300V
670, 4ejgC, 0.7979, 4.10, 0.167, 464, 437, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
671, 3t3qB, 0.7979, 4.07, 0.165, 463, 436, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PILOCARPINE
672, 3ebsA, 0.7979, 4.10, 0.167, 465, 437, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PHENACETIN
673, 5wbgC, 0.7978, 4.17, 0.160, 464, 438, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
674, 5irvD, 0.7977, 3.74, 0.172, 472, 424, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITOR VT-464
675, 4ejhC, 0.7977, 4.10, 0.172, 464, 437, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
676, 5wbgF, 0.7976, 4.17, 0.160, 464, 438, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
677, 5irvC, 0.7976, 3.74, 0.170, 475, 424, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITOR VT-464
678, 3rukD, 0.7976, 3.79, 0.167, 473, 425, HUMAN CYTOCHROME P450 CYP17A1 IN COMPLEX WITH ABIRATERONE
679, 2fdwD, 0.7976, 4.10, 0.165, 464, 437, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH THE INHIBITOR (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
680, 1z10A, 0.7976, 4.11, 0.162, 465, 437, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH COUMARIN BOUND
681, 4nkvC, 0.7975, 3.75, 0.170, 471, 424, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH INHIBITOR ABIRATERONE
682, 2pg5A, 0.7974, 4.11, 0.165, 464, 437, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q
683, 5wbgA, 0.7973, 4.16, 0.160, 463, 438, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
684, 4ejgD, 0.7973, 4.10, 0.167, 465, 437, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
685, 3qu8A, 0.7973, 4.11, 0.160, 462, 438, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
686, 4ejgB, 0.7971, 4.14, 0.174, 464, 438, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
687, 2fdyB, 0.7971, 4.04, 0.161, 464, 435, MICROSOMAL P450 2A6 WITH THE INHIBITOR ADRITHIOL BOUND
688, 5wbgE, 0.7970, 4.16, 0.160, 463, 438, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
689, 5uysD, 0.7970, 3.84, 0.171, 473, 426, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 WITH 3ALPHAOH-5ALPHA- ABIRATERONE ANALOG
690, 4ejhB, 0.7970, 4.11, 0.169, 464, 437, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
691, 2q6nB, 0.7970, 4.13, 0.158, 465, 438, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
692, 4ejhF, 0.7969, 4.10, 0.169, 464, 437, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
693, 4ejhA, 0.7969, 4.11, 0.169, 464, 437, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
694, 2p85E, 0.7969, 4.11, 0.172, 464, 437, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
695, 2fdwA, 0.7969, 4.12, 0.162, 465, 437, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH THE INHIBITOR (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
696, 4ejhD, 0.7968, 4.15, 0.174, 464, 438, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
697, 3t3sC, 0.7968, 4.16, 0.174, 464, 438, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
698, 2pg6D, 0.7968, 4.12, 0.162, 464, 437, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 L240C/N297Q
699, 6chiC, 0.7967, 3.79, 0.172, 476, 425, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 AMIDE 
700, 5wbgD, 0.7967, 4.18, 0.155, 464, 438, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
701, 4ejjD, 0.7967, 4.11, 0.165, 464, 437, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH NICOTINE
702, 5irqC, 0.7966, 3.71, 0.168, 472, 423, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITORS (R)- AND (S)- ORTERONEL
703, 4r21A, 0.7966, 3.33, 0.171, 422, 409, ZEBRA FISH CYTOCHROME P450 17A2 WITH PROGESTERONE
704, 3sn5A, 0.7966, 3.67, 0.178, 468, 422, CRYSTAL STRUCTURE OF HUMAN CYP7A1 IN COMPLEX WITH CHOLEST-4-EN-3-ONE
705, 2pg6A, 0.7966, 4.13, 0.160, 465, 437, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 L240C/N297Q
706, 2fdvD, 0.7966, 4.11, 0.165, 464, 437, MICROSOMAL P450 2A6 WITH THE INHIBITOR N-METHYL(5-(PYRIDIN- 3-YL)FURAN-2-YL)METHANAMINE BOUND
707, 6cizC, 0.7965, 3.85, 0.171, 477, 426, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 NITRILE 
708, 3t3sD, 0.7965, 4.11, 0.169, 464, 437, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
709, 3qu8B, 0.7963, 4.05, 0.156, 459, 435, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
710, 4h1nA, 0.7962, 4.07, 0.147, 459, 435, CRYSTAL STRUCTURE OF P450 2B4 F297A MUTANT IN COMPLEX WITH ANTI- PLATELET DRUG CLOPIDOGREL
711, 3qu8C, 0.7962, 4.16, 0.160, 462, 438, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
712, 3kohB, 0.7961, 4.14, 0.158, 463, 437, CYTOCHROME P450 2E1 WITH OMEGA-IMIDAZOLYL OCTANOIC ACID
713, 3t3sB, 0.7960, 4.12, 0.172, 464, 437, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
714, 2q6nF, 0.7960, 4.20, 0.164, 465, 439, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
715, 2p85C, 0.7958, 4.12, 0.167, 464, 437, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
716, 3qu8E, 0.7957, 4.05, 0.156, 459, 435, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
717, 5irqD, 0.7956, 3.84, 0.169, 465, 425, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITORS (R)- AND (S)- ORTERONEL
718, 3swzC, 0.7956, 3.83, 0.172, 470, 425, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH TOK-001
719, 3r1aA, 0.7956, 4.19, 0.164, 465, 439, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
720, 3t3sA, 0.7955, 4.16, 0.174, 464, 438, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
721, 3t3qA, 0.7955, 4.10, 0.165, 463, 436, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PILOCARPINE
722, 6cizD, 0.7954, 3.86, 0.171, 468, 426, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 NITRILE 
723, 5em4A, 0.7954, 4.08, 0.149, 460, 435, STRUCTURE OF CYP2B4 F244W IN A LIGAND FREE CONFORMATION
724, 6cirC, 0.7953, 3.78, 0.170, 472, 424, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 OXIME 
725, 3t3rB, 0.7953, 4.10, 0.161, 463, 436, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH PILOCARPINE
726, 3kohA, 0.7953, 4.16, 0.158, 463, 437, CYTOCHROME P450 2E1 WITH OMEGA-IMIDAZOLYL OCTANOIC ACID
727, 5em4B, 0.7952, 4.08, 0.152, 459, 435, STRUCTURE OF CYP2B4 F244W IN A LIGAND FREE CONFORMATION
728, 4j14A, 0.7952, 3.48, 0.153, 436, 412, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 CYP46A1 WITH POSACONAZOLE BOUND
729, 2fdyA, 0.7951, 4.13, 0.165, 465, 437, MICROSOMAL P450 2A6 WITH THE INHIBITOR ADRITHIOL BOUND
730, 6chiD, 0.7950, 3.87, 0.171, 467, 426, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 AMIDE 
731, 3t3rC, 0.7950, 4.10, 0.161, 463, 436, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH PILOCARPINE
732, 3r1aC, 0.7950, 4.16, 0.160, 465, 438, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
733, 3rukC, 0.7949, 3.88, 0.167, 472, 426, HUMAN CYTOCHROME P450 CYP17A1 IN COMPLEX WITH ABIRATERONE
734, 4ejiA, 0.7948, 4.17, 0.172, 464, 437, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH TWO MOLECULES OF 4- (METHYLNITROSAMINO)-1-(3-PURIDYL)-1-BUTANONE
735, 2fdyD, 0.7948, 4.14, 0.162, 464, 437, MICROSOMAL P450 2A6 WITH THE INHIBITOR ADRITHIOL BOUND
736, 4nkyC, 0.7947, 3.78, 0.170, 467, 424, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPROGESTERONE
737, 3sn5B, 0.7947, 3.63, 0.183, 466, 420, CRYSTAL STRUCTURE OF HUMAN CYP7A1 IN COMPLEX WITH CHOLEST-4-EN-3-ONE
738, 2p85F, 0.7947, 4.18, 0.176, 464, 438, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
739, 4nkwC, 0.7946, 3.76, 0.168, 467, 423, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PREGNENOLONE
740, 6cirD, 0.7945, 3.81, 0.167, 471, 424, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 OXIME 
741, 3t3sG, 0.7945, 4.16, 0.176, 464, 438, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
742, 4rqlA, 0.7944, 4.21, 0.159, 465, 439, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH A MONOTERPENE - SABINENE
743, 3t3sF, 0.7944, 4.13, 0.167, 464, 437, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
744, 4nkwD, 0.7943, 3.77, 0.173, 467, 423, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PREGNENOLONE
745, 3e6iA, 0.7943, 4.15, 0.161, 462, 436, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH THE INHIBITOR INDAZOLE
746, 5e58C, 0.7942, 4.16, 0.148, 465, 438, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
747, 4rqlB, 0.7942, 4.21, 0.159, 465, 439, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH A MONOTERPENE - SABINENE
748, 3r1aD, 0.7941, 4.18, 0.160, 465, 438, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
749, 3danA, 0.7941, 3.46, 0.140, 473, 413, CRYSTAL STRUCTURE OF ALLENE OXIDE SYNTHASE
750, 2p85D, 0.7941, 4.18, 0.171, 464, 438, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
751, 4nkvD, 0.7940, 3.80, 0.170, 466, 424, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH INHIBITOR ABIRATERONE
752, 3qoaA, 0.7940, 4.16, 0.153, 460, 437, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-BENZYLPYRIDINE.
753, 4nkxC, 0.7939, 3.77, 0.168, 469, 423, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PROGESTERONE
754, 2q9fA, 0.7939, 3.32, 0.152, 433, 409, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 46A1 IN COMPLEX WITH CHOLESTEROL-3-SULPHATE
755, 3mdmA, 0.7938, 3.45, 0.160, 435, 412, THIOPERAMIDE COMPLEX OF CYTOCHROME P450 46A1
756, 2q6nC, 0.7938, 4.17, 0.162, 465, 438, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
757, 3qu8D, 0.7937, 4.06, 0.157, 458, 434, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
758, 3e6iB, 0.7937, 4.16, 0.161, 461, 436, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH THE INHIBITOR INDAZOLE
759, 2q9gA, 0.7937, 3.26, 0.148, 422, 406, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 46A1
760, 2p85A, 0.7937, 4.16, 0.172, 464, 437, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
761, 4i91A, 0.7936, 4.16, 0.153, 465, 437, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH ALPHA-PINENE.
762, 3e4eA, 0.7935, 4.13, 0.161, 461, 435, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH THE INHIBITOR 4- METHYLPYRAZOLE
763, 2rclA, 0.7935, 3.38, 0.144, 465, 411, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 12R13S-VERNOLIC ACID AT 2.4 A RESOLUTION
764, 4nkxD, 0.7934, 3.82, 0.165, 468, 424, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PROGESTERONE
765, 3mdrA, 0.7934, 3.23, 0.157, 427, 407, TRANYLCYPROMINE COMPLEX OF CYTOCHROME P450 46A1
766, 3cliA, 0.7933, 3.39, 0.144, 465, 411, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) AT 1.80 A RESOLUTION
767, 4zv8A, 0.7932, 4.22, 0.159, 465, 439, STRUCTURE OF CYP2B6 (Y226H/K262R) WITH ADDITIONAL MUTATION Y244W IN COMPLEX WITH ALPHA-PINENE
768, 3t3zA, 0.7932, 4.16, 0.161, 464, 436, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH PILOCARPINE
769, 3gphB, 0.7932, 4.16, 0.161, 461, 436, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH OMEGA-IMIDAZOLYL-DECANOIC ACID
770, 5e58A, 0.7931, 4.16, 0.146, 464, 437, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
771, 3r1aG, 0.7931, 4.19, 0.160, 465, 438, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
772, 2rcmA, 0.7931, 3.39, 0.144, 465, 411, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A) AT 1.73 A RESOLUTION
773, 5uecA, 0.7929, 4.23, 0.159, 465, 439, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH MYRTENYL BROMIDE.
774, 3t3zB, 0.7929, 4.17, 0.161, 464, 436, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH PILOCARPINE
775, 3e4eB, 0.7928, 4.14, 0.161, 461, 435, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH THE INHIBITOR 4- METHYLPYRAZOLE
776, 3damA, 0.7928, 3.46, 0.140, 467, 413, CRYSTAL STRUCTURE OF ALLENE OXIDE SYNTHASE
777, 3mdtB, 0.7927, 3.19, 0.151, 424, 404, VORICONAZOLE COMPLEX OF CYTOCHROME P450 46A1
778, 3lc4B, 0.7926, 4.09, 0.148, 459, 433, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH OMEGA-IMIDAZOLYL-DODECANOIC ACID
779, 4nkyD, 0.7924, 3.83, 0.170, 465, 424, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPROGESTERONE
780, 3swzD, 0.7924, 3.82, 0.167, 466, 424, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH TOK-001
781, 3gphA, 0.7924, 4.17, 0.161, 461, 436, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH OMEGA-IMIDAZOLYL-DECANOIC ACID
782, 2q6nD, 0.7924, 4.22, 0.162, 465, 439, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
783, 3t3sE, 0.7923, 4.15, 0.169, 464, 437, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
784, 3r1aF, 0.7923, 4.19, 0.164, 465, 438, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
785, 3t3sH, 0.7922, 4.15, 0.174, 464, 437, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
786, 3lc4A, 0.7922, 4.15, 0.159, 460, 435, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH OMEGA-IMIDAZOLYL-DODECANOIC ACID
787, 3dsjA, 0.7922, 3.43, 0.133, 465, 412, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOD AT 1.60 A RESOLUTION
788, 5e58D, 0.7920, 4.14, 0.147, 463, 436, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
789, 3dsiA, 0.7920, 3.44, 0.133, 466, 412, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOT AT 1.60 A RESOLUTION
790, 4enhA, 0.7919, 3.29, 0.160, 426, 407, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 CYP46A1 WITH FLUVOXAMINE BOUND
791, 2rchA, 0.7919, 3.43, 0.133, 465, 412, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOD AT 1.85 A RESOLUTION
792, 2q6nE, 0.7919, 4.17, 0.162, 465, 437, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
793, 2q6nA, 0.7919, 4.20, 0.158, 465, 438, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
794, 3mdrB, 0.7918, 3.23, 0.158, 425, 406, TRANYLCYPROMINE COMPLEX OF CYTOCHROME P450 46A1
795, 3dskA, 0.7918, 3.44, 0.133, 466, 412, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 12R13S-VERNOLIC ACID AT 1.55 A RESOLUTION
796, 4r21B, 0.7917, 3.36, 0.164, 423, 408, ZEBRA FISH CYTOCHROME P450 17A2 WITH PROGESTERONE
797, 3t3zC, 0.7917, 4.18, 0.161, 464, 436, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH PILOCARPINE
798, 3dbmA, 0.7917, 3.48, 0.140, 467, 413, CRYSTAL STRUCTURE OF ALLENE OXIDE SYNTHASE
799, 4rrtA, 0.7916, 4.17, 0.156, 461, 436, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH (+)-3-CARENE
800, 3v8dA, 0.7916, 3.79, 0.166, 479, 422, CRYSTAL STRUCTURE OF HUMAN CYP7A1 IN COMPLEX WITH 7-KETOCHOLESTEROL
801, 3r1aE, 0.7916, 4.12, 0.163, 465, 436, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
802, 3mdtA, 0.7916, 3.17, 0.149, 424, 403, VORICONAZOLE COMPLEX OF CYTOCHROME P450 46A1
803, 3t3zD, 0.7915, 4.18, 0.161, 464, 436, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH PILOCARPINE
804, 1r9oA, 0.7915, 3.98, 0.150, 455, 427, CRYSTAL STRUCTURE OF P4502C9 WITH FLURBIPROFEN BOUND
805, 5e58E, 0.7913, 4.19, 0.149, 462, 437, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
806, 4rrtB, 0.7912, 4.18, 0.156, 461, 436, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH (+)-3-CARENE
807, 3r1aH, 0.7912, 4.16, 0.158, 464, 436, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
808, 4nkzC, 0.7910, 3.78, 0.166, 464, 422, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPREGNENOLONE
809, 3mdvB, 0.7910, 3.21, 0.158, 424, 405, CLOTRIMAZOLE COMPLEX OF CYTOCHROME P450 46A1
810, 3mdvA, 0.7910, 3.21, 0.158, 424, 405, CLOTRIMAZOLE COMPLEX OF CYTOCHROME P450 46A1
811, 4nkzD, 0.7909, 3.87, 0.165, 465, 424, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPREGNENOLONE
812, 3psxB, 0.7909, 2.69, 0.192, 414, 391, CRYSTAL STRUCTURE OF THE KT2 MUTANT OF CYTOCHROME P450 BM3
813, 5uapB, 0.7908, 4.24, 0.155, 463, 438, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH BORNYL BROMIDE
814, 4fiaA, 0.7908, 3.29, 0.160, 426, 407, CRYSTAL STRUCTURE OF HUMAN CYP46A1 P450 WITH BICALUTAMIDE BOUND
815, 5uapA, 0.7906, 4.24, 0.160, 464, 438, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH BORNYL BROMIDE
816, 5a5jA, 0.7905, 4.11, 0.149, 455, 429, CYTOCHROME 2C9 P450 INHIBITOR COMPLEX
817, 3daxB, 0.7903, 3.75, 0.176, 470, 421, CRYSTAL STRUCTURE OF HUMAN CYP7A1
818, 2w09A, 0.7901, 3.22, 0.287, 421, 404, CYP51 OF M. TUBERCULOSIS BOUND TO AN INHIBITOR CIS-4- METHYL-N-[(1S)-3-(METHYLSULFANYL)-1-(PYRIDIN-4- YLCARBAMOYL)PROPYL]CYCLOHEXANECARBOXAMIDE
819, 5udaA, 0.7900, 4.24, 0.160, 461, 438, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH A MONOTERPENE BORNANE
820, 3psxA, 0.7898, 2.84, 0.191, 412, 392, CRYSTAL STRUCTURE OF THE KT2 MUTANT OF CYTOCHROME P450 BM3
821, 5ufgA, 0.7897, 4.19, 0.149, 464, 436, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R/I114V) IN COMPLEX WITH MYRTENYL BROMIDE
822, 5udaB, 0.7897, 4.20, 0.156, 460, 436, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH A MONOTERPENE BORNANE
823, 2w0aA, 0.7897, 3.29, 0.285, 424, 407, CYP51 OF M. TUBERCULOSIS BOUND TO AN INHIBITOR N-[(1S)-2-METHYL-1-(PYRIDIN-4-YLCARBAMOYL)PROPYL] CYCLOHEXANECARBOXAMIDE
824, 3r1aB, 0.7895, 4.19, 0.160, 465, 437, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
825, 5a5iA, 0.7893, 3.95, 0.151, 453, 425, CYTOCHROME 2C9 P450 INHIBITOR COMPLEX
826, 4mgjA, 0.7893, 3.98, 0.157, 452, 428, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 F429H IN COMPLEX WITH 4-CPI
827, 3qi8A, 0.7892, 3.19, 0.179, 424, 403, EVOLVED VARIANT OF CYTOCHROME P450 (BM3 CYP102A1)
828, 5e58B, 0.7886, 4.10, 0.141, 458, 433, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
829, 3daxA, 0.7886, 3.81, 0.165, 472, 423, CRYSTAL STRUCTURE OF HUMAN CYP7A1
830, 5m0pA, 0.7881, 3.37, 0.135, 424, 408, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET F79A IN COMPLEX WITH ARACHIDONIC ACID
831, 5k7kA, 0.7878, 4.17, 0.164, 455, 432, DESIGN AND OPTIMIZATION OF BIARYL ETHER ARYL SULFONAMIDES AS SELECTIVE INHIBITORS OF NAV1.7: DISCOVERY OF CLINICAL CANDIDATE PF-05089771
832, 5m0pB, 0.7874, 3.27, 0.133, 421, 405, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET F79A IN COMPLEX WITH ARACHIDONIC ACID
833, 3g5nA, 0.7872, 4.18, 0.151, 456, 425, TRIPLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
834, 3v8dB, 0.7868, 3.84, 0.164, 467, 421, CRYSTAL STRUCTURE OF HUMAN CYP7A1 IN COMPLEX WITH 7-KETOCHOLESTEROL
835, 3pm0A, 0.7867, 3.73, 0.149, 459, 415, STRUCTURAL CHARACTERIZATION OF THE COMPLEX BETWEEN ALPHA- NAPHTHOFLAVONE AND HUMAN CYTOCHROME P450 1B1 (CYP1B1)
836, 2rclB, 0.7863, 3.63, 0.144, 465, 411, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 12R13S-VERNOLIC ACID AT 2.4 A RESOLUTION
837, 3g5nB, 0.7853, 4.16, 0.158, 451, 423, TRIPLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
838, 3cliB, 0.7850, 3.60, 0.144, 465, 410, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) AT 1.80 A RESOLUTION
839, 2rcmB, 0.7850, 3.53, 0.144, 465, 409, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A) AT 1.73 A RESOLUTION
840, 5m0nA, 0.7848, 3.34, 0.133, 423, 406, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET IN COMPLEX WITH FORMATE
841, 3qu8F, 0.7843, 4.06, 0.156, 453, 429, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
842, 3g5nC, 0.7838, 4.00, 0.148, 452, 419, TRIPLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
843, 5m0oA, 0.7837, 3.25, 0.139, 419, 402, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET H85Q IN COMPLEX WITH ARACHIDONIC ACID
844, 4r20B, 0.7834, 3.26, 0.172, 414, 401, ZEBRA FISH CYTOCHROME P450 17A2 WITH ABIRATERONE
845, 2rchB, 0.7830, 3.57, 0.144, 465, 409, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOD AT 1.85 A RESOLUTION
846, 3dsjB, 0.7829, 3.65, 0.134, 465, 411, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOD AT 1.60 A RESOLUTION
847, 3dsiB, 0.7827, 3.65, 0.134, 465, 411, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOT AT 1.60 A RESOLUTION
848, 3dskB, 0.7826, 3.52, 0.145, 465, 408, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 12R13S-VERNOLIC ACID AT 1.55 A RESOLUTION
849, 3g5nD, 0.7823, 4.14, 0.140, 451, 422, TRIPLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
850, 5m0oC, 0.7821, 3.36, 0.138, 421, 405, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET H85Q IN COMPLEX WITH ARACHIDONIC ACID
851, 5e58F, 0.7821, 4.22, 0.141, 457, 433, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
852, 4l54A, 0.7791, 3.35, 0.136, 419, 403, STRUCTURE OF CYTOCHROME P450 OLET LIGAND-FREE
853, 2ci0A, 0.7790, 3.32, 0.286, 421, 402, HIGH THROUGHPUT SCREENING AND X-RAY CRYSTALLOGRAPHY ASSISTED EVALUATION OF SMALL MOLECULE SCAFFOLDS FOR CYP51 INHIBITORS
854, 4l40A, 0.7789, 3.41, 0.136, 419, 404, STRUCTURE OF THE P450 OLET WITH A C20 FATTY ACID SUBSTRATE BOUND
855, 3r1bB, 0.7783, 4.25, 0.162, 465, 425, OPEN CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
856, 2cibA, 0.7778, 3.27, 0.287, 419, 400, HIGH THROUGHPUT SCREENING AND X-RAY CRYSTALLOGRAPHY ASSISTED EVALUATION OF SMALL MOLECULE SCAFFOLDS FOR CYP51 INHIBITORS
857, 3g93A, 0.7773, 4.23, 0.153, 454, 425, SINGLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
858, 5w0cA, 0.7765, 4.06, 0.141, 464, 419, CYTOCHROME P450 (CYP) 2C9 TCA007 INHIBITOR COMPLEX
859, 3r1bA, 0.7762, 4.22, 0.151, 465, 425, OPEN CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
860, 3r1bD, 0.7750, 4.20, 0.147, 464, 423, OPEN CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
861, 4r20A, 0.7726, 3.30, 0.172, 406, 395, ZEBRA FISH CYTOCHROME P450 17A2 WITH ABIRATERONE
862, 3g93B, 0.7724, 4.05, 0.142, 442, 416, SINGLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
863, 5yhjB, 0.7694, 3.37, 0.155, 411, 399, CYTOCHROME P450EX ALPHA (CYP152N1) WILD-TYPE WITH MYRISTIC ACID
864, 3r1bC, 0.7687, 4.20, 0.147, 456, 422, OPEN CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
865, 5yhjA, 0.7683, 3.38, 0.156, 406, 398, CYTOCHROME P450EX ALPHA (CYP152N1) WILD-TYPE WITH MYRISTIC ACID
866, 2zqjC, 0.7683, 3.43, 0.153, 411, 399, SUBSTRATE-FREE FORM OF CYTOCHROME P450BSBETA
867, 2zqxC, 0.7677, 3.40, 0.153, 411, 398, CYTOCHROME P450BSBETA COCRYSTALLIZED WITH HEPTANOIC ACID
868, 1izoB, 0.7669, 3.51, 0.155, 411, 400, CYTOCHROME P450 BS BETA COMPLEXED WITH FATTY ACID
869, 1izoA, 0.7662, 3.43, 0.153, 411, 398, CYTOCHROME P450 BS BETA COMPLEXED WITH FATTY ACID
870, 1cptA, 0.7661, 3.12, 0.172, 412, 389, CRYSTAL STRUCTURE AND REFINEMENT OF CYTOCHROME P450-TERP AT 2.3 ANGSTROMS RESOLUTION
871, 2zqjB, 0.7659, 3.44, 0.153, 411, 399, SUBSTRATE-FREE FORM OF CYTOCHROME P450BSBETA
872, 1izoC, 0.7653, 3.51, 0.155, 411, 400, CYTOCHROME P450 BS BETA COMPLEXED WITH FATTY ACID
873, 2zqjA, 0.7651, 3.47, 0.153, 411, 399, SUBSTRATE-FREE FORM OF CYTOCHROME P450BSBETA
874, 3b99A, 0.7647, 3.78, 0.162, 445, 407, CRYSTAL STRUCTURE OF ZEBRAFISH PROSTACYCLIN SYNTHASE (CYTOCHROME P450 8A1) IN COMPLEX WITH SUBSTRATE ANALOG U51605
875, 2zqxB, 0.7646, 3.46, 0.153, 411, 399, CYTOCHROME P450BSBETA COCRYSTALLIZED WITH HEPTANOIC ACID
876, 3g93D, 0.7645, 4.06, 0.155, 440, 412, SINGLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
877, 3b98A, 0.7643, 3.81, 0.159, 446, 408, CRYSTAL STRUCTURE OF ZEBRAFISH PROSTACYCLIN SYNTHASE (CYTOCHROME P450 8A1)
878, 2zqxA, 0.7640, 3.48, 0.153, 411, 399, CYTOCHROME P450BSBETA COCRYSTALLIZED WITH HEPTANOIC ACID
879, 3g93C, 0.7631, 4.08, 0.158, 442, 412, SINGLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
880, 3tktA, 0.7606, 3.02, 0.169, 411, 385, CRYSTAL STRUCTURE OF CYP108D1 FROM NOVOSPHINGOBIUM AROMATICIVORANS DSM12444
881, 1po5A, 0.7606, 4.33, 0.149, 465, 416, STRUCTURE OF MAMMALIAN CYTOCHROME P450 2B4
882, 5fygA, 0.7592, 3.56, 0.139, 422, 397, STRUCTURE OF CYP153A FROM MARINOBACTER AQUAEOLEI IN COMPLEX WITH HYDROXYDODECANOIC ACID
883, 3vm4A, 0.7587, 3.38, 0.153, 407, 393, CYTOCHROME P450SP ALPHA (CYP152B1) IN COMPLEX WITH (R)-IBUPROPHEN
884, 5fyfA, 0.7584, 3.60, 0.144, 420, 397, STRUCTURE OF CYP153A FROM MARINOBACTER AQUAEOLEI
885, 4uaxA, 0.7579, 3.10, 0.150, 401, 386, X-RAY CRYSTAL STRUCTURE OF LIGAND FREE CYP142A2 FROM MYCOBACTERIUM SMEGMATIS
886, 3awqA, 0.7578, 3.40, 0.153, 407, 393, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT L78F
887, 5fygB, 0.7575, 3.62, 0.149, 419, 397, STRUCTURE OF CYP153A FROM MARINOBACTER AQUAEOLEI IN COMPLEX WITH HYDROXYDODECANOIC ACID
888, 3vooA, 0.7571, 3.40, 0.150, 407, 393, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT A245E
889, 3awmA, 0.7571, 3.42, 0.150, 407, 393, CYTOCHROME P450SP ALPHA (CYP152B1) WILD-TYPE WITH PALMITIC ACID
890, 3vnoA, 0.7569, 3.42, 0.150, 407, 393, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT R241E
891, 2bdmA, 0.7568, 4.48, 0.145, 465, 420, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND BIFONAZOLE
892, 3zbyF, 0.7564, 3.41, 0.151, 402, 391, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
893, 3zbyA, 0.7564, 3.41, 0.151, 402, 391, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
894, 3zbyE, 0.7562, 3.41, 0.151, 402, 391, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
895, 3zbyC, 0.7561, 3.42, 0.151, 402, 391, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
896, 3vtjA, 0.7561, 3.43, 0.153, 407, 393, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT A245H
897, 3zbyD, 0.7560, 3.41, 0.151, 402, 391, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
898, 3zbyB, 0.7560, 3.41, 0.151, 404, 391, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
899, 3awpA, 0.7560, 3.43, 0.153, 407, 393, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT F288G
900, 5omrA, 0.7547, 3.50, 0.142, 403, 395, CRYSTAL STRUCTURE OF AMYCOLATOPSIS CYTOCHROME P450 GCOA IN COMPLEX WITH VANILLIN. 
901, 5omuA, 0.7545, 3.53, 0.142, 402, 395, CRYSTAL STRUCTURE OF AMYCOLATOPSIS CYTOCHROME P450 GCOA IN COMPLEX WITH SYRINGOL 
902, 5omsA, 0.7545, 3.51, 0.142, 403, 395, CRYSTAL STRUCTURE OF AMYCOLATOPSIS CYTOCHROME P450 GCOA IN COMPLEX WITH GUAETHOL. 
903, 2xkrA, 0.7504, 3.35, 0.163, 395, 387, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP142: A NOVEL CHOLESTEROL OXIDASE
904, 4r1zB, 0.7491, 3.43, 0.178, 411, 388, ZEBRA FISH CYTOCHROME P450 17A1 WITH ABIRATERONE
905, 3dbgB, 0.7490, 2.75, 0.200, 379, 370, CRYSTAL STRUCTURE OF CYTOCHROME P450 170A1 (CYP170A1) FROM STREPTOMYCES COELICOLOR
906, 3dbgA, 0.7489, 2.75, 0.200, 379, 370, CRYSTAL STRUCTURE OF CYTOCHROME P450 170A1 (CYP170A1) FROM STREPTOMYCES COELICOLOR
907, 3bujA, 0.7486, 3.18, 0.167, 397, 384, CRYSTAL STRUCTURE OF CALO2
908, 3rwlA, 0.7481, 3.42, 0.158, 404, 386, STRUCTURE OF P450PYR HYDROXYLASE
909, 1n97A, 0.7477, 3.12, 0.186, 385, 377, CRYSTAL STUCTURE OF CYP175A1 FROM THERMUS THERMOPHILLUS STRAIN HB27
910, 5livC, 0.7472, 3.21, 0.135, 395, 384, CRYSTAL STRUCTURE OF MYXOBACTERIAL CYP260A1
911, 1egyA, 0.7471, 3.18, 0.167, 403, 383, CYTOCHROME P450ERYF WITH 9-AMINOPHENANTHRENE BOUND
912, 1eupA, 0.7470, 3.19, 0.159, 403, 383, X-RAY CRYSTAL STRUCTURE OF CYTOCHROME P450ERYF WITH ANDROSTENDIONE BOUND
913, 4dxyA, 0.7462, 3.51, 0.156, 406, 391, CRYSTAL STRUCTURES OF CYP101D2 Y96A MUTANT
914, 5fyfB, 0.7457, 3.54, 0.136, 411, 391, STRUCTURE OF CYP153A FROM MARINOBACTER AQUAEOLEI
915, 4r1zA, 0.7455, 3.59, 0.174, 417, 390, ZEBRA FISH CYTOCHROME P450 17A1 WITH ABIRATERONE
916, 1jioA, 0.7455, 3.15, 0.162, 403, 382, P450ERYF/6DEB
917, 1jinA, 0.7455, 3.14, 0.162, 403, 382, P450ERYF/KETOCONAZOLE
918, 1k2oB, 0.7451, 3.42, 0.165, 406, 387, CYTOCHROME P450CAM WITH BOUND BIS(22 -BIPYRIDINE)-(5-METHYL-2-2 - BIPYRIDINE)-C2-ADAMANTANE RUTHENIUM (II)
919, 1jipA, 0.7451, 3.15, 0.160, 403, 382, P450ERYF(A245S)/KETOCONAZOLE
920, 1oxaA, 0.7449, 3.15, 0.162, 403, 382, CYTOCHROME P450 (DONOR:O2 OXIDOREDUCTASE)
921, 1k2oA, 0.7442, 3.50, 0.162, 406, 388, CYTOCHROME P450CAM WITH BOUND BIS(22 -BIPYRIDINE)-(5-METHYL-2-2 - BIPYRIDINE)-C2-ADAMANTANE RUTHENIUM (II)
922, 6f8cA, 0.7440, 3.19, 0.131, 394, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276I) BOUND WITH PROGESTERONE
923, 6f8aB, 0.7438, 3.20, 0.134, 394, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276I) BOUND WITH HISTIDINE
924, 4ep6A, 0.7433, 3.36, 0.143, 392, 384, CRYSTAL STRUCTURE OF THE XPLA HEME DOMAIN IN COMPLEX WITH IMIDAZOLE AND PEG
925, 5ncbA, 0.7432, 3.47, 0.144, 396, 388, CRYSTAL STRUCTURE OF AMYCOLATOPSIS CYTOCHROME P450 GCOA IN COMPLEX WITH GUAIACOL. 
926, 6f88A, 0.7431, 3.20, 0.134, 394, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276N) BOUND WITH PROGESTERONE
927, 4jx1B, 0.7430, 3.52, 0.165, 405, 387, CRYSTAL STRUCTURE OF REDUCED CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX BOUND TO CAMPHOR AND 5-EXO-HYDROXYCAMPHOR
928, 2wm5A, 0.7426, 3.54, 0.147, 425, 388, X-RAY STRUCTURE OF THE SUBSTRATE-FREE MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP124
929, 3abaA, 0.7425, 3.14, 0.172, 397, 379, CRYSTAL STRUCTURE OF CYP105P1 IN COMPLEX WITH FILIPIN I
930, 5livA, 0.7423, 3.32, 0.133, 397, 384, CRYSTAL STRUCTURE OF MYXOBACTERIAL CYP260A1
931, 5hiwA, 0.7423, 3.14, 0.161, 391, 380, SORANGIUM CELLULOSUM SO CE56 CYTOCHROME P450 260B1
932, 3b98B, 0.7423, 3.50, 0.173, 427, 387, CRYSTAL STRUCTURE OF ZEBRAFISH PROSTACYCLIN SYNTHASE (CYTOCHROME P450 8A1)
933, 2wiyA, 0.7422, 3.43, 0.143, 394, 385, CYTOCHROME P450 XPLA HEME DOMAIN P21212
934, 1z8qA, 0.7422, 3.17, 0.165, 403, 381, FERROUS DIOXYGEN COMPLEX OF THE A245T CYTOCHROME P450ERYF
935, 1qmqA, 0.7419, 3.49, 0.165, 406, 387, OPTICAL DETECTION OF CYTOCHROME P450 BY SENSITIZER-LINKED SUBSTRATES
936, 5nwsA, 0.7418, 3.27, 0.176, 395, 380, CRYSTAL STRUCTURE OF SAACMM INVOLVED IN ACTINOMYCIN BIOSYNTHESIS
937, 1z8pA, 0.7418, 3.21, 0.162, 403, 382, FERROUS DIOXYGEN COMPLEX OF THE A245S CYTOCHROME P450ERYF
938, 3wriB, 0.7415, 3.39, 0.169, 403, 384, CRYSTAL STRUCTURE OF P450CAM
939, 6f8cB, 0.7414, 3.26, 0.134, 394, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276I) BOUND WITH PROGESTERONE
940, 3wriA, 0.7414, 3.40, 0.169, 403, 384, CRYSTAL STRUCTURE OF P450CAM
941, 2z36B, 0.7414, 3.52, 0.159, 404, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450 MOXA FROM NONOMURAEA RECTICATENA (CYP105)
942, 1z8oA, 0.7413, 3.19, 0.163, 402, 381, FERROUS DIOXYGEN COMPLEX OF THE WILD-TYPE CYTOCHROME P450ERYF
943, 3nv5A, 0.7412, 3.42, 0.155, 399, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101D2
944, 6giiA, 0.7409, 3.64, 0.143, 416, 391, THE CRYSTAL STRUCTURE OF TEPIDIPHILUS THERMOPHILUS P450 HEME DOMAIN 
945, 3nv6A, 0.7409, 3.53, 0.154, 404, 389, CRYSTAL STRUCTURE OF CAMPHOR-BOUND CYP101D2
946, 4jwuA, 0.7408, 3.48, 0.166, 405, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX
947, 4jx1A, 0.7407, 3.53, 0.162, 405, 388, CRYSTAL STRUCTURE OF REDUCED CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX BOUND TO CAMPHOR AND 5-EXO-HYDROXYCAMPHOR
948, 6bldA, 0.7406, 3.54, 0.170, 414, 388, MYCOBACTERIUM MARINUM CYTOCHROME P450 CYP268A2 IN COMPLEX WITH PSEUDOIONONE
949, 3p6sA, 0.7406, 3.45, 0.169, 404, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC2-C8-DANS
950, 6f85A, 0.7405, 3.18, 0.134, 392, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276N) BOUND WITH HISTIDINE
951, 3p6uA, 0.7404, 3.53, 0.168, 402, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC3-C6-DANS
952, 2z36A, 0.7403, 3.44, 0.160, 403, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 MOXA FROM NONOMURAEA RECTICATENA (CYP105)
953, 1uedA, 0.7398, 3.12, 0.186, 391, 377, CRYSTAL STRUCTURE OF OXYC A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE C-C COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS.
954, 4jx1F, 0.7397, 3.44, 0.161, 405, 385, CRYSTAL STRUCTURE OF REDUCED CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX BOUND TO CAMPHOR AND 5-EXO-HYDROXYCAMPHOR
955, 2wivB, 0.7397, 3.38, 0.144, 391, 383, CYTOCHROME-P450 XPLA HEME DOMAIN P21
956, 6f8aA, 0.7394, 3.29, 0.134, 394, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276I) BOUND WITH HISTIDINE
957, 6f85B, 0.7393, 3.19, 0.134, 392, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276N) BOUND WITH HISTIDINE
958, 3p6tA, 0.7392, 3.50, 0.168, 404, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC2-C8-DANS
959, 3p6qA, 0.7391, 3.42, 0.167, 401, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC2-ETG-BOC
960, 1n97B, 0.7390, 3.36, 0.187, 385, 379, CRYSTAL STUCTURE OF CYP175A1 FROM THERMUS THERMOPHILLUS STRAIN HB27
961, 5it1B, 0.7388, 3.16, 0.172, 395, 378, STREPTOMYCES PEUCETIUS CYP105P2 COMPLEX WITH BIPHENYL COMPOUND
962, 4jx1E, 0.7388, 3.48, 0.168, 405, 386, CRYSTAL STRUCTURE OF REDUCED CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX BOUND TO CAMPHOR AND 5-EXO-HYDROXYCAMPHOR
963, 5it1D, 0.7387, 3.17, 0.164, 395, 378, STREPTOMYCES PEUCETIUS CYP105P2 COMPLEX WITH BIPHENYL COMPOUND
964, 5it1C, 0.7386, 3.17, 0.164, 395, 378, STREPTOMYCES PEUCETIUS CYP105P2 COMPLEX WITH BIPHENYL COMPOUND
965, 3p6vA, 0.7386, 3.53, 0.169, 398, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG 3ET-ADAC1-ETG-BOC
966, 3p3zA, 0.7386, 3.69, 0.151, 407, 390, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH FROM STREPTOMYCES THIOLUTEUS IN COMPLEX WITH ANCYMIDOL
967, 1uedB, 0.7386, 3.09, 0.189, 391, 375, CRYSTAL STRUCTURE OF OXYC A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE C-C COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS.
968, 6f88B, 0.7385, 3.27, 0.131, 393, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276N) BOUND WITH PROGESTERONE
969, 3p6wA, 0.7385, 3.52, 0.166, 400, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC3-ETG-BOC
970, 3l62A, 0.7384, 3.58, 0.168, 400, 386, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CAM AT LOW [K+]
971, 5it1A, 0.7383, 3.17, 0.164, 395, 378, STREPTOMYCES PEUCETIUS CYP105P2 COMPLEX WITH BIPHENYL COMPOUND
972, 2wm4A, 0.7383, 3.49, 0.142, 426, 386, X-RAY STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP124 IN COMPLEX WITH PHYTANIC ACID
973, 4jwuB, 0.7382, 3.46, 0.161, 403, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX
974, 2wivA, 0.7382, 3.41, 0.144, 391, 383, CYTOCHROME-P450 XPLA HEME DOMAIN P21
975, 1rf9A, 0.7382, 3.53, 0.168, 404, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450-CAM WITH A FLUORESCENT PROBE D-4-AD (ADAMANTANE-1-CARBOXYLIC ACID-5-DIMETHYLAMINO- NAPHTHALENE-1-SULFONYLAMINO-BUTYL-AMIDE)
976, 3cv9A, 0.7381, 3.36, 0.141, 401, 383, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R73A/R84A MUTANT) IN COMPLEX WITH 1ALPHA25- DIHYDROXYVITAMIN D3
977, 2zbzA, 0.7381, 3.35, 0.136, 404, 382, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R84A MUTANT) IN COMPLEX WITH 125-DIHYDROXYVITAMIN D3
978, 1pkfA, 0.7380, 3.27, 0.163, 403, 380, CRYSTAL STRUCTURE OF EPOTHILONE D-BOUND CYTOCHROME P450EPOK
979, 3w9cA, 0.7379, 3.42, 0.164, 401, 383, CRYSTAL STRUCTURE OF THE ELECTRON TRANSFER COMPLEX OF CYTOCHROME P450CAM WITH PUTIDAREDOXIN
980, 5x7eA, 0.7377, 3.48, 0.135, 404, 384, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R84A MUTANT) IN COMPLEX WITH 125-DIHYDROXYVITAMIN D2
981, 5gxgA, 0.7375, 3.43, 0.164, 401, 383, HIGH-RESOLUTION CRYSTAL STRUCTURE OF THE ELECTRON TRANSFER COMPLEX OF CYTOCHROME P450CAM WITH PUTIDAREDOXIN
982, 3p3oA, 0.7372, 3.68, 0.149, 416, 390, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (NTERMII) FROM STREPTOMYCES THIOLUTEUS
983, 3p6xA, 0.7371, 3.46, 0.172, 399, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC3-C8-DANS
984, 3cv8A, 0.7370, 3.40, 0.141, 402, 383, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R84F MUTANT)
985, 4mm0B, 0.7369, 3.33, 0.179, 394, 379, CRYSTAL STRUCTURE ANALYSIS OF THE PUTATIVE THIOETHER SYNTHASE SGVP INVOLVED IN THE TAILORING STEP OF GRISEOVIRIDIN
986, 3p6oA, 0.7369, 3.43, 0.158, 405, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-ETG-DANS
987, 3ol5A, 0.7369, 3.48, 0.158, 405, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED WITH A TETHERED SUBSTRATE ANALOG 3OH-ADAC1-C8-DANS
988, 4dnjA, 0.7367, 3.53, 0.143, 399, 385, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A2
989, 3oiaA, 0.7365, 3.48, 0.158, 405, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-C8GLUETG-BIO
990, 3p6mA, 0.7364, 3.50, 0.158, 404, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-C8-DANS
991, 2d0eA, 0.7364, 3.45, 0.154, 404, 384, SUBSTRATE ASSITED IN OXYGEN ACTIVATION IN CYTOCHROME P450 158A2
992, 3ejdD, 0.7363, 3.28, 0.152, 385, 376, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH HEXADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
993, 3p6rA, 0.7362, 3.46, 0.173, 398, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG 3OH-ADAC1-ETG-BOC
994, 3p3lA, 0.7362, 3.75, 0.151, 403, 390, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (WILDTYPE) FROM STREPTOMYCES THIOLUTEUS
995, 3ejbH, 0.7362, 3.34, 0.153, 387, 378, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH TETRADECANOIC ACID LIGATED ACYL CARRIER PROTEIN
996, 1q5eA, 0.7362, 3.30, 0.161, 404, 380, SUBSTRATE-FREE CYTOCHROME P450EPOK
997, 3p6pA, 0.7361, 3.45, 0.161, 407, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-C6-BIO
998, 3p3lB, 0.7360, 3.74, 0.151, 403, 390, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (WILDTYPE) FROM STREPTOMYCES THIOLUTEUS
999, 5foiA, 0.7359, 3.16, 0.155, 389, 375, CRYSTAL STRUCTURE OF MYCINAMICIN VIII C21 METHYL HYDROXYLASE MYCCI FROM MICROMONOSPORA GRISEORUBIDA BOUND TO MYCINAMICIN VIII
1000, 1s1fA, 0.7359, 3.35, 0.157, 397, 381, CRYSTAL STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP158A2 FROM ANTIBIOTIC BIOSYNTHETIC PATHWAYS
1001, 4mm0A, 0.7358, 3.23, 0.178, 392, 377, CRYSTAL STRUCTURE ANALYSIS OF THE PUTATIVE THIOETHER SYNTHASE SGVP INVOLVED IN THE TAILORING STEP OF GRISEOVIRIDIN
1002, 1gwiB, 0.7358, 3.35, 0.174, 400, 380, THE 1.92 A STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP154C1: A NEW MONOOXYGENASE THAT FUNCTIONALIZES MACROLIDE RING SYSTEMS
1003, 4jbtB, 0.7357, 3.54, 0.172, 407, 384, THE 2.2 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH ANDROSTENEDIONE
1004, 3p6nA, 0.7356, 3.50, 0.158, 404, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-C8-DANS
1005, 1xqdA, 0.7356, 3.30, 0.161, 399, 380, CRYSTAL STRUCTURE OF P450NOR COMPLEXED WITH 3- PYRIDINEALDEHYDE ADENINE DINUCLEOTIDE
1006, 4j6cB, 0.7355, 3.61, 0.171, 406, 385, THE 1.9 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH PROGESTERONE
1007, 1lwlA, 0.7355, 3.45, 0.158, 404, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450-CAM WITH A FLUORESCENT PROBE D-8-AD (ADAMANTANE-1-CARBOXYLIC ACID-5-DIMETHYLAMINO- NAPHTHALENE-1-SULFONYLAMINO-OCTYL-AMIDE)
1008, 3be0A, 0.7354, 3.44, 0.136, 397, 382, THE ROLE OF ASN 242 IN P450CIN
1009, 1re9A, 0.7354, 3.45, 0.158, 404, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450-CAM WITH A FLUORESCENT PROBE D-8-AD (ADAMANTANE-1-CARBOXYLIC ACID-5-DIMETHYLAMINO- NAPHTHALENE-1-SULFONYLAMINO-OCTYL-AMIDE)
1010, 4jbtA, 0.7352, 3.55, 0.172, 407, 384, THE 2.2 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH ANDROSTENEDIONE
1011, 4j6cA, 0.7352, 3.55, 0.172, 407, 384, THE 1.9 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH PROGESTERONE
1012, 1q5dA, 0.7352, 3.31, 0.169, 401, 379, EPOTHILONE B-BOUND CYTOCHROME P450EPOK
1013, 3ejeD, 0.7351, 3.31, 0.154, 385, 376, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH OCTADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
1014, 2zbyA, 0.7351, 3.39, 0.139, 400, 382, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R84A MUTANT)
1015, 4triB, 0.7350, 3.55, 0.153, 400, 386, X-RAY CRYSTAL STRUCTURE OF CYP142A2 FROM MYCOBACTERIUM SMEGMATIS COMPLEXED WITH CHOLESTEROL SULFATE.
1016, 3ejbD, 0.7350, 3.28, 0.149, 386, 376, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH TETRADECANOIC ACID LIGATED ACYL CARRIER PROTEIN
1017, 4j6dB, 0.7349, 3.50, 0.172, 406, 383, THE 2.4 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH TESTOSTERONE
1018, 3bdzB, 0.7348, 3.50, 0.141, 397, 383, THE ROLE OF ASN 242 IN P450CIN
1019, 3be0B, 0.7347, 3.50, 0.141, 397, 383, THE ROLE OF ASN 242 IN P450CIN
1020, 5ikiB, 0.7345, 3.49, 0.175, 399, 382, CYP106A2 WITH SUBSTRATE ABIETIC ACID
1021, 5foiB, 0.7345, 3.15, 0.155, 388, 374, CRYSTAL STRUCTURE OF MYCINAMICIN VIII C21 METHYL HYDROXYLASE MYCCI FROM MICROMONOSPORA GRISEORUBIDA BOUND TO MYCINAMICIN VIII
1022, 5cjeA, 0.7345, 3.26, 0.170, 390, 376, STRUCTURE OF CYP107L2
1023, 4l0eA, 0.7345, 3.51, 0.169, 440, 385, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS (HEME-COORDINATED EXPRESSION TAG)
1024, 2zbxA, 0.7344, 3.54, 0.141, 399, 384, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (WILD TYPE) WITH IMIDAZOLE BOUND
1025, 2jjpA, 0.7344, 3.70, 0.152, 397, 388, STRUCTURE OF CYTOCHROME P450 ERYK IN COMPLEX WITH INHIBITOR KETOCONAZOLE (KC)
1026, 5h1zA, 0.7343, 3.60, 0.147, 400, 382, CYP153D17 FROM SPHINGOMONAS SP. PAMC 26605
1027, 3ejdB, 0.7343, 3.16, 0.147, 382, 373, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH HEXADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
1028, 2fr7A, 0.7342, 3.75, 0.139, 397, 388, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP199A2
1029, 4apyA, 0.7340, 3.79, 0.170, 414, 388, ETHYLENE GLYCOL-BOUND FORM OF P450 CYP125A3 FROM MYCOBACTERIUM SMEGMATIS
1030, 4j6dA, 0.7339, 3.53, 0.175, 406, 383, THE 2.4 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH TESTOSTERONE
1031, 4j6bB, 0.7338, 3.51, 0.165, 405, 382, THE 2.2 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH PREGNENOLONE
1032, 4jwsB, 0.7337, 3.56, 0.170, 395, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX
1033, 3p3xA, 0.7336, 3.66, 0.152, 397, 388, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (NTERM- AURH-I) FROM STREPTOMYCES THIOLUTEUS
1034, 2jjoA, 0.7335, 3.58, 0.162, 393, 383, STRUCTURE OF CYTOCHROME P450 ERYK IN COMPLEX WITH ITS NATURAL SUBSTRATE ERD
1035, 4j6bA, 0.7334, 3.52, 0.168, 405, 382, THE 2.2 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH PREGNENOLONE
1036, 4wq0A, 0.7333, 3.26, 0.146, 397, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP107W1 FROM STREPTOMYCES AVERMITILIS IN COMPLEX WITH OLIGOMYCIN A
1037, 4l0fA, 0.7333, 3.73, 0.167, 437, 389, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS (OPEN ACTIVE SITE)
1038, 3p3xB, 0.7333, 3.63, 0.160, 399, 387, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (NTERM- AURH-I) FROM STREPTOMYCES THIOLUTEUS
1039, 3ejdF, 0.7333, 3.17, 0.145, 381, 373, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH HEXADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
1040, 3nc6B, 0.7331, 3.21, 0.171, 389, 375, CYP134A1 1-PHENYLIMIDAZOLE BOUND STRUCTURE
1041, 4yzrA, 0.7330, 3.38, 0.158, 388, 379, BACILLUS SUBTILIS 168 BACILLAENE POLYKETIDE SYNTHASE (PKS) CYTOCHROME P450 PKSS
1042, 3ejeH, 0.7330, 3.26, 0.152, 383, 374, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH OCTADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
1043, 4l77B, 0.7329, 3.53, 0.141, 397, 383, P450CIN ACTIVE SITE WATER: IMPLICATIONS FOR SUBSTRATE BINDING AND SOLVENT ACCESSIBILITY
1044, 4l77A, 0.7329, 3.50, 0.138, 396, 383, P450CIN ACTIVE SITE WATER: IMPLICATIONS FOR SUBSTRATE BINDING AND SOLVENT ACCESSIBILITY
1045, 3bdzA, 0.7329, 3.53, 0.141, 397, 383, THE ROLE OF ASN 242 IN P450CIN
1046, 3e5lA, 0.7327, 3.26, 0.170, 394, 376, CRYSTAL STRUCTURE OF CYP105P1 H72A MUTANT
1047, 4ggvA, 0.7324, 3.61, 0.170, 396, 382, CRYSTAL STRUCTURE OF HMTT INVOLVED IN HIMASTATIN BIOSYNTHESIS
1048, 4c9oA, 0.7324, 3.77, 0.145, 408, 392, STRUCTURE OF CYANIDE AND CAMPHOR BOUND D259N MUTANT OF CYP101D1
1049, 2jjnA, 0.7324, 3.66, 0.155, 395, 386, STRUCTURE OF CLOSED CYTOCHROME P450 ERYK
1050, 5gweC, 0.7323, 3.62, 0.166, 405, 385, CYTOCHROME P450 CREJ
1051, 5dqnA, 0.7322, 3.63, 0.177, 410, 384, POLYETHYLENE 600-BOUND FORM OF P450 CYP125A3 MUTANT FROM MYOBACTERIUM SMEGMATIS - W83Y
1052, 4c9pA, 0.7322, 3.75, 0.146, 408, 391, STRUCTURE OF CAMPHOR BOUND T260A MUTANT OF CYP101D1
1053, 4c9nA, 0.7322, 3.78, 0.145, 408, 392, STRUCTURE OF CAMPHOR AND HYDROXYCAMPHOR BOUND D259N MUTANT OF CYP101D1
1054, 4egoC, 0.7321, 3.46, 0.160, 393, 381, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH INDOLE-6- CARBOXYLIC ACID
1055, 3l61A, 0.7321, 3.51, 0.171, 396, 381, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CAM AT 200 MM [K+]
1056, 3ejbB, 0.7321, 3.22, 0.150, 380, 373, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH TETRADECANOIC ACID LIGATED ACYL CARRIER PROTEIN
1057, 2yooA, 0.7321, 3.54, 0.149, 396, 383, CHOLEST-4-EN-3-ONE BOUND STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
1058, 6gk6A, 0.7320, 3.39, 0.189, 403, 380, CRYSTAL STRUCTURE OF MYXOBACTERIAL CYTOCHROME P450 CYP267B1 IN COMPLEX WITH MYRISTIC ACID 
1059, 4c9mA, 0.7319, 3.74, 0.148, 408, 391, STRUCTURE OF SUBSTRATE FREE GLYCEROL BOUND WILD TYPE CYP101D1
1060, 5gweA, 0.7316, 3.62, 0.161, 405, 385, CYTOCHROME P450 CREJ
1061, 3lxhA, 0.7316, 3.76, 0.146, 408, 391, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101D1
1062, 3ejdH, 0.7316, 3.18, 0.153, 382, 372, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH HEXADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
1063, 2yooC, 0.7316, 3.54, 0.164, 395, 383, CHOLEST-4-EN-3-ONE BOUND STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
1064, 2d09A, 0.7316, 3.60, 0.174, 404, 385, A ROLE FOR ACTIVE SITE WATER MOLECULES AND HYDROXYL GROUPS OF SUBSTRATE FOR OXYGEN ACTIVATION IN CYTOCHROME P450 158A2
1065, 6gk5A, 0.7314, 3.39, 0.189, 403, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP267B1 FROM SORANGIUM CELLULOSUM SO CE56 
1066, 5xjnA, 0.7314, 3.60, 0.164, 403, 384, CYTOCHROME P450 CREJ IN COMPLEX WITH (4-ETHYLPHENYL) DIHYDROGEN PHOSPHATE
1067, 4egmC, 0.7314, 3.47, 0.157, 393, 381, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 4-ETHYLBENZOIC ACID
1068, 4c9oB, 0.7313, 3.75, 0.146, 407, 391, STRUCTURE OF CYANIDE AND CAMPHOR BOUND D259N MUTANT OF CYP101D1
1069, 4c9mB, 0.7313, 3.76, 0.146, 407, 391, STRUCTURE OF SUBSTRATE FREE GLYCEROL BOUND WILD TYPE CYP101D1
1070, 2yooD, 0.7313, 3.54, 0.162, 394, 383, CHOLEST-4-EN-3-ONE BOUND STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
1071, 2x5wA, 0.7313, 3.58, 0.157, 409, 383, X-RAY STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 IN COMPLEX WITH SUBSTRATE CHOLEST-4-EN-3-ONE
1072, 5kdbA, 0.7312, 3.46, 0.160, 393, 381, THE CRYSTAL STRUCTURE OF 4-ISOPROPYLBENZOATE-BOUND CYP199A4
1073, 4do1C, 0.7312, 3.47, 0.160, 393, 381, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A4
1074, 4c9kA, 0.7312, 3.80, 0.143, 408, 392, STRUCTURE OF CAMPHOR AND HYDROXYCAMPHOR BOUND WILD TYPE CYP101D1
1075, 5u6tA, 0.7311, 3.46, 0.157, 393, 381, THE CRYSTAL STRUCTURE OF 4-ETHOXYBENZOATE-BOUND CYP199A4 
1076, 4c9pB, 0.7311, 3.82, 0.143, 407, 392, STRUCTURE OF CAMPHOR BOUND T260A MUTANT OF CYP101D1
1077, 3lxiA, 0.7311, 3.77, 0.148, 408, 391, CRYSTAL STRUCTURE OF CAMPHOR-BOUND CYP101D1
1078, 5cweA, 0.7310, 3.44, 0.166, 393, 379, STRUCTURE OF CYP107L2 FROM STREPTOMYCES AVERMITILIS WITH LAURIC ACID
1079, 4lhtA, 0.7310, 3.57, 0.141, 396, 383, CRYSTAL STRUCTURE OF P450CIN Y81F MUTANT CRYSTALLIZED IN 3 MM 18- CINEOLE
1080, 4egpB, 0.7310, 3.72, 0.153, 393, 385, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 2-NAPHTHOIC ACID
1081, 4egnC, 0.7310, 3.51, 0.162, 393, 382, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH VERATRIC ACID
1082, 1t93A, 0.7310, 3.57, 0.166, 403, 385, EVIDENCE FOR MULTIPLE SUBSTRATE RECOGNITION AND MOLECULAR MECHANISM OF C-C REACTION BY CYTOCHROME P450 CYP158A2 FROM STREPTOMYCES COELICOLOR A3(2)
1083, 4triA, 0.7309, 3.52, 0.162, 401, 383, X-RAY CRYSTAL STRUCTURE OF CYP142A2 FROM MYCOBACTERIUM SMEGMATIS COMPLEXED WITH CHOLESTEROL SULFATE.
1084, 3abbA, 0.7309, 3.15, 0.164, 383, 372, CRYSTAL STRUCTURE OF CYP105D6
1085, 5kdyA, 0.7308, 3.47, 0.160, 393, 381, THE CRYSTAL STRUCTURE OF THE D251N MUTANT OF CYP199A4 IN COMPLEX WITH 4-METHOXYBENZOATE
1086, 4fmxA, 0.7308, 3.57, 0.141, 397, 383, CRYSTAL STRUCTURE OF SUBSTRATE-BOUND P450CIN
1087, 4dnzD, 0.7308, 3.49, 0.160, 393, 381, THE CRYSTAL STRUCTURES OF CYP199A4
1088, 5u6wA, 0.7307, 3.47, 0.163, 393, 381, THE CRYSTAL STRUCTURE OF 4-METHYLAMINOBENZOATE-BOUND CYP199A4 
1089, 5u6uA, 0.7307, 3.46, 0.160, 393, 381, THE CRYSTAL STRUCTURE OF 4-ETHYLTHIOBENZOATE-BOUND CYP199A4 
1090, 4c9nB, 0.7307, 3.75, 0.146, 407, 391, STRUCTURE OF CAMPHOR AND HYDROXYCAMPHOR BOUND D259N MUTANT OF CYP101D1
1091, 3lxiB, 0.7307, 3.82, 0.148, 407, 392, CRYSTAL STRUCTURE OF CAMPHOR-BOUND CYP101D1
1092, 3a1lA, 0.7307, 3.67, 0.166, 411, 385, CRYSTAL STRUCTURE OF 1111 -DICHLOROCHROMOPYRROLIC ACID BOUND CYTOCHROME P450 STAP (CYP245A1)
1093, 4pxhA, 0.7306, 3.50, 0.160, 417, 382, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS IN COMPLEX WITH A PEPTIDYL CARRIER PROTEIN DOMAIN
1094, 5cweB, 0.7305, 3.44, 0.169, 393, 379, STRUCTURE OF CYP107L2 FROM STREPTOMYCES AVERMITILIS WITH LAURIC ACID
1095, 4lhtB, 0.7305, 3.58, 0.141, 396, 383, CRYSTAL STRUCTURE OF P450CIN Y81F MUTANT CRYSTALLIZED IN 3 MM 18- CINEOLE
1096, 4fyzA, 0.7305, 3.58, 0.141, 397, 383, CRYSTAL STRUCTURE OF NITROSYL CYTOCHROME P450CIN
1097, 4egoD, 0.7305, 3.49, 0.160, 393, 381, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH INDOLE-6- CARBOXYLIC ACID
1098, 4c9lA, 0.7305, 3.75, 0.143, 408, 391, STRUCTURE OF CYANIDE AND CAMPHOR BOUND WILD TYPE CYP101D1
1099, 3b99B, 0.7305, 3.49, 0.171, 415, 380, CRYSTAL STRUCTURE OF ZEBRAFISH PROSTACYCLIN SYNTHASE (CYTOCHROME P450 8A1) IN COMPLEX WITH SUBSTRATE ANALOG U51605
1100, 5kt1A, 0.7304, 3.47, 0.157, 393, 381, THE CRYSTAL STRUCTURE OF 4-METHYLTHIOBENZOATE-BOUND CYP199A4
1101, 4l4dA, 0.7304, 3.59, 0.151, 405, 385, STRUCTURE OF CYANIDE AND CAMPHOR BOUND P450CAM MUTANT L358A
1102, 4c9lB, 0.7304, 3.82, 0.143, 407, 392, STRUCTURE OF CYANIDE AND CAMPHOR BOUND WILD TYPE CYP101D1
1103, 4egmB, 0.7303, 3.51, 0.157, 394, 382, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 4-ETHYLBENZOIC ACID
1104, 4dnzC, 0.7303, 3.49, 0.160, 393, 381, THE CRYSTAL STRUCTURES OF CYP199A4
1105, 3ofuC, 0.7302, 3.60, 0.164, 396, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
1106, 4egmD, 0.7301, 3.48, 0.157, 393, 381, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 4-ETHYLBENZOIC ACID
1107, 4c9kB, 0.7301, 3.76, 0.146, 407, 391, STRUCTURE OF CAMPHOR AND HYDROXYCAMPHOR BOUND WILD TYPE CYP101D1
1108, 2z3uA, 0.7301, 3.64, 0.169, 411, 384, CRYSTAL STRUCTURE OF CHROMOPYRROLIC ACID BOUND CYTOCHROME P450 STAP (CYP245A1)
1109, 5l1pA, 0.7300, 3.39, 0.166, 397, 379, X-RAY STRUCTURE OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE
1110, 4l6gA, 0.7300, 3.58, 0.141, 397, 383, CRYSTAL STRUCTURE OF P450CIN Y81F MUTANT CRYSTALLIZED IN 7 MM 18- CINEOLE
1111, 4l4fA, 0.7300, 3.61, 0.151, 405, 385, STRUCTURE OF CYANIDE AND CAMPHOR BOUND P450CAM MUTANT L358A/K178G/D182N
1112, 4fmxB, 0.7300, 3.58, 0.141, 397, 383, CRYSTAL STRUCTURE OF SUBSTRATE-BOUND P450CIN
1113, 3ejbF, 0.7300, 3.11, 0.149, 378, 370, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH TETRADECANOIC ACID LIGATED ACYL CARRIER PROTEIN
1114, 2yooB, 0.7300, 3.53, 0.162, 395, 383, CHOLEST-4-EN-3-ONE BOUND STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
1115, 5kdzA, 0.7299, 3.49, 0.157, 393, 381, THE CRYSTAL STRUCTURE OF THE T252A MUTANT OF CYP199A4 IN COMPLEX WITH 4-METHOXYBENZOATE
1116, 4l4eA, 0.7299, 3.61, 0.151, 405, 385, STRUCTURE OF CYANIDE AND CAMPHOR BOUND P450CAM MUTANT L358A/K178G
1117, 4egnD, 0.7299, 3.50, 0.160, 393, 381, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH VERATRIC ACID
1118, 4do1D, 0.7299, 3.49, 0.160, 393, 381, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A4
1119, 1gwiA, 0.7299, 3.43, 0.184, 402, 380, THE 1.92 A STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP154C1: A NEW MONOOXYGENASE THAT FUNCTIONALIZES MACROLIDE RING SYSTEMS
1120, 4pxhE, 0.7298, 3.57, 0.159, 407, 383, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS IN COMPLEX WITH A PEPTIDYL CARRIER PROTEIN DOMAIN
1121, 4l6gB, 0.7297, 3.59, 0.141, 397, 383, CRYSTAL STRUCTURE OF P450CIN Y81F MUTANT CRYSTALLIZED IN 7 MM 18- CINEOLE
1122, 1t2bA, 0.7297, 3.59, 0.141, 397, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450CIN COMPLEXED WITH ITS SUBSTRATE 18-CINEOLE
1123, 5l1qA, 0.7296, 3.39, 0.166, 397, 379, X-RAY STRUCTURE OF CYTOCHROME P450 PNTM WITH DIHYDROPENTALENOLACTONE F
1124, 1t2bB, 0.7295, 3.60, 0.141, 397, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450CIN COMPLEXED WITH ITS SUBSTRATE 18-CINEOLE
1125, 5uvbA, 0.7294, 3.49, 0.160, 393, 381, THE CRYSTAL STRUCTURE OF 4-CYCLOPROPYLBENZOATE-BOUND CYP199A4
1126, 5gweD, 0.7294, 3.61, 0.164, 403, 384, CYTOCHROME P450 CREJ
1127, 2xfhA, 0.7294, 3.79, 0.167, 394, 383, STRUCTURE OF CYTOCHROME P450 ERYK COCRYSTALLIZED WITH INHIBITOR CLOTRIMAZOLE.
1128, 2whwA, 0.7294, 3.52, 0.202, 396, 381, SELECTIVE OXIDATION OF CARBOLIDE C-H BONDS BY ENGINEERED MACROLIDE P450 MONOOXYGENASE
1129, 5l1sA, 0.7293, 3.40, 0.166, 397, 379, X-RAY STRUCTURE OF F232L MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
1130, 5l1oA, 0.7293, 3.40, 0.166, 397, 379, X-RAY STRUCTURE OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
1131, 3ejeF, 0.7293, 3.21, 0.153, 380, 372, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH OCTADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
1132, 5l1rA, 0.7292, 3.40, 0.166, 397, 379, X-RAY STRUCTURE OF THE SUBSTRATE-FREE CYTOCHROME P450 PNTM
1133, 4jwsA, 0.7292, 3.47, 0.169, 392, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX
1134, 3zkpA, 0.7292, 3.54, 0.163, 390, 380, STRUCTURE OF A MUTANT OF P450 ERYK IN COMPLEX WITH ERYTHROMYCIN B.
1135, 2h7qA, 0.7292, 3.61, 0.148, 405, 385, CYTOCHROME P450CAM COMPLEXED WITH IMIDAZOLE
1136, 5l1vA, 0.7291, 3.40, 0.166, 397, 379, X-RAY STRUCTURE OF M81C MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
1137, 3ofuA, 0.7291, 3.62, 0.164, 396, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
1138, 5l1uA, 0.7290, 3.41, 0.166, 397, 379, X-RAY STRUCTURE OF M81A MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
1139, 4fyzB, 0.7290, 3.58, 0.141, 397, 383, CRYSTAL STRUCTURE OF NITROSYL CYTOCHROME P450CIN
1140, 5wk9A, 0.7289, 3.63, 0.153, 405, 385, R186AP450CAM WITH CN AND CAMPHOR
1141, 4dnzB, 0.7289, 3.57, 0.157, 393, 382, THE CRYSTAL STRUCTURES OF CYP199A4
1142, 5l1tA, 0.7288, 3.41, 0.166, 397, 379, X-RAY STRUCTURE OF M77S MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
1143, 4l4aA, 0.7288, 3.63, 0.151, 405, 385, STRUCTURE OF L358A/K178G MUTANT OF P450CAM BOUND TO CAMPHOR
1144, 5wk7A, 0.7287, 3.65, 0.153, 405, 385, P450CAM MUTANT R186A
1145, 3oftA, 0.7287, 3.63, 0.169, 396, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
1146, 4ubsA, 0.7286, 3.35, 0.155, 393, 375, THE CRYSTAL STRUCTURE OF CYTOCHROME P450 105D7 FROM STREPTOMYCES AVERMITILIS IN COMPLEX WITH DICLOFENAC
1147, 4egoA, 0.7286, 3.51, 0.160, 393, 381, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH INDOLE-6- CARBOXYLIC ACID
1148, 5l91A, 0.7285, 3.35, 0.176, 391, 374, THE 2.2 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM BOUND WITH FOUR CORTICOSTERONE MOLECULES
1149, 4egmA, 0.7285, 3.58, 0.154, 393, 382, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 4-ETHYLBENZOIC ACID
1150, 3tywD, 0.7285, 3.51, 0.168, 399, 380, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR A3(2)
1151, 5cp4A, 0.7284, 3.60, 0.153, 406, 385, CRYOGENIC STRUCTURE OF P450CAM
1152, 4egoB, 0.7282, 3.53, 0.157, 393, 381, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH INDOLE-6- CARBOXYLIC ACID
1153, 3lxhB, 0.7282, 3.83, 0.143, 405, 391, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101D1
1154, 1t86A, 0.7282, 3.59, 0.156, 406, 384, CRYSTAL STRUCTURE OF THE FERROUS CYTOCHROME P450CAM MUTANT (L358P/C334A)
1155, 4l4bA, 0.7281, 3.62, 0.153, 405, 385, STRUCTURE OF L358A/K178G/D182N MUTANT OF P450CAM BOUND TO CAMPHOR
1156, 4ek1B, 0.7281, 3.60, 0.154, 404, 384, CRYSTAL STRUCTURE OF ELECTRON-SPIN LABELED CYTOCHROME P450CAM
1157, 4egnA, 0.7281, 3.55, 0.154, 393, 382, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH VERATRIC ACID
1158, 4do1B, 0.7281, 3.52, 0.160, 393, 381, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A4
1159, 1phcA, 0.7281, 3.61, 0.151, 405, 384, CRYSTAL STRUCTURE OF SUBSTRATE-FREE PSEUDOMONAS PUTIDA CYTOCHROME P450
1160, 4do1A, 0.7280, 3.53, 0.157, 393, 381, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A4
1161, 4dnzA, 0.7280, 3.53, 0.157, 393, 381, THE CRYSTAL STRUCTURES OF CYP199A4
1162, 4pxhC, 0.7279, 3.60, 0.159, 409, 383, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS IN COMPLEX WITH A PEPTIDYL CARRIER PROTEIN DOMAIN
1163, 4egnB, 0.7279, 3.53, 0.157, 393, 381, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH VERATRIC ACID
1164, 3cp4A, 0.7279, 3.62, 0.148, 405, 385, CRYSTAL STRUCTURE OF THE CYTOCHROME P450-CAM ACTIVE SITE MUTANT THR252ALA
1165, 1romA, 0.7279, 3.57, 0.155, 399, 380, CRYSTAL STRUCTURE OF NITRIC REDUCTASE FROM DENITRIFYING FUNGUS FUSARIUM OXYSPORUM
1166, 1iwkA, 0.7279, 3.62, 0.151, 405, 385, PUTIDAREDOXIN-BINDING STABLILIZES AN ACTIVE CONFORMER OF CYTOCHROME P450CAM IN ITS REDUCED STATE; CRYSTAL STRUCTURE OF MUTANT(112K) CYTOCHROME P450CAM
1167, 5l1wA, 0.7277, 3.38, 0.167, 396, 378, X-RAY STRUCTURE OF 2-MERCAPTOETHANOL MODIFIED M81C MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
1168, 2bvjB, 0.7277, 3.40, 0.202, 391, 377, LIGAND-FREE STRUCTURE OF CYTOCHROME P450 PIKC (CYP107L1)
1169, 4l49A, 0.7276, 3.62, 0.153, 405, 385, STRUCTURE OF L358A MUTANT OF P450CAM BOUND TO CAMPHOR
1170, 4fb2B, 0.7276, 3.60, 0.142, 392, 381, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CIN
1171, 1pheA, 0.7275, 3.63, 0.154, 405, 384, CRYSTAL STRUCTURES OF METYRAPONE-AND PHENYLIMIDAZOLE-INHIBITED COMPLEXES OF CYTOCHROME P450-CAM
1172, 4egpA, 0.7274, 3.54, 0.150, 393, 381, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 2-NAPHTHOIC ACID
1173, 1ulwA, 0.7274, 3.38, 0.162, 399, 376, CRYSTAL STRUCTURE OF P450NOR SER73GLY/SER75GLY MUTANT
1174, 5ik1A, 0.7273, 3.45, 0.161, 394, 378, OPEN STATE OF P450CAM AFTER SOAKING IN CAMPHOR
1175, 2wi9A, 0.7273, 3.52, 0.199, 396, 382, SELECTIVE OXIDATION OF CARBOLIDE C-H BONDS BY ENGINEERED MACROLIDE P450 MONOOXYGENASE
1176, 3ejeB, 0.7272, 3.18, 0.146, 378, 370, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH OCTADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
1177, 6cppA, 0.7271, 3.63, 0.151, 405, 384, CRYSTAL STRUCTURES OF CYTOCHROME P450-CAM COMPLEXED WITH CAMPHANE THIOCAMPHOR AND ADAMANTANE: FACTORS CONTROLLING P450 SUBSTRATE HYDROXYLATION
1178, 2romA, 0.7271, 3.56, 0.164, 399, 379, CRYSTAL STRUCTURE OF NITRIC REDUCTASE FROM DENITRIFYING FUNGUS FUSARIUM OXYSPORUM COMPLEX WITH CARBON MONOXIDE
1179, 1iwiA, 0.7271, 3.61, 0.154, 405, 384, PUTIDAREDOXIN-BINDING STABLILIZES AN ACTIVE CONFORMER OF CYTOCHROME P450CAM IN ITS REDUCED STATE; CRYSTAL STRUCTURE OF CYTOCHROME P450CAM
1180, 1gemA, 0.7270, 3.61, 0.154, 405, 384, STRUCTURAL CHARACTERIZATION OF N-BUTYL-ISOCYANIDE COMPLEXES OF CYTOCHROMES P450NOR AND P450CAM
1181, 1nooA, 0.7269, 3.61, 0.156, 405, 384, CYTOCHROME P450-CAM COMPLEXED WITH 5-EXO-HYDROXYCAMPHOR
1182, 1akdA, 0.7269, 3.58, 0.151, 405, 384, CYTOCHROME P450CAM FROM PSEUDOMONAS PUTIDA COMPLEXED WITH 1S-CAMPHOR
1183, 4umzA, 0.7268, 3.56, 0.194, 396, 381, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED SUBSTRATE MIMIC BEARING A 2-DIMETHYLAMINOMETHYLBENZOATE GROUP
1184, 3l63A, 0.7268, 3.61, 0.159, 405, 384, CRYSTAL STRUCTURE OF CAMPHOR-BOUND P450CAM AT LOW [K+]
1185, 1iwjA, 0.7268, 3.61, 0.151, 405, 384, PUTIDAREDOXIN-BINDING STABLILIZES AN ACTIVE CONFORMER OF CYTOCHROME P450CAM IN ITS REDUCED STATE; CRYSTAL STRUCTURE OF MUTANT(109K) CYTOCHROME P450CAM
1186, 5y1iB, 0.7267, 3.41, 0.152, 394, 376, THE CRYSTAL STRUCTURE OF GFSF
1187, 4cppA, 0.7267, 3.64, 0.151, 405, 384, CRYSTAL STRUCTURES OF CYTOCHROME P450-CAM COMPLEXED WITH CAMPHANE THIOCAMPHOR AND ADAMANTANE: FACTORS CONTROLLING P450 SUBSTRATE HYDROXYLATION
1188, 2x5lA, 0.7267, 3.62, 0.160, 414, 382, X-RAY STRUCTURE OF THE SUBSTRATE-FREE MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 ALTERNATIVE CRYSTAL FORM
1189, 1gekA, 0.7267, 3.63, 0.153, 406, 385, STRUCTURAL CHARACTERIZATION OF N-BUTYL-ISOCYANIDE COMPLEXES OF CYTOCHROMES P450NOR AND P450CAM
1190, 5l90A, 0.7266, 3.35, 0.169, 385, 373, THE CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109E1 FROM BACILLUS MEGATERIUM AT 2.55 ANGSTROM RESOLUTION
1191, 1phaA, 0.7266, 3.63, 0.151, 405, 384, INHIBITOR-INDUCED CONFORMATIONAL CHANGE IN CYTOCHROME P450- CAM
1192, 4kkyX, 0.7265, 3.68, 0.158, 411, 385, CRYSTAL STRUCTURE OF N-(1-PYRENE)ACETAMIDE LABELED P450CAM IN SUBSTRATE BOUND FORM.
1193, 1t86B, 0.7264, 3.61, 0.156, 406, 384, CRYSTAL STRUCTURE OF THE FERROUS CYTOCHROME P450CAM MUTANT (L358P/C334A)
1194, 1phbA, 0.7264, 3.63, 0.151, 405, 384, INHIBITOR-INDUCED CONFORMATIONAL CHANGE IN CYTOCHROME P450- CAM
1195, 3nc3B, 0.7263, 3.30, 0.171, 385, 374, CYP134A1 STRUCTURE WITH A CLOSED SUBSTRATE BINDING LOOP
1196, 1dz6B, 0.7263, 3.60, 0.154, 405, 384, FERROUS P450CAM FROM PSEUDOMONAS PUTIDA
1197, 5de9A, 0.7262, 3.56, 0.176, 402, 381, THE ROLE OF ILE87 OF CYP158A2 IN OXIDATIVE COUPLING REACTION
1198, 3tywC, 0.7262, 3.55, 0.166, 398, 380, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR A3(2)
1199, 2vz7A, 0.7262, 3.66, 0.198, 396, 383, CRYSTAL STRUCTURE OF THE YC-17-BOUND PIKC D50N MUTANT
1200, 2cppA, 0.7262, 3.65, 0.151, 405, 384, HIGH-RESOLUTION CRYSTAL STRUCTURE OF CYTOCHROME P450-CAM
1201, 1geiA, 0.7262, 3.57, 0.161, 399, 379, STRUCTURAL CHARACTERIZATION OF N-BUTYL-ISOCYANIDE COMPLEXES OF CYTOCHROMES P450NOR AND P450CAM
1202, 8cppA, 0.7261, 3.65, 0.154, 405, 384, CRYSTAL STRUCTURES OF CYTOCHROME P450-CAM COMPLEXED WITH CAMPHANE THIOCAMPHOR AND ADAMANTANE: FACTORS CONTROLLING P450 SUBSTRATE HYDROXYLATION
1203, 5de9B, 0.7261, 3.60, 0.176, 402, 381, THE ROLE OF ILE87 OF CYP158A2 IN OXIDATIVE COUPLING REACTION
1204, 4cp4A, 0.7261, 3.65, 0.154, 405, 384, CRYSTAL STRUCTURE OF THE CYTOCHROME P450-CAM ACTIVE SITE MUTANT THR252ALA
1205, 1phgA, 0.7261, 3.65, 0.151, 405, 384, CRYSTAL STRUCTURES OF METYRAPONE-AND PHENYLIMIDAZOLE- INHIBITED COMPLEXES OF CYTOCHROME P450-CAM
1206, 1cp4A, 0.7261, 3.64, 0.154, 405, 384, FORMATION CRYSTAL STRUCTURE AND REARRANGEMENT OF A CYTOCHROME P450-CAM IRON-PHENYL COMPLEX
1207, 5vwsA, 0.7260, 3.17, 0.189, 376, 371, LIGAND FREE STRUCTURE OF CYTOCHROME P450 TBTJ1
1208, 5livD, 0.7260, 3.34, 0.122, 389, 377, CRYSTAL STRUCTURE OF MYXOBACTERIAL CYP260A1
1209, 5l90B, 0.7260, 3.29, 0.172, 385, 372, THE CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109E1 FROM BACILLUS MEGATERIUM AT 2.55 ANGSTROM RESOLUTION
1210, 1phfA, 0.7260, 3.64, 0.151, 405, 384, CRYSTAL STRUCTURES OF METYRAPONE-AND PHENYLIMIDAZOLE- INHIBITED COMPLEXES OF CYTOCHROME P450-CAM
1211, 1dz8B, 0.7260, 3.59, 0.154, 405, 383, OXYGEN COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
1212, 7cppA, 0.7259, 3.65, 0.154, 405, 384, THE STRUCTURAL BASIS FOR SUBSTRATE-INDUCED CHANGES IN REDOX POTENTIAL AND SPIN EQUILIBRIUM IN CYTOCHROME P450(CAM)
1213, 6cp4A, 0.7259, 3.62, 0.151, 405, 384, P450CAM D251N MUTANT
1214, 5cppA, 0.7259, 3.65, 0.154, 405, 384, THE STRUCTURAL BASIS FOR SUBSTRATE-INDUCED CHANGES IN REDOX POTENTIAL AND SPIN EQUILIBRIUM IN CYTOCHROME P-450(CAM)
1215, 4oqrA, 0.7259, 3.01, 0.145, 386, 366, STRUCTURE OF A CYP105AS1 MUTANT IN COMPLEX WITH COMPACTIN
1216, 3r9cA, 0.7259, 3.55, 0.179, 400, 380, CRYSTAL STRUCTURE OF MYCOBACTERIUM SMEGMATIS CYP164A2 WITH ECONAZOLE BOUND
1217, 1t87A, 0.7259, 3.61, 0.154, 407, 384, CRYSTAL STRUCTURE OF THE FERROUS CO-BOUND CYTOCHROME P450CAM (C334A)
1218, 4ek1A, 0.7258, 3.62, 0.156, 403, 384, CRYSTAL STRUCTURE OF ELECTRON-SPIN LABELED CYTOCHROME P450CAM
1219, 3ofuB, 0.7258, 3.70, 0.167, 396, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
1220, 2cp4A, 0.7258, 3.59, 0.149, 405, 383, CRYSTAL STRUCTURE OF THE CYTOCHROME P450-CAM ACTIVE SITE MUTANT THR252ALA
1221, 1t85A, 0.7258, 3.67, 0.156, 406, 385, CRYSTAL STRUCTURE OF THE FERROUS CO-BOUND CYTOCHROME P450CAM MUTANT (L358P/C334A)
1222, 1phdA, 0.7258, 3.64, 0.151, 405, 385, CRYSTAL STRUCTURES OF METYRAPONE-AND PHENYLIMIDAZOLE-INHIBITED COMPLEXES OF CYTOCHROME P450-CAM
1223, 1o76B, 0.7257, 3.62, 0.154, 405, 384, CYANIDE COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
1224, 3cppA, 0.7256, 3.60, 0.154, 405, 383, CRYSTAL STRUCTURE OF THE CARBON MONOXY-SUBSTRATE-CYTOCHROME P450-CAM TERNARY COMPLEX
1225, 1uyuB, 0.7256, 3.62, 0.154, 405, 384, XENON COMPLEX OF WILDTYPE P450CAM FROM PSEUDOMONAS PUTIDA
1226, 3ofuD, 0.7255, 3.62, 0.165, 394, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
1227, 3iw0A, 0.7255, 3.50, 0.164, 407, 379, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 C2221 CRYSTAL FORM
1228, 2a1oA, 0.7255, 3.63, 0.151, 405, 384, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF T252A CYTOCHROME P450CAM
1229, 1dz4B, 0.7255, 3.62, 0.154, 405, 384, FERRIC P450CAM FROM PSEUDOMONAS PUTIDA
1230, 5l91B, 0.7254, 3.35, 0.168, 389, 374, THE 2.2 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM BOUND WITH FOUR CORTICOSTERONE MOLECULES
1231, 4umzB, 0.7254, 3.59, 0.203, 395, 380, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED SUBSTRATE MIMIC BEARING A 2-DIMETHYLAMINOMETHYLBENZOATE GROUP
1232, 3tzoB, 0.7254, 3.60, 0.178, 402, 381, THE ROLE OF I87 OF CYP158A2 IN OXIDATIVE COUPLING REACTION
1233, 1dz9B, 0.7254, 3.63, 0.154, 405, 384, PUTATIVE OXO COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
1234, 3nc7B, 0.7253, 3.22, 0.167, 384, 371, CYP134A1 2-PHENYLIMIDAZOLE BOUND STRUCTURE
1235, 2h7sC, 0.7253, 3.66, 0.153, 405, 385, L244A MUTANT OF CYTOCHROME P450CAM
1236, 1f25A, 0.7253, 3.63, 0.150, 399, 380, CRYSTAL STRUCTURE OF NO COMPLEX OF THR243ASN MUTANTS OF CYTOCHROME P450NOR
1237, 5y5mA, 0.7252, 3.47, 0.156, 399, 377, SFX STRUCTURE OF CYTOCHROME P450NOR: A COMPLETE DARK DATA WITHOUT PUMP LASER (RESTING STATE) 
1238, 5livB, 0.7252, 3.37, 0.146, 389, 377, CRYSTAL STRUCTURE OF MYXOBACTERIAL CYP260A1
1239, 2a1mA, 0.7252, 3.63, 0.154, 405, 384, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF WILD-TYPE CYTOCHROME P450CAM
1240, 1jfbA, 0.7252, 3.61, 0.156, 399, 379, X-RAY STRUCTURE OF NITRIC OXIDE REDUCTASE (CYTOCHROME P450NOR) IN THE FERRIC RESTING STATE AT ATOMIC RESOLUTION
1241, 5y5jB, 0.7251, 3.54, 0.151, 399, 378, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: DARK-2 DATA IN THE PRESENCE OF NADH (RESTING STATE)
1242, 1cmjA, 0.7251, 3.59, 0.156, 399, 379, CRYSTAL STRUCTURES OF FERRIC-NO COMPLEXES OF FUNGAL NITRIC OXIDE REDUCTASE AND THEIR SER286 MUTANTS AT CRYOGENIC TEMPERATURE
1243, 5y5mB, 0.7250, 3.54, 0.151, 399, 378, SFX STRUCTURE OF CYTOCHROME P450NOR: A COMPLETE DARK DATA WITHOUT PUMP LASER (RESTING STATE) 
1244, 5y5iB, 0.7250, 3.54, 0.151, 399, 378, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: 20 MS AFTER PHOTO- IRRADIATION OF CAGED NO IN THE PRESENCE OF NADH (NO-BOUND STATE) LIGHT DATA
1245, 4wpzA, 0.7250, 3.31, 0.150, 386, 374, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP107W1 FROM STREPTOMYCES AVERMITILIS
1246, 2ferA, 0.7250, 3.59, 0.154, 405, 383, P450CAM FROM PSEUDOMONAS PUTIDA RECONSTITUTED WITH MANGANIC PROTOPORPHYRIN IX
1247, 1t88A, 0.7250, 3.63, 0.154, 407, 384, CRYSTAL STRUCTURE OF THE FERROUS CYTOCHROME P450CAM (C334A)
1248, 1dz8A, 0.7250, 3.60, 0.154, 404, 383, OXYGEN COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
1249, 5y5kB, 0.7249, 3.54, 0.151, 399, 378, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR : 20 MS AFTER PHOTO- IRRADIATION OF CAGED NO IN THE ABSENCE OF NADH (NO-BOUND STATE) LIGHT DATA
1250, 5y5kA, 0.7249, 3.47, 0.156, 399, 377, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR : 20 MS AFTER PHOTO- IRRADIATION OF CAGED NO IN THE ABSENCE OF NADH (NO-BOUND STATE) LIGHT DATA
1251, 4l4gA, 0.7249, 3.59, 0.154, 405, 383, STRUCTURE OF CYANIDE AND CAMPHOR BOUND P450CAM MUTANT L358P/K178G
1252, 4fb2C, 0.7249, 3.51, 0.143, 390, 378, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CIN
1253, 3oftB, 0.7249, 3.60, 0.163, 393, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
1254, 2y5nB, 0.7249, 3.61, 0.153, 400, 380, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN V IN P21 SPACE GROUP
1255, 2h7sA, 0.7249, 3.67, 0.153, 405, 385, L244A MUTANT OF CYTOCHROME P450CAM
1256, 2feuB, 0.7249, 3.63, 0.154, 405, 384, P450CAM FROM PSEUDOMONAS PUTIDA RECONSTITUTED WITH MANGANIC PROTOPORPHYRIN IX
1257, 1j51A, 0.7249, 3.63, 0.156, 405, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A) WITH 135-TRICHLOROBENZENE
1258, 4bf4M, 0.7248, 3.69, 0.180, 397, 383, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1259, 1o76A, 0.7248, 3.60, 0.154, 404, 383, CYANIDE COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
1260, 1jfcA, 0.7248, 3.63, 0.161, 399, 379, X-RAY STRUCTURE OF NITRIC OXIDE REDUCTASE (CYTOCHROME P450NOR) IN THE FERROUS CO STATE AT ATOMIC RESOLUTION
1261, 4fb2A, 0.7247, 3.59, 0.144, 392, 381, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CIN
1262, 3tzoA, 0.7247, 3.60, 0.176, 402, 381, THE ROLE OF I87 OF CYP158A2 IN OXIDATIVE COUPLING REACTION
1263, 2a1nA, 0.7247, 3.64, 0.154, 407, 384, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF D251N CYTOCHROME P450CAM
1264, 1mpwA, 0.7247, 3.63, 0.156, 405, 384, MOLECULAR RECOGNITION IN (+)-A-PINENE OXIDATION BY CYTOCHROME P450CAM
1265, 1lgfA, 0.7247, 3.21, 0.167, 388, 371, CRYSTAL STRUCTURE OF OXYB A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE PHENOL COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS
1266, 5y5lB, 0.7246, 3.49, 0.156, 399, 377, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: DARK-2 DATA IN THE ABSENCE OF NADH (RESTING STATE)
1267, 5ex6C, 0.7246, 3.25, 0.189, 388, 370, STRUCTURE OF P450 STAH FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS
1268, 3wrhA, 0.7246, 3.64, 0.154, 405, 384, CRYSTAL STRUCTURE OF P450CAM
1269, 2whwB, 0.7246, 3.47, 0.193, 393, 379, SELECTIVE OXIDATION OF CARBOLIDE C-H BONDS BY ENGINEERED MACROLIDE P450 MONOOXYGENASE
1270, 2qbmA, 0.7246, 3.60, 0.154, 405, 383, CRYSTAL STRUCTURE OF THE P450CAM G248T MUTANT IN THE CYANIDE BOUND STATE
1271, 1gebA, 0.7246, 3.64, 0.154, 405, 384, X-RAY CRYSTAL STRUCTURE AND CATALYTIC PROPERTIES OF THR252ILE MUTANT OF CYTOCHROME P450CAM
1272, 5y5lA, 0.7245, 3.45, 0.160, 399, 376, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: DARK-2 DATA IN THE ABSENCE OF NADH (RESTING STATE)
1273, 4bf4D, 0.7245, 3.71, 0.182, 397, 384, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1274, 3wrlA, 0.7245, 3.64, 0.154, 405, 384, CRYSTAL STRUCTURE OF P450CAM
1275, 2a1oB, 0.7245, 3.61, 0.151, 405, 383, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF T252A CYTOCHROME P450CAM
1276, 1se6B, 0.7245, 3.46, 0.169, 402, 378, CRYSTAL STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP158A2 FROM ANTIBIOTIC BIOSYNTHETIC PATHWAYS
1277, 5y5jA, 0.7244, 3.45, 0.160, 399, 376, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: DARK-2 DATA IN THE PRESENCE OF NADH (RESTING STATE)
1278, 5y5iA, 0.7244, 3.45, 0.160, 399, 376, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: 20 MS AFTER PHOTO- IRRADIATION OF CAGED NO IN THE PRESENCE OF NADH (NO-BOUND STATE) LIGHT DATA
1279, 4bf4O, 0.7244, 3.63, 0.185, 397, 383, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1280, 3wrmA, 0.7244, 3.61, 0.154, 405, 383, CRYSTAL STRUCTURE OF P450CAM
1281, 3r9bC, 0.7244, 3.50, 0.183, 391, 377, CRYSTAL STRUCTURE OF MYCOBACTERIUM SMEGMATIS CYP164A2 IN LIGAND FREE STATE
1282, 3r9bB, 0.7244, 3.50, 0.183, 391, 377, CRYSTAL STRUCTURE OF MYCOBACTERIUM SMEGMATIS CYP164A2 IN LIGAND FREE STATE
1283, 2gqxA, 0.7244, 3.64, 0.156, 405, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/L244A/V247L/C334A) WITH PENTACHLOROBENZENE
1284, 1dz9A, 0.7244, 3.62, 0.157, 404, 383, PUTATIVE OXO COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
1285, 3wrjA, 0.7243, 3.64, 0.154, 405, 384, CRYSTAL STRUCTURE OF P450CAM
1286, 3r9bA, 0.7243, 3.50, 0.183, 391, 377, CRYSTAL STRUCTURE OF MYCOBACTERIUM SMEGMATIS CYP164A2 IN LIGAND FREE STATE
1287, 2z97A, 0.7243, 3.66, 0.158, 405, 385, CRYSTAL STRUCTURE OF FERRIC CYTOCHROME P450CAM RECONSTITUTED WITH 7- METHYL-7-DEPROPIONATED HEMIN
1288, 1j51C, 0.7243, 3.58, 0.154, 405, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A) WITH 135-TRICHLOROBENZENE
1289, 4l4cA, 0.7242, 3.63, 0.154, 405, 383, STRUCTURE OF L358P/K178G MUTANT OF P450CAM BOUND TO CAMPHOR
1290, 4b7dB, 0.7242, 3.48, 0.188, 393, 378, PIKC BOUND TO THE 10-DML ANALOG WITH THE 3-(NN-DIMETHYLAMINO) PROPANOATE ANCHORING GROUP
1291, 1cmnA, 0.7242, 3.61, 0.150, 399, 379, CRYSTAL STRUCTURES OF FERRIC-NO COMPLEXES OF FUNGAL NITRIC OXIDE REDUCTASE AND THEIR SER286 MUTANTS AT CRYOGENIC TEMPERATURE
1292, 2wi9B, 0.7241, 3.56, 0.192, 394, 381, SELECTIVE OXIDATION OF CARBOLIDE C-H BONDS BY ENGINEERED MACROLIDE P450 MONOOXYGENASE
1293, 1cl6A, 0.7241, 3.59, 0.153, 399, 378, CRYSTAL STRUCTURES OF FERRIC-NO COMPLEXES OF FUNGAL NITRIC OXIDE REDUCTASE AND ITS SER286 MUTANTS AT CRYOGENIC TEMPERATURE
1294, 2frzA, 0.7240, 3.68, 0.151, 405, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A)
1295, 1uyuA, 0.7240, 3.64, 0.151, 404, 384, XENON COMPLEX OF WILDTYPE P450CAM FROM PSEUDOMONAS PUTIDA
1296, 1t87B, 0.7240, 3.61, 0.154, 405, 383, CRYSTAL STRUCTURE OF THE FERROUS CO-BOUND CYTOCHROME P450CAM (C334A)
1297, 1gejA, 0.7240, 3.47, 0.160, 399, 376, STRUCTURAL CHARACTERIZATION OF N-BUTYL-ISOCYANIDE COMPLEXES OF CYTOCHROMES P450NOR AND P450CAM
1298, 1dz6A, 0.7240, 3.63, 0.151, 404, 384, FERROUS P450CAM FROM PSEUDOMONAS PUTIDA
1299, 4g3rA, 0.7239, 3.65, 0.154, 407, 384, CRYSTAL STRUCTURE OF NITROSYL CYTOCHROME P450CAM
1300, 4bf4L, 0.7239, 3.68, 0.188, 397, 382, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1301, 2gr6A, 0.7239, 3.58, 0.157, 405, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/L244A/V247L/C334A)
1302, 3fwgB, 0.7238, 3.65, 0.159, 405, 384, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM ARG365LEU GLU366GLN MONOCLINIC CRYSTAL FORM
1303, 2vzmA, 0.7238, 3.67, 0.196, 395, 382, CRYSTAL STRUCTURE OF THE NARBOMYCIN-BOUND PIKC D50N MUTANT
1304, 2qblA, 0.7238, 3.60, 0.154, 405, 383, CRYSTAL STRUCTURE OF FERRIC G248T CYTOCHROME P450CAM
1305, 1gedA, 0.7238, 3.56, 0.159, 399, 378, A POSITIVE CHARGE ROUTE FOR THE ACCESS OF NADH TO HEME FORMED IN THE DISTAL HEME POCKET OF CYTOCHROME P450NOR
1306, 5y5hA, 0.7237, 3.56, 0.159, 400, 378, SF-ROX STRUCTURE OF CYTOCHROME P450NOR (NO-BOUND STATE) DETERMINED AT SACLA
1307, 5y5gA, 0.7237, 3.59, 0.148, 400, 379, STRUCTURE OF CYTOCHROME P450NOR IN NO-BOUND STATE: DAMAGED BY LOW-DOSE (0.72 MGY) X-RAY
1308, 2qboA, 0.7237, 3.62, 0.154, 405, 383, CRYSTAL STRUCTURE OF THE P450CAM G248V MUTANT IN THE CYANIDE BOUND STATE
1309, 3e5jA, 0.7236, 3.55, 0.177, 390, 379, CRYSTAL STRUCTURE OF CYP105P1 WILD-TYPE LIGAND-FREE FORM
1310, 2qbnA, 0.7236, 3.62, 0.154, 405, 383, CRYSTAL STRUCTURE OF FERRIC G248V CYTOCHROME P450CAM
1311, 2h7rA, 0.7236, 3.67, 0.159, 405, 384, L244A MUTANT OF CYTOCHROME P450CAM COMPLEXED WITH IMIDAZOLE
1312, 1c8jA, 0.7236, 3.65, 0.154, 405, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F)
1313, 5kyoB, 0.7235, 3.38, 0.143, 393, 377, CRYSTAL STRUCTURE OF CYP101J2
1314, 4g47A, 0.7235, 3.51, 0.150, 394, 380, STRUCTURE OF CYTOCHROME P450 CYP121 IN COMPLEX WITH 4-(1H-124- TRIAZOL-1-YL)PHENOL
1315, 4g44A, 0.7235, 3.51, 0.150, 394, 380, STRUCTURE OF P450 CYP121 IN COMPLEX WITH LEAD COMPOUND MB286 3-((1H- 124-TRIAZOL-1-YL)METHYL)ANILINE
1316, 4fb2D, 0.7235, 3.60, 0.145, 391, 379, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CIN
1317, 2a1mB, 0.7235, 3.64, 0.151, 405, 384, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF WILD-TYPE CYTOCHROME P450CAM
1318, 1f26A, 0.7235, 3.47, 0.157, 399, 376, CRYSTAL STRUCTURE OF NO COMPLEX OF THR243VAL MUTANTS OF CYTOCHROME P450NOR
1319, 1f24A, 0.7235, 3.47, 0.157, 399, 376, CRYSTAL STRUCTURE OF NO COMPLEX OF THR243ALA MUTANTS OF CYTOCHROME P450NOR
1320, 5op9A, 0.7234, 3.51, 0.150, 394, 380, THE CRYSTAL STRUCTURE OF P450 CYP121 IN COMPLEX WITH LEAD COMPOUND 7E
1321, 5xntA, 0.7233, 3.54, 0.183, 392, 378, STRUCTURE OF CYP106A2 FROM BACILLUS SP. PAMC 23377
1322, 4yt3B, 0.7233, 3.59, 0.183, 388, 377, CYP106A2
1323, 3wrmF, 0.7233, 3.64, 0.151, 405, 384, CRYSTAL STRUCTURE OF P450CAM
1324, 3cxzA, 0.7233, 3.51, 0.147, 394, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 R386L MUTANT FROM M. TUBERCULOSIS
1325, 2vzmB, 0.7233, 3.64, 0.187, 394, 380, CRYSTAL STRUCTURE OF THE NARBOMYCIN-BOUND PIKC D50N MUTANT
1326, 3g5fA, 0.7232, 3.52, 0.145, 394, 380, CRYSTALLOGRAPHIC ANALYSIS OF CYTOCHROME P450 CYP121
1327, 1ehgA, 0.7232, 3.56, 0.151, 399, 378, CRYSTAL STRUCTURES OF CYTOCHROME P450NOR AND ITS MUTANTS (SER286 VAL THR) IN THE FERRIC RESTING STATE AT CRYOGENIC TEMPERATURE: A COMPARATIVE ANALYSIS WITH MONOOXYGENASE CYTOCHROME P450S
1328, 1eheA, 0.7232, 3.49, 0.160, 399, 376, CRYSTAL STRUCTURES OF CYTOCHROME P450NOR AND ITS MUTANTS (SER286 VAL THR) IN THE FERRIC RESTING STATE AT CRYOGENIC TEMPERATURE: A COMPARATIVE ANALYSIS WITH MONOOXYGENASE CYTOCHROME P450S
1329, 5o4kA, 0.7231, 3.51, 0.147, 394, 380, CRYSTAL STRUCTURE OF P450 CYP121 IN COMPLEX WITH COMPOUND 6B.
1330, 4ktjA, 0.7231, 3.53, 0.145, 394, 380, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 4-(3-AMINO-1H-PYRAZOL-4-YL)PHENOL
1331, 4g46A, 0.7231, 3.52, 0.150, 394, 380, STRUCTURE OF CYTOCHROME P450 CYP121 IN COMPLEX WITH 4-OXO-4567- TETRAHYDROBENZOFURAN-3-CARBOXYLATE
1332, 5edtA, 0.7230, 3.53, 0.147, 394, 380, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH LIG9
1333, 4g1xA, 0.7230, 3.53, 0.145, 394, 380, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 4-(1H-124-TRIAZOL-1-YL)QUINOLIN-6-AMINE
1334, 3wrlE, 0.7230, 3.68, 0.151, 405, 385, CRYSTAL STRUCTURE OF P450CAM
1335, 4ktlA, 0.7229, 3.52, 0.147, 394, 380, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 44 -(3-((4-HYDROXYPHENYL)AMINO)-1H-PYRAZOLE-45-DIYL)DIPHENOL
1336, 4ictA, 0.7229, 3.52, 0.150, 394, 380, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
1337, 4g48A, 0.7229, 3.52, 0.150, 394, 380, STRUCTURE OF CYP121 IN COMPLEX WITH 4-(4-PHENOXY-1H-PYRAZOL-3-YL) BENZENE-13-DIOL
1338, 3wrhE, 0.7229, 3.65, 0.156, 405, 384, CRYSTAL STRUCTURE OF P450CAM
1339, 2vz7B, 0.7229, 3.62, 0.195, 393, 380, CRYSTAL STRUCTURE OF THE YC-17-BOUND PIKC D50N MUTANT
1340, 2m56A, 0.7229, 3.62, 0.154, 404, 383, THE STRUCTURE OF THE COMPLEX OF CYTOCHROME P450CAM AND ITS ELECTRON DONOR PUTIDAREDOXIN DETERMINED BY PARAMAGNETIC NMR SPECTROSCOPY
1341, 5mnvA, 0.7228, 3.66, 0.174, 397, 380, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1342, 5ibeA, 0.7228, 3.52, 0.147, 394, 380, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 25A
1343, 4ktkA, 0.7228, 3.54, 0.145, 394, 380, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 4-(3-AMINO-4-(4-HYDROXYPHENYL)-1H-PYRAZOL-5-YL)BENZENE-13-DIOL
1344, 4g2gA, 0.7228, 3.52, 0.150, 394, 380, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 44 -(1H-123-TRIAZOLE-15-DIYL)DIPHENOL
1345, 4bf4N, 0.7228, 3.67, 0.196, 397, 383, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1346, 3cxvA, 0.7228, 3.51, 0.145, 394, 380, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 CYP121 A233G MUTANT FROM MYCOBACTERIUM TUBERCULOSIS
1347, 1ehfA, 0.7228, 3.52, 0.156, 399, 377, CRYSTAL STRUCTURES OF CYTOCHROME P450NOR AND ITS MUTANTS (SER286 VAL THR) IN THE FERRIC RESTING STATE AT CRYOGENIC TEMPERATURE: A COMPARATIVE ANALYSIS WITH MONOOXYGENASE CYTOCHROME P450S
1348, 5kyoA, 0.7227, 3.35, 0.138, 394, 376, CRYSTAL STRUCTURE OF CYP101J2
1349, 3cxxA, 0.7227, 3.53, 0.142, 394, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 F338H FROM M. TUBERCULOSIS
1350, 2a1nB, 0.7227, 3.66, 0.151, 405, 384, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF D251N CYTOCHROME P450CAM
1351, 1dz4A, 0.7227, 3.65, 0.151, 404, 384, FERRIC P450CAM FROM PSEUDOMONAS PUTIDA
1352, 4iq7A, 0.7226, 3.53, 0.147, 394, 380, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
1353, 4g45A, 0.7226, 3.52, 0.147, 394, 380, STRUCTURE OF CYTOCHROME CYP121 IN COMPLEX WITH 2-METHYLQUINOLIN-6- AMINE
1354, 3wrjE, 0.7226, 3.65, 0.154, 405, 384, CRYSTAL STRUCTURE OF P450CAM
1355, 3cy0A, 0.7226, 3.54, 0.145, 394, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 S237A MUTANT FROM MYCOBACTERIUM TUBERCULOSIS
1356, 2fe6A, 0.7226, 3.66, 0.154, 405, 384, P450CAM FROM PSEUDOMONAS PUTIDA RECONSTITUTED WITH MANGANIC PROTOPORPHYRIN IX
1357, 4bf4J, 0.7225, 3.71, 0.188, 397, 383, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1358, 3zk5B, 0.7225, 3.55, 0.193, 394, 379, PIKC D50N MUTANT BOUND TO THE 10-DML ANALOG WITH THE 3-(NN-DIMETHYLAMINO)ETHANOATE ANCHORING GROUP
1359, 2xbkA, 0.7225, 3.35, 0.149, 391, 370, X-RAY STRUCTURE OF THE SUBSTRATE-BOUND CYTOCHROME P450 PIMD - A POLYENE MACROLIDE ANTIBIOTIC PIMARICIN EPOXIDASE
1360, 1mpwB, 0.7225, 3.66, 0.151, 405, 384, MOLECULAR RECOGNITION IN (+)-A-PINENE OXIDATION BY CYTOCHROME P450CAM
1361, 5ibiA, 0.7224, 3.49, 0.148, 393, 379, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 26A
1362, 4yt3A, 0.7224, 3.57, 0.186, 388, 376, CYP106A2
1363, 4iq9A, 0.7224, 3.53, 0.147, 394, 380, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
1364, 1t88B, 0.7224, 3.66, 0.151, 405, 384, CRYSTAL STRUCTURE OF THE FERROUS CYTOCHROME P450CAM (C334A)
1365, 1p2yA, 0.7224, 3.66, 0.154, 407, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM IN COMPLEX WITH (S)- (-)-NICOTINE
1366, 1n40A, 0.7224, 3.52, 0.147, 394, 380, ATOMIC STRUCTURE OF CYP121 A MYCOBACTERIAL P450
1367, 1j51D, 0.7224, 3.66, 0.154, 405, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A) WITH 135-TRICHLOROBENZENE
1368, 3fwgA, 0.7223, 3.65, 0.156, 404, 384, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM ARG365LEU GLU366GLN MONOCLINIC CRYSTAL FORM
1369, 5ibdA, 0.7222, 3.53, 0.147, 394, 380, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 24A
1370, 3fwjA, 0.7222, 3.68, 0.161, 405, 384, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM CONTAINING A SELENOCYSTEINE AS THE 5TH HEME LIGAND ORTHOROMBIC CRYSTAL FORM
1371, 3fwiA, 0.7222, 3.68, 0.161, 405, 384, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM CONTAINING A SELENOCYSTEINE AS THE 5TH HEME LIGAND TETRAGONAL CRYSTAL FORM
1372, 3cy1A, 0.7222, 3.52, 0.147, 394, 380, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 CYP121 S279A MUTANT FROM M. TUBERCULOSIS
1373, 4ipsA, 0.7221, 3.53, 0.150, 394, 380, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
1374, 4bf4H, 0.7221, 3.74, 0.180, 396, 383, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1375, 3wrkD, 0.7221, 3.47, 0.165, 392, 375, CRYSTAL STRUCTURE OF P450CAM
1376, 2zwtA, 0.7221, 3.64, 0.157, 405, 383, CRYSTAL STRUCTURE OF FERRIC CYTOCHROME P450CAM
1377, 1p7rA, 0.7221, 3.67, 0.154, 407, 384, CRYSTAL STRUCTURE OF REDUCED CO-EXPOSED COMPLEX OF CYTOCHROME P450CAM WITH (S)-(-)-NICOTINE
1378, 5wp2A, 0.7220, 3.55, 0.147, 394, 380, 1.44 ANGSTROM CRYSTAL STRUCTURE OF CYP121 FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH SUBSTRATE AND CN 
1379, 4ipwA, 0.7220, 3.54, 0.147, 394, 380, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
1380, 3g5hA, 0.7220, 3.55, 0.145, 394, 380, CRYSTALLOGRAPHIC ANALYSIS OF CYTOCHROME P450 CYP121
1381, 3e5kA, 0.7220, 3.28, 0.173, 382, 371, CRYSTAL STRUCTURE OF CYP105P1 WILD-TYPE 4-PHENYLIMIDAZOLE COMPLEX
1382, 2zuiA, 0.7220, 3.70, 0.156, 405, 385, CRYSTAL STRUCTURE OF CAMPHOR-SOAKED FERRIC CYTOCHROME P450CAM MUTANT (D297N)
1383, 2gqxB, 0.7219, 3.67, 0.154, 405, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/L244A/V247L/C334A) WITH PENTACHLOROBENZENE
1384, 5y5fA, 0.7218, 3.59, 0.148, 399, 378, STRUCTURE OF CYTOCHROME P450NOR IN NO-BOUND STATE: DAMAGED BY LOW-DOSE (0.72 MGY) X-RAY
1385, 3zpiB, 0.7218, 3.72, 0.188, 396, 382, PIKC D50N MUTANT IN P21 SPACE GROUP
1386, 3cxyA, 0.7218, 3.49, 0.148, 393, 379, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 CYP121 P346L MUTANT FROM M. TUBERCULOSIS
1387, 2gr6B, 0.7218, 3.61, 0.154, 405, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/L244A/V247L/C334A)
1388, 2zujA, 0.7217, 3.68, 0.161, 405, 384, CRYSTAL STRUCTURE OF CAMPHOR-SOAKED FERRIC CYTOCHROME P450CAM MUTANT(D297L)
1389, 1yrdA, 0.7217, 3.64, 0.157, 405, 383, X-RAY CRYSTAL STRUCTURE OF PERDEUTERATED CYTOCHROME P450CAM
1390, 1yrcA, 0.7217, 3.64, 0.157, 405, 383, X-RAY CRYSTAL STRUCTURE OF HYDROGENATED CYTOCHROME P450CAM
1391, 4bf4P, 0.7216, 3.60, 0.200, 396, 380, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1392, 4bf4B, 0.7216, 3.68, 0.188, 397, 382, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1393, 2zwuA, 0.7216, 3.67, 0.154, 405, 384, CRYSTAL STRUCTURE OF CAMPHOR SOAKED FERRIC CYTOCHROME P450CAM
1394, 2zuhA, 0.7216, 3.67, 0.154, 405, 384, CRYSTAL STRUCTURE OF CAMPHOR-SOAKED FERRIC CYTOCHROME P450CAM MUTANT (D297A)
1395, 5o4lA, 0.7215, 3.51, 0.148, 393, 379, CRYSTAL STRUCTURE OF P450 CYP121 IN COMPLEX WITH COMPOUND 6A.
1396, 5ibjA, 0.7215, 3.50, 0.148, 393, 379, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 6
1397, 2zaxA, 0.7215, 3.67, 0.154, 405, 384, CRYSTAL STRUCTURE OF FERRIC CYTOCHROME P450CAM
1398, 1j51B, 0.7215, 3.61, 0.154, 405, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A) WITH 135-TRICHLOROBENZENE
1399, 5ikiA, 0.7214, 3.33, 0.183, 383, 371, CYP106A2 WITH SUBSTRATE ABIETIC ACID
1400, 2c6hA, 0.7214, 3.54, 0.193, 393, 378, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC (CYP107L1)
1401, 5ibhA, 0.7213, 3.52, 0.148, 393, 379, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 26H
1402, 5ex6A, 0.7213, 3.28, 0.190, 386, 369, STRUCTURE OF P450 STAH FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS
1403, 2zawA, 0.7213, 3.70, 0.156, 405, 385, CRYSTAL STRUCTURE OF FERRIC CYTOCHROME P450CAM RECONSTITUTED WITH 6- METHYL-6-DEPROPIONATED HEMIN
1404, 5opaA, 0.7212, 3.53, 0.145, 393, 379, THE CRYSTAL STRUCTURE OF P450 CYP121 IN COMPLEX WITH LEAD COMPOUND 7B
1405, 4l4cB, 0.7212, 3.66, 0.157, 405, 383, STRUCTURE OF L358P/K178G MUTANT OF P450CAM BOUND TO CAMPHOR
1406, 3fwfB, 0.7212, 3.74, 0.158, 405, 385, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM CONTAINING A SELENOCYSTEINE AS THE 5TH HEME LIGAND MONOCLINIC CRYSTAL FORM
1407, 1wiyB, 0.7212, 2.81, 0.192, 362, 359, CRYSTAL STRUCTURE ANALYSIS OF A 6-COORDINATED CYTOCHOROME P450 FROM THERMUS THERMOPHILUS HB8
1408, 2c6hB, 0.7210, 3.60, 0.195, 394, 379, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC (CYP107L1)
1409, 1c8jB, 0.7210, 3.69, 0.151, 405, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F)
1410, 3a51A, 0.7208, 3.79, 0.176, 402, 381, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
1411, 3a4zA, 0.7208, 3.79, 0.176, 402, 381, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
1412, 2xn8A, 0.7208, 3.64, 0.153, 409, 380, X-RAY STRUCTURE OF THE SUBSTRATE-FREE MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125
1413, 2feuA, 0.7208, 3.69, 0.154, 404, 384, P450CAM FROM PSEUDOMONAS PUTIDA RECONSTITUTED WITH MANGANIC PROTOPORPHYRIN IX
1414, 5y1iA, 0.7207, 3.52, 0.150, 388, 374, THE CRYSTAL STRUCTURE OF GFSF
1415, 4g3rB, 0.7207, 3.66, 0.157, 405, 383, CRYSTAL STRUCTURE OF NITROSYL CYTOCHROME P450CAM
1416, 3a4hA, 0.7207, 3.55, 0.175, 400, 377, STRUCTURE OF CYTOCHROME P450 VDH FROM PSEUDONOCARDIA AUTOTROPHICA (ORTHORHOMBIC CRYSTAL FORM)
1417, 5ibfA, 0.7206, 3.54, 0.145, 393, 379, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 19A
1418, 4b7sA, 0.7206, 3.71, 0.191, 397, 382, PIKC D50N MUTANT BOUND TO THE 10-DML ANALOG WITH THE 3-(NN- DIMETHYLAMINO)PROPANOATE ANCHORING GROUP
1419, 2frzB, 0.7205, 3.69, 0.156, 405, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A)
1420, 5kyoE, 0.7204, 3.48, 0.138, 390, 378, CRYSTAL STRUCTURE OF CYP101J2
1421, 4b7sB, 0.7204, 3.56, 0.190, 393, 378, PIKC D50N MUTANT BOUND TO THE 10-DML ANALOG WITH THE 3-(NN- DIMETHYLAMINO)PROPANOATE ANCHORING GROUP
1422, 3a50A, 0.7204, 3.79, 0.176, 402, 381, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
1423, 4bf4E, 0.7203, 3.77, 0.188, 397, 383, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1424, 3zpiA, 0.7203, 3.72, 0.189, 396, 381, PIKC D50N MUTANT IN P21 SPACE GROUP
1425, 3zk5A, 0.7203, 3.72, 0.185, 397, 383, PIKC D50N MUTANT BOUND TO THE 10-DML ANALOG WITH THE 3-(NN-DIMETHYLAMINO)ETHANOATE ANCHORING GROUP
1426, 4bf4A, 0.7202, 3.68, 0.192, 396, 381, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1427, 3wrkA, 0.7201, 3.47, 0.166, 391, 374, CRYSTAL STRUCTURE OF P450CAM
1428, 4bf4I, 0.7200, 3.69, 0.192, 396, 381, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1429, 3oftC, 0.7200, 3.58, 0.169, 390, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
1430, 3tywB, 0.7199, 3.65, 0.166, 397, 379, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR A3(2)
1431, 1lg9A, 0.7199, 3.11, 0.178, 377, 365, CRYSTAL STRUCTURE OF OXYB A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE PHENOL COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS
1432, 4ktfA, 0.7198, 3.52, 0.143, 392, 378, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 44 -(3-AMINO-1H-PYRAZOLE-45-DIYL)DIPHENOL
1433, 3nc5A, 0.7197, 3.37, 0.173, 384, 370, CYP134A1 STRUCTURE WITH AN OPEN SUBSTRATE BINDING LOOP
1434, 3a4zB, 0.7197, 3.70, 0.179, 402, 379, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
1435, 1gjmA, 0.7197, 3.88, 0.153, 405, 386, COVALENT ATTACHMENT OF AN ELECTROACTIVE SULPHYDRYL REAGENT IN THE ACTIVE SITE OF CYTOCHROME P450CAM
1436, 4bf4K, 0.7196, 3.76, 0.180, 397, 383, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1437, 2wioA, 0.7195, 3.73, 0.156, 393, 378, STRUCTURE OF THE  HISTIDINE TAGGED OPEN CYTOCHROME P450 ERYK FROM S. ERYTHRAEA
1438, 3tywA, 0.7194, 3.59, 0.164, 397, 378, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR A3(2)
1439, 3ofuE, 0.7194, 3.58, 0.164, 390, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
1440, 1lfkA, 0.7194, 3.18, 0.166, 375, 367, CRYSTAL STRUCTURE OF OXYB A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE PHENOL COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS
1441, 4aw3B, 0.7193, 3.48, 0.155, 393, 375, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286V MUTANT IN COMPLEX WITH MYCINAMICIN V IN P1 SPACE GROUP
1442, 3a51B, 0.7193, 3.70, 0.179, 402, 379, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
1443, 2xc3A, 0.7193, 3.56, 0.154, 409, 377, X-RAY STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP125 BOUND TO THE REVERSE TYPE I INHIBITOR
1444, 3a51D, 0.7192, 3.77, 0.179, 402, 380, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
1445, 2y5zC, 0.7192, 3.76, 0.152, 394, 381, MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN III IN C2221 SPACE GROUP
1446, 1odoA, 0.7192, 3.60, 0.148, 395, 379, 1.85 A STRUCTURE OF CYP154A1 FROM STREPTOMYCES COELICOLOR A3(2)
1447, 4bf4G, 0.7191, 3.73, 0.197, 396, 381, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1448, 4bf4C, 0.7191, 3.73, 0.197, 396, 381, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1449, 1n4gA, 0.7191, 3.53, 0.148, 392, 378, STRUCTURE OF CYP121 A MYCOBACTERIAL P450 IN COMPLEX WITH IODOPYRAZOLE
1450, 5mnvD, 0.7190, 3.63, 0.172, 394, 377, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1451, 4bf4F, 0.7190, 3.68, 0.200, 396, 380, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1452, 3a50B, 0.7190, 3.70, 0.179, 402, 379, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
1453, 2ygxD, 0.7190, 3.65, 0.156, 393, 378, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN P21 SPACE GROUP
1454, 4b7dA, 0.7189, 3.57, 0.188, 393, 378, PIKC BOUND TO THE 10-DML ANALOG WITH THE 3-(NN-DIMETHYLAMINO) PROPANOATE ANCHORING GROUP
1455, 2y5zB, 0.7189, 3.77, 0.150, 394, 381, MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN III IN C2221 SPACE GROUP
1456, 2ygxB, 0.7188, 3.65, 0.156, 393, 378, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN P21 SPACE GROUP
1457, 2ycaA, 0.7188, 3.73, 0.150, 393, 380, MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN III IN P21212 SPACE GROUP
1458, 5yswA, 0.7187, 3.07, 0.157, 374, 364, CRYSTAL STRUCTURE ANALYSIS OF RIF16 IN COMPLEX WITH R-L 
1459, 5gnmD, 0.7185, 3.73, 0.169, 401, 379, CYTOCHROME P450 VDH (CYP107BR1) L348M MUTANT
1460, 5ex8A, 0.7183, 3.69, 0.136, 414, 376, STRUCTURE OF P450 STAF FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS; ETHYLENE GLYCOL CRYO
1461, 2y5nA, 0.7183, 3.53, 0.152, 394, 376, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN V IN P21 SPACE GROUP
1462, 2ca0A, 0.7183, 3.60, 0.199, 393, 377, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC ( CYP107L1)
1463, 6fshD, 0.7181, 3.21, 0.188, 382, 367, CRYSTAL STRUCTURE OF HYBRID P450 OXYBTEI(BC/FGVAN) 
1464, 2l8mA, 0.7181, 3.78, 0.148, 405, 385, REDUCED AND CO-BOUND CYTOCHROME P450CAM (CYP101A1)
1465, 3ofuF, 0.7180, 3.63, 0.169, 390, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
1466, 5mnsE, 0.7179, 3.60, 0.156, 395, 378, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
1467, 5ex9A, 0.7179, 3.70, 0.138, 414, 376, STRUCTURE OF P450 STAF FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS; GLYCEROL CRYO
1468, 3wvsA, 0.7177, 3.60, 0.149, 393, 377, CRYSTAL STRUCTURE OF CYTOCHROME P450REVI
1469, 3a51C, 0.7177, 3.80, 0.179, 401, 380, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
1470, 2ij5C, 0.7177, 3.64, 0.136, 394, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
1471, 5kyoC, 0.7176, 3.34, 0.139, 390, 373, CRYSTAL STRUCTURE OF CYP101J2
1472, 3a4zC, 0.7176, 3.81, 0.176, 401, 380, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
1473, 2ygxA, 0.7176, 3.67, 0.156, 393, 378, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN P21 SPACE GROUP
1474, 5mnvH, 0.7175, 3.68, 0.169, 395, 378, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1475, 3ivyA, 0.7175, 3.56, 0.163, 399, 374, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 P212121 CRYSTAL FORM
1476, 2ygxC, 0.7175, 3.68, 0.156, 393, 378, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN P21 SPACE GROUP
1477, 2nz5A, 0.7175, 3.70, 0.143, 399, 378, STRUCTURE AND FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
1478, 2dkkA, 0.7175, 3.60, 0.138, 399, 376, STRUCTURE/FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
1479, 5l94A, 0.7174, 3.52, 0.167, 385, 372, THE 2.25 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM IN COMPLEX WITH TESTOSTERONE
1480, 4z5pA, 0.7174, 3.28, 0.159, 388, 370, CRYSTAL STRUCTURE OF THE LNMA CYTOCHROME P450 HYDROXYLASE FROM THE LEINAMYCIN BIOSYNTHETIC PATHWAY OF STREPTOMYCES ATROOLIVACEUS S-140 AT 1.9 A RESOLUTION
1481, 3zsnC, 0.7174, 3.77, 0.150, 393, 380, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286A MUTANT IN COMPLEX WITH MYCINAMICIN IV
1482, 3zsnA, 0.7173, 3.77, 0.150, 393, 380, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286A MUTANT IN COMPLEX WITH MYCINAMICIN IV
1483, 3a4gA, 0.7173, 3.58, 0.173, 395, 376, STRUCTURE OF CYTOCHROME P450 VDH FROM PSEUDONOCARDIA AUTOTROPHICA (TRIGONAL CRYSTAL FORM)
1484, 2c7xA, 0.7173, 3.80, 0.188, 396, 382, CRYSTAL STRUCTURE OF NARBOMYCIN-BOUND CYTOCHROME P450 PIKC (CYP107L1)
1485, 3zsnB, 0.7172, 3.77, 0.150, 393, 380, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286A MUTANT IN COMPLEX WITH MYCINAMICIN IV
1486, 3fwfA, 0.7172, 3.69, 0.157, 404, 383, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM CONTAINING A SELENOCYSTEINE AS THE 5TH HEME LIGAND MONOCLINIC CRYSTAL FORM
1487, 4xe3A, 0.7171, 3.71, 0.164, 394, 379, OLEP THE CYTOCHROME P450 EPOXIDASE FROM STREPTOMYCES ANTIBIOTICUS INVOLVED IN OLEANDOMYCIN BIOSYNTHESIS: FUNCTIONAL ANALYSIS AND CRYSTALLOGRAPHIC STRUCTURE IN COMPLEX WITH CLOTRIMAZOLE.
1488, 3a51E, 0.7171, 3.70, 0.177, 401, 378, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
1489, 5l92A, 0.7170, 3.48, 0.167, 386, 371, THE 2.1 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM IN COMPLEX WITH CORTICOSTERONE
1490, 3a4zE, 0.7170, 3.70, 0.180, 401, 378, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
1491, 3a4zD, 0.7170, 3.72, 0.177, 401, 378, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
1492, 2y46C, 0.7170, 3.78, 0.150, 393, 380, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN IV IN C 2 2 21 SPACE GROUP
1493, 2y46B, 0.7169, 3.78, 0.150, 393, 380, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN IV IN C 2 2 21 SPACE GROUP
1494, 3a50C, 0.7168, 3.82, 0.179, 401, 380, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
1495, 3iw1A, 0.7167, 3.48, 0.164, 398, 372, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 IN COMPLEX WITH ANDROSTENEDIONE
1496, 5mnvC, 0.7166, 3.64, 0.156, 396, 379, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1497, 2y46A, 0.7166, 3.78, 0.150, 393, 380, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN IV IN C 2 2 21 SPACE GROUP
1498, 4aw3A, 0.7165, 3.54, 0.155, 393, 375, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286V MUTANT IN COMPLEX WITH MYCINAMICIN V IN P1 SPACE GROUP
1499, 5li8A, 0.7164, 3.58, 0.130, 390, 376, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH KETOCONAZOLE
1500, 5mnsA, 0.7162, 3.67, 0.158, 395, 379, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
1501, 3a50D, 0.7162, 3.72, 0.177, 401, 378, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
1502, 2ij5A, 0.7162, 3.60, 0.140, 392, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
1503, 5gweB, 0.7161, 3.55, 0.165, 396, 375, CYTOCHROME P450 CREJ
1504, 4z5pB, 0.7161, 3.30, 0.159, 388, 370, CRYSTAL STRUCTURE OF THE LNMA CYTOCHROME P450 HYDROXYLASE FROM THE LEINAMYCIN BIOSYNTHETIC PATHWAY OF STREPTOMYCES ATROOLIVACEUS S-140 AT 1.9 A RESOLUTION
1505, 4pwvA, 0.7161, 3.63, 0.164, 404, 377, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS IN COMPLEX WITH A PEPTIDYL CARRIER PROTEIN DOMAIN
1506, 2y98A, 0.7161, 3.80, 0.150, 393, 380, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN IV IN P21212 SPACE GROUP
1507, 2ij5B, 0.7161, 3.50, 0.146, 390, 377, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
1508, 2bvjA, 0.7161, 3.66, 0.199, 394, 377, LIGAND-FREE STRUCTURE OF CYTOCHROME P450 PIKC (CYP107L1)
1509, 4tpoA, 0.7160, 3.67, 0.124, 398, 379, HIGH-RESOLUTION STRUCTURE OF TXTE WITH BOUND TRYPTOPHAN SUBSTRATE
1510, 3a50E, 0.7160, 3.71, 0.177, 401, 378, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
1511, 5gnmC, 0.7159, 3.69, 0.172, 401, 377, CYTOCHROME P450 VDH (CYP107BR1) L348M MUTANT
1512, 2y5zA, 0.7159, 3.69, 0.153, 393, 378, MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN III IN C2221 SPACE GROUP
1513, 5ofqD, 0.7158, 3.37, 0.152, 387, 369, CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109A2 FROM BACILLUS MEGATERIUM
1514, 5mnvF, 0.7158, 3.73, 0.169, 395, 378, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1515, 5mnsB, 0.7158, 3.64, 0.156, 395, 378, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
1516, 5d3uA, 0.7158, 3.89, 0.120, 403, 383, CRYSTAL STRUCTURE OF THE 5-SELECTIVE H176F MUTANT OF CYTOCHROME TXTE
1517, 4xe3B, 0.7158, 3.78, 0.158, 394, 380, OLEP THE CYTOCHROME P450 EPOXIDASE FROM STREPTOMYCES ANTIBIOTICUS INVOLVED IN OLEANDOMYCIN BIOSYNTHESIS: FUNCTIONAL ANALYSIS AND CRYSTALLOGRAPHIC STRUCTURE IN COMPLEX WITH CLOTRIMAZOLE.
1518, 5d40A, 0.7157, 3.89, 0.120, 403, 383, CRYSTAL STRUCTURE OF THE 5-SELECTIVE H176Y MUTANT OF CYTOCHROME TXTE
1519, 2z3tA, 0.7157, 3.46, 0.177, 385, 373, CRYSTAL STRUCTURE OF SUBSTRATE FREE CYTOCHROME P450 STAP (CYP245A1)
1520, 5gnlA, 0.7156, 3.73, 0.175, 395, 378, CYTOCHROME P450 VDH (CYP107BR1) F106V MUTANT
1521, 2z3tC, 0.7156, 3.46, 0.177, 383, 373, CRYSTAL STRUCTURE OF SUBSTRATE FREE CYTOCHROME P450 STAP (CYP245A1)
1522, 3iw2A, 0.7155, 3.42, 0.164, 398, 371, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 IN COMPLEX WITH ECONAZOLE
1523, 6fshA, 0.7154, 3.25, 0.189, 378, 366, CRYSTAL STRUCTURE OF HYBRID P450 OXYBTEI(BC/FGVAN) 
1524, 5mnvB, 0.7153, 3.61, 0.159, 394, 377, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1525, 2nz5B, 0.7151, 3.90, 0.139, 399, 381, STRUCTURE AND FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
1526, 5mnsC, 0.7150, 3.63, 0.154, 395, 377, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
1527, 2nzaB, 0.7149, 3.65, 0.152, 388, 376, STRUCTURE AND FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
1528, 2ca0B, 0.7149, 3.68, 0.190, 393, 378, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC ( CYP107L1)
1529, 2cd8B, 0.7148, 3.60, 0.193, 392, 378, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC (CYP107L1)
1530, 4l36A, 0.7147, 3.59, 0.122, 396, 377, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 ENZYME TXTE
1531, 3vrmA, 0.7147, 3.60, 0.181, 402, 375, STRUCTURE OF CYTOCHROME P450 VDH MUTANT T107A WITH BOUND VITAMIN D3
1532, 5mnsD, 0.7145, 3.64, 0.153, 395, 378, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
1533, 5l92B, 0.7145, 3.04, 0.180, 370, 361, THE 2.1 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM IN COMPLEX WITH CORTICOSTERONE
1534, 5d3uB, 0.7143, 3.91, 0.123, 403, 383, CRYSTAL STRUCTURE OF THE 5-SELECTIVE H176F MUTANT OF CYTOCHROME TXTE
1535, 3wecA, 0.7142, 3.49, 0.147, 401, 375, STRUCTURE OF P450 RAUA (CYP1050A1) COMPLEXED WITH A BIOSYNTHETIC INTERMEDIATE OF AURACHIN RE
1536, 2nzaA, 0.7141, 3.69, 0.159, 397, 377, STRUCTURE AND FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
1537, 6fshC, 0.7140, 3.21, 0.189, 380, 365, CRYSTAL STRUCTURE OF HYBRID P450 OXYBTEI(BC/FGVAN) 
1538, 6fshB, 0.7140, 3.24, 0.189, 380, 366, CRYSTAL STRUCTURE OF HYBRID P450 OXYBTEI(BC/FGVAN) 
1539, 5ibgA, 0.7140, 3.56, 0.141, 390, 376, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 25B
1540, 5ofqC, 0.7139, 3.50, 0.164, 386, 372, CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109A2 FROM BACILLUS MEGATERIUM
1541, 5ofqA, 0.7139, 3.34, 0.147, 386, 368, CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109A2 FROM BACILLUS MEGATERIUM
1542, 5mnvE, 0.7137, 3.57, 0.174, 390, 373, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1543, 5d40B, 0.7137, 3.93, 0.125, 403, 384, CRYSTAL STRUCTURE OF THE 5-SELECTIVE H176Y MUTANT OF CYTOCHROME TXTE
1544, 5gnmB, 0.7135, 3.68, 0.176, 399, 376, CYTOCHROME P450 VDH (CYP107BR1) L348M MUTANT
1545, 4fxbA, 0.7135, 3.64, 0.171, 390, 375, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR: A CYTOCHROME P450 OXIDASE IN THE COELIBACTIN SIDEROPHORE BIOSYNTHETIC PATHWAY
1546, 5hdiA, 0.7134, 3.45, 0.137, 397, 371, STRUCTURAL CHARACTERIZATION OF CYP144A1 A MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450
1547, 5hh3C, 0.7133, 3.48, 0.143, 393, 371, OXYA FROM ACTINOPLANES TEICHOMYCETICUS
1548, 4tx3A, 0.7132, 3.16, 0.185, 373, 363, COMPLEX OF THE X-DOMAIN AND OXYB FROM TEICOPLANIN BIOSYNTHESIS
1549, 3nc7A, 0.7132, 3.35, 0.172, 379, 367, CYP134A1 2-PHENYLIMIDAZOLE BOUND STRUCTURE
1550, 2ij7A, 0.7132, 3.61, 0.143, 391, 377, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
1551, 5ex6B, 0.7131, 3.15, 0.184, 371, 364, STRUCTURE OF P450 STAH FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS
1552, 4tpnA, 0.7131, 3.71, 0.127, 386, 378, HIGH-RESOLUTION STRUCTURE OF TXTE IN THE ABSENCE OF SUBSTRATE
1553, 2ij7E, 0.7130, 3.58, 0.141, 391, 376, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
1554, 2lqdA, 0.7128, 3.91, 0.150, 405, 386, REDUCED AND CO-BOUND CYTOCHROME P450CAM (CYP101A1)
1555, 2ij7B, 0.7127, 3.52, 0.144, 391, 375, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
1556, 5gnmA, 0.7126, 3.75, 0.176, 399, 376, CYTOCHROME P450 VDH (CYP107BR1) L348M MUTANT
1557, 2ij7F, 0.7126, 3.63, 0.141, 391, 377, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
1558, 2ij7C, 0.7121, 3.65, 0.138, 391, 378, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
1559, 2cd8A, 0.7121, 3.66, 0.188, 391, 377, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC (CYP107L1)
1560, 2ij7D, 0.7118, 3.63, 0.141, 391, 377, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
1561, 2ij5D, 0.7118, 3.62, 0.141, 391, 377, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
1562, 2uuqA, 0.7116, 3.71, 0.132, 394, 378, CRYSTAL STRUCTURE OF CYP130 FROM MYCOBACTERIUM TUBERCULOSIS IN THE LIGAND-FREE FORM
1563, 3nc3A, 0.7115, 3.37, 0.172, 380, 366, CYP134A1 STRUCTURE WITH A CLOSED SUBSTRATE BINDING LOOP
1564, 2z3tD, 0.7112, 3.44, 0.176, 379, 370, CRYSTAL STRUCTURE OF SUBSTRATE FREE CYTOCHROME P450 STAP (CYP245A1)
1565, 5lieB, 0.7105, 3.74, 0.133, 397, 376, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH IMIDAZOLE
1566, 5ofqB, 0.7104, 3.41, 0.149, 386, 368, CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109A2 FROM BACILLUS MEGATERIUM
1567, 5l94B, 0.7103, 2.97, 0.182, 360, 358, THE 2.25 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM IN COMPLEX WITH TESTOSTERONE
1568, 2x9pA, 0.7103, 3.40, 0.145, 385, 365, X-RAY STRUCTURE OF THE SUBSTRATE-FREE CYTOCHROME P450 PIMD - A POLYENE MACROLIDE ANTIBIOTIC PIMARICIN EPOXIDASE
1569, 5mnsF, 0.7102, 3.67, 0.162, 393, 376, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
1570, 2whfA, 0.7102, 3.77, 0.135, 394, 379, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
1571, 3nc6A, 0.7100, 3.18, 0.168, 374, 363, CYP134A1 1-PHENYLIMIDAZOLE BOUND STRUCTURE
1572, 3mgxB, 0.7096, 3.65, 0.150, 391, 374, CRYSTAL STRUCTURE OF P450 OXYD THAT IS INVOLVED IN THE BIOSYNTHESIS OF VANCOMYCIN-TYPE ANTIBIOTICS
1573, 4oqsA, 0.7095, 3.26, 0.152, 384, 361, CRYSTAL STRUCTURE OF CYP105AS1
1574, 2wgyA, 0.7089, 3.76, 0.135, 394, 378, CRYSTAL STRUCTURE OF THE G243A MUTANT OF CYP130 FROM M. TUBERCULOSIS
1575, 1wiyA, 0.7083, 2.75, 0.194, 358, 351, CRYSTAL STRUCTURE ANALYSIS OF A 6-COORDINATED CYTOCHOROME P450 FROM THERMUS THERMOPHILUS HB8
1576, 3mgxA, 0.7082, 3.62, 0.147, 387, 373, CRYSTAL STRUCTURE OF P450 OXYD THAT IS INVOLVED IN THE BIOSYNTHESIS OF VANCOMYCIN-TYPE ANTIBIOTICS
1577, 4rm4A, 0.7080, 3.20, 0.166, 364, 361, THE CRYSTAL STRUCTURE OF THE VERSATILE CYTOCHROME P450 ENZYME CYP109B1 FROM BACILLUS SUBTILIS
1578, 4fxbB, 0.7073, 3.45, 0.178, 370, 366, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR: A CYTOCHROME P450 OXIDASE IN THE COELIBACTIN SIDEROPHORE BIOSYNTHETIC PATHWAY
1579, 4l36B, 0.7068, 3.51, 0.121, 392, 372, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 ENZYME TXTE
1580, 3o1aA, 0.7064, 3.40, 0.143, 383, 363, STRUCTURE OF OXYE (CYP165D3) A CYTOCHROME P450 INVOLVED IN TEICOPLANIN BIOSYNTHESIS
1581, 5kyoF, 0.7063, 3.60, 0.151, 383, 370, CRYSTAL STRUCTURE OF CYP101J2
1582, 5hdiB, 0.7059, 3.55, 0.135, 393, 370, STRUCTURAL CHARACTERIZATION OF CYP144A1 A MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450
1583, 5kyoD, 0.7058, 3.44, 0.144, 384, 369, CRYSTAL STRUCTURE OF CYP101J2
1584, 3nc5B, 0.7056, 3.27, 0.171, 373, 362, CYP134A1 STRUCTURE WITH AN OPEN SUBSTRATE BINDING LOOP
1585, 2ij5E, 0.7056, 3.59, 0.142, 387, 372, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
1586, 2z3tB, 0.7053, 3.45, 0.174, 376, 367, CRYSTAL STRUCTURE OF SUBSTRATE FREE CYTOCHROME P450 STAP (CYP245A1)
1587, 2ij5F, 0.7047, 3.53, 0.143, 384, 371, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
1588, 5ysmA, 0.7041, 2.91, 0.155, 364, 354, CRYSTAL STRUCTURE ANALYSIS OF RIF16 
1589, 2wh8A, 0.7040, 3.69, 0.134, 392, 374, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
1590, 3oo3A, 0.7032, 3.37, 0.147, 371, 361, CRYSTAL STRUCTURE OF THE ORF6* (CYP165D3) MONOOXYGENASE INVOLVED IN TEICOPLANIN BIOSYNTHESIS
1591, 5hh3A, 0.7031, 3.79, 0.144, 381, 369, OXYA FROM ACTINOPLANES TEICHOMYCETICUS
1592, 2wh8C, 0.7029, 3.61, 0.140, 388, 372, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
1593, 2wh8B, 0.7024, 3.82, 0.136, 392, 375, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
1594, 2wh8D, 0.7022, 3.66, 0.137, 389, 373, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
1595, 5mnvG, 0.7020, 3.42, 0.176, 380, 364, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1596, 1se6A, 0.7012, 3.36, 0.182, 384, 363, CRYSTAL STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP158A2 FROM ANTIBIOTIC BIOSYNTHETIC PATHWAYS
1597, 5uhuA, 0.7010, 3.64, 0.162, 393, 371, SOLUTION CONFORMATION OF CYTOCHROME P450 MYCG WITH MYCINAMICIN IV BOUND
1598, 5lieA, 0.6970, 3.36, 0.138, 379, 362, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH IMIDAZOLE
1599, 5li6B, 0.6952, 3.27, 0.139, 376, 359, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH N-ISOPROPYL-N-((3-(4-METHOXYPHENYL)-124-OXADIAZOL-5-YL) METHYL)-2-(4-NITROPHENYL)ACETAMIDE
1600, 3b4xA, 0.6947, 3.10, 0.167, 367, 353, CRYSTAL STRUCTURE ANALYSIS OF SULFOLOBUS TOKODAII STRAIN7 CYTOCHROM P450
1601, 5li6A, 0.6946, 3.34, 0.139, 377, 360, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH N-ISOPROPYL-N-((3-(4-METHOXYPHENYL)-124-OXADIAZOL-5-YL) METHYL)-2-(4-NITROPHENYL)ACETAMIDE
1602, 2uvnA, 0.6914, 4.17, 0.132, 399, 378, CRYSTAL STRUCTURE OF ECONAZOLE-BOUND CYP130 FROM MYCOBACTERIUM TUBERCULOSIS
1603, 4e2pA, 0.6904, 3.55, 0.150, 370, 360, CRYSTAL STRUCTURE OF A POST-TAILORING HYDROXYLASE (HMTN) INVOLVED IN THE HIMASTATIN BIOSYNTHESIS
1604, 1ue8A, 0.6902, 3.21, 0.161, 367, 354, CRYSTAL STRUCTURE OF THERMOPHILIC CYTOCHROME P450 FROM SULFOLOBUS TOKODAII
1605, 1f4tB, 0.6886, 3.20, 0.150, 367, 353, THERMOPHILIC P450: CYP119 FROM SULFOLOBUS SOLFACTARICUS WITH 4- PHENYLIMIDAZOLE BOUND
1606, 5xw2A, 0.6868, 3.51, 0.142, 375, 358, CRYSTAL STRUCTURE OF THE HYDROXYLASE HMTN IN C 1 2 1 CRYSTAL FORM 
1607, 5li7B, 0.6864, 3.28, 0.138, 372, 355, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH 1-(3-(1H-IMIDAZOL-1-YL)PROPYL)-3-((3S5S7S)-ADAMANTAN-1-YL)UREA
1608, 5li7A, 0.6862, 3.35, 0.134, 373, 357, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH 1-(3-(1H-IMIDAZOL-1-YL)PROPYL)-3-((3S5S7S)-ADAMANTAN-1-YL)UREA
1609, 4wpdB, 0.6852, 3.24, 0.147, 367, 353, X-RAY CRYSTAL STRUCTURE OF CYP119 COMPLEXED WITH 4-(4-FLOUROPHENYL)- 1H-IMIDAZOLE
1610, 1f4tA, 0.6851, 3.29, 0.144, 367, 354, THERMOPHILIC P450: CYP119 FROM SULFOLOBUS SOLFACTARICUS WITH 4- PHENYLIMIDAZOLE BOUND
1611, 4wpdA, 0.6845, 3.30, 0.147, 367, 354, X-RAY CRYSTAL STRUCTURE OF CYP119 COMPLEXED WITH 4-(4-FLOUROPHENYL)- 1H-IMIDAZOLE
1612, 4wqjA, 0.6844, 3.24, 0.145, 367, 352, CRYSTAL STRUCTURE OF CYP119 FROM SULFOLOBUS ACIDOCALDARIUS COLLECTED AT 298K AND COMPLEXED WITH 4-(4-BROMOPHENYL)-1H IMIDAZOLE
1613, 1f4uB, 0.6841, 3.29, 0.145, 366, 352, THERMOPHILIC P450: CYP119 FROM SULFOLOBUS SOLFACTARICUS
1614, 1f4uA, 0.6840, 3.29, 0.145, 366, 352, THERMOPHILIC P450: CYP119 FROM SULFOLOBUS SOLFACTARICUS
1615, 4tuvA, 0.6839, 3.25, 0.145, 367, 352, X-RAY CRYSTAL STRUCTURE OF CYP119 FROM SULFOLOBUS ACIDOCALDARIUS COMPLEXED WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
1616, 4tt5A, 0.6835, 3.26, 0.145, 367, 352, CRYSTAL STRUCTURE OF CYP119 FROM SULFOLOBUS ACIDOCALDARIUS COMPLEXED WITH 4-(4-BROMOPHENYL)-1H IMIDAZOLE
1617, 4tvfA, 0.6829, 2.90, 0.186, 352, 344, OXYB FROM ACTINOPLANES TEICHOMYCETICUS
1618, 2uvnB, 0.6817, 4.12, 0.135, 391, 370, CRYSTAL STRUCTURE OF ECONAZOLE-BOUND CYP130 FROM MYCOBACTERIUM TUBERCULOSIS
1619, 1io9A, 0.6817, 3.35, 0.148, 366, 351, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1620, 1io7A, 0.6793, 3.36, 0.145, 366, 351, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1621, 1io8A, 0.6774, 3.32, 0.146, 366, 350, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1622, 1io8B, 0.6749, 3.17, 0.154, 359, 345, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1623, 1io7B, 0.6748, 3.17, 0.154, 359, 345, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1624, 4z5qA, 0.6734, 3.33, 0.138, 363, 347, CRYSTAL STRUCTURE OF THE LNMZ CYTOCHROME P450 HYDROXYLASE FROM THE LEINAMYCIN BIOSYNTHETIC PATHWAY OF STREPTOMYCES ATROOLIVACEUS S-140 AT 1.8 A RESOLUTION
1625, 1io9B, 0.6696, 3.09, 0.153, 354, 340, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1626, 2rfcD, 0.6661, 2.92, 0.137, 338, 335, LIGAND BOUND (4-PHENYLIMIDAZOLE) CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1627, 2rfbA, 0.6601, 3.23, 0.137, 338, 335, CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1628, 2rfcB, 0.6576, 3.09, 0.138, 338, 333, LIGAND BOUND (4-PHENYLIMIDAZOLE) CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1629, 2rfcC, 0.6570, 3.19, 0.137, 338, 335, LIGAND BOUND (4-PHENYLIMIDAZOLE) CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1630, 2rfbB, 0.6528, 3.10, 0.139, 335, 330, CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1631, 2rfcA, 0.6527, 3.20, 0.131, 338, 335, LIGAND BOUND (4-PHENYLIMIDAZOLE) CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1632, 2rfbC, 0.6511, 3.14, 0.139, 333, 330, CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1633, 5bv5A, 0.6160, 3.18, 0.124, 315, 314, STRUCTURE OF CYP119 WITH T213A AND C317H MUTATIONS
1634, 5bv5D, 0.6053, 3.50, 0.130, 327, 316, STRUCTURE OF CYP119 WITH T213A AND C317H MUTATIONS
1635, 5bv5C, 0.5899, 3.34, 0.135, 311, 304, STRUCTURE OF CYP119 WITH T213A AND C317H MUTATIONS
1636, 5bv5B, 0.5767, 2.77, 0.139, 288, 287, STRUCTURE OF CYP119 WITH T213A AND C317H MUTATIONS
1637, 2yjnB, 0.5552, 3.77, 0.162, 337, 296, STRUCTURE OF THE GLYCOSYLTRANSFERASE ERYCIII FROM THE ERYTHROMYCIN BIOSYNTHETIC PATHWAY IN COMPLEX WITH ITS ACTIVATING PARTNER ERYCII
1638, 5mnvI, 0.5413, 3.32, 0.177, 286, 282, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
